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Abstract 
The  Notch  signalling  pathway  regulates  many  developmental  processes  in 
metazoan embryos and adults such as cell proliferation, stem cell maintenance, cell fate 
specification and apoptosis. Despite the importance of this pathway, few targets have 
been identified, with the Hes (Hairy and Enhancer-of-split) protein family being the 
best-characterised group of downstream effectors. 
I  have  established  transgenic  mice  carrying  Biotin  Acceptor  Peptide  (BAP)-
tagged versions of Notch1. The tagged protein is fully functional and is biotinylated 
after  crossing  to  mice  expressing  the  biotinylase  from  E.  coli.  Biotinylation  was 
confirmed in a range of different tissues. However, streptavidin chromatin pull-down 
(bioChIP) experiments from these tissues showed no significant enrichment of known 
Notch1 target sequences. A possible explanation could be the indirect and transient 
nature of the interaction between Notch, its DNA binding partner CSL and the promoter 
of the target gene.  
A transgenic mouse line expressing a BAP-tagged version of the transcription 
factor  Hes7,  a  downstream  effector  of  Notch  signalling  and  key  regulator  of 
somitogenesis, was similarly generated. Although the tagged Hes7 protein is functional 
and  gets  biotinylated  in  cell  culture  assays,  the  transgenic  mice  exhibit  a  severe 
somite/skeletal phenotype indicating that the tagged allele is hypomorphic. A detailed 
analysis of the phenotype revealed differential axial requirements for Hes7.  
 
4 
Acknowledgements 
I thank Cancer Research UK for the generous sponsorship of my Ph.D. and the 
many people who have supported me in the past four years. 
I would first like to thank my wonderful husband, my parents and the rest of the 
family for their mentoring and encouragement: it would not have been possible without 
your support.  
I  am  most  grateful  to  my  supervisor  David Ish-Horowicz  for  his  support  and 
advice and allowing me the freedom to develop my scientific skills.  
I thank my second and third supervisors, Julian Lewis and Nic Tapon, for their 
encouragement and valuable comments during our committee meetings. 
I thank all past and present members of the Developmental Genetics Laboratory: 
Mark  Wainwright,  Sheena  Pinchin,  Michael  Stauber,  Chris  Molenaar,  Chetana 
Sachidanandan, Christian Dillon, Babis Rallis, Rhian Walther, Inbal Ringel, Emmanuel 
Vanrobays, Ravindra Prajapati, Barbara Jennings, Annalisa Vezzaro, Krzysztof Wicher, 
Rippei  Hayashi  and  Ned  Hoyle  for  providing  a  great  environment  to  work  in.  I 
especially thank Michael Stauber for his continuous support in the lab, his suggestions 
and most importantly for his friendship.  
I thank Holger Gerhardt for taking on the collaboration to identify Notch targets 
in the retina. Many thanks also to the members of the Vascular Biology lab, especially 
to Marta Busse, for introducing me to the mouse retina model system. 
I thank Michael Stauber, Barbara Jennings, Claudia Linker, Mark Wainwright and 
Ned Hoyle for their helpful comments on this thesis. 
I am grateful to Tim Zverev and Anthony Iglesias for taking care of my mice and 
setting up the crosses. I also thank Emma Murray, Clare Watkins and Scott Lighterness 
from the mouse facility at LIF and all other people from the Cancer Research UK core 
facilities for their support. 
Finally, I thank my friends Tamara Grüner and Julia Eckl-Dorna for contributing 
to a wonderful time in London. Table of contents
 
 
5 
Table of contents 
Abstract..............................................................................................................................................3 
Acknowledgements...........................................................................................................................4 
Table of contents...............................................................................................................................5 
Table of figures .................................................................................................................................9 
List of tables.................................................................................................................................... 11 
CHAPTER 1:  INTRODUCTION ................................................................................................ 13 
1.1  Cell-cell signalling – A concept for communication....................................................... 13 
1.2  The Notch signalling pathway........................................................................................... 15 
1.2.1  Key player and core principle of Notch induced signalling....................................... 15 
1.2.2  Regulated proteolysis triggers Notch pathway activation .......................................... 22 
1.2.3  Notch mediated transcriptional switch......................................................................... 23 
1.2.4  Modes of Notch signalling............................................................................................ 25 
1.2.5  Notch signalling targets ................................................................................................ 26 
1.3  Vertebrate somitogenesis ................................................................................................... 31 
1.3.1  Role of Notch signalling during vertebrate somitogenesis......................................... 34 
1.3.2  Wnt pathway oscillations within the segmentation clock........................................... 36 
1.3.3  Oscillatory expression of Fgf targets during somitogenesis....................................... 37 
1.4  Aim of this thesis.................................................................................................................. 38 
CHAPTER 2:  ESTABLISHING A NOVEL TECHNIQUE TO IDENTIFY IN VIVO 
TARGETS OF NOTCH SIGNALLING..................................................................................................... 40 
2.1  Introduction.......................................................................................................................... 40 
2.2  Results................................................................................................................................... 41 
2.2.1  Validation of BAP-tagged Hes7 and Notch1 intracellular domain (NICD) in cell 
culture…………......................................................................................................................... 42 
2.2.2  Validation of Hes7
BAP and NICD
BAP in vivo ............................................................... 49 
2.2.3  Establishing transgenic Hes7
BAP/BAP and Notch1
BAP/BAP mouse lines ......................... 51 
2.2.4  Establishing homozygous Hes7
BAP/BAP and Notch1
BAP/BAP mouse lines co-expressing 
BirA and phenotypic analysis.................................................................................................... 58 
2.3  Discussion ............................................................................................................................. 67 
CHAPTER 3:  TESTING VARIOUS APPLICATIONS OF THE NOTCH1
BAP/BIOTIN-
AVIDIN SYSTEM IN CULTURED CELLS AND TRANSGENIC MOUSE TISSUES.................... 69 
3.1  Introduction.......................................................................................................................... 69 
3.2  Results................................................................................................................................... 71 
3.2.1  Establishing a bioChIP protocol using the well-studied binding of the transcription 
factor GATA-1 to the Erythroid Kruppel-like Factor (EKLF) gene promoter ...................... 71 
3.2.2  Testing stable [NICD
BAP; BirA] cell lines for bioChIP .............................................. 75 Table of contents
 
 
6 
3.2.3  Optimisation of NICD bioChIP experiments in established cell lines ...................... 79 
3.2.4  Visualisation of NICD
BAP in cultured cells and transgenic mouse embryos............. 84 
3.2.5  Identifying Notch target genes from Notch1
BAP/BAP;Rosa26
BirA/BirA transgenic mice by 
bioChIP and high-throughput sequencing................................................................................. 87 
3.2.6  Interaction of NICD with CSL in mouse embryos...................................................... 91 
3.2.7  Identification of NICD protein binding partners in vivo via biotin-streptavidin 
binding………............................................................................................................................ 93 
3.3  Discussion ............................................................................................................................. 98 
3.3.1  Testing the BAP/biotin-avidin system......................................................................... 98 
3.3.2  Decoding the mouse retina “Notch targetome”.........................................................100 
CHAPTER 4:  CHARACTERISATION OF HES7
BAP/BAP MICE REVEAL 
DIFFERENTIAL AXIAL REQUIREMENTS FOR HES7 TRANSCRIPTION...............................102 
4.1  Introduction........................................................................................................................102 
4.2  Results.................................................................................................................................102 
4.2.1  BAP/BAP mutant skeletons show a regionalised axial phenotype...........................102 
4.2.2  Regionally disrupted somite organisation in BAP/BAP embryos ............................108 
4.2.3  Hes7 does not need to oscillate when the sacral area is formed...............................110 
4.2.4  Altered gene expression of somitogenesis key factors in Hes7
BAP/BAP mutants ......111 
4.3  Discussion ...........................................................................................................................117 
CHAPTER 5:  ANALYSIS OF HES7 TRANSCRIPTIONAL REGULATION.................120 
5.1  Introduction........................................................................................................................120 
5.2  Results.................................................................................................................................120 
5.2.1  Two separate blocks within 4.9 kb of the mouse Hes7 promoter are conserved in 
higher mammals........................................................................................................................121 
5.2.2  Identification of Hes7 binding sites in the Hes7 promoter.......................................123 
5.3  Discussion ...........................................................................................................................129 
CHAPTER 6:  CONCLUDING REMARKS ............................................................................132 
6.1  Direct Notch signalling targets........................................................................................133 
6.2  Indirect Notch signalling targets during vertebrate somitogenesis...........................135 
6.2.1  Differential transcription of Hes7...............................................................................136 
6.3  Final conclusion.................................................................................................................137 
CHAPTER 7:  MATERIALS AND METHODS......................................................................138 
7.1  Molecular Biology..............................................................................................................138 
7.1.1  Polymerase Chain Reaction (PCR)............................................................................138 
7.1.2  Ligation........................................................................................................................139 
7.1.3  Cloning of BAP-tagged constructs for expression in cell culture............................139 
7.1.4  Cloning of BAP-tagged constructs for homologous recombination in embryonic 
stem (ES) cells..........................................................................................................................141 Table of contents
 
 
7 
7.1.5  Cloning of BAP-tagged constructs for viral gene transfer .......................................143 
7.1.6  Cloning of Hes7 constructs for protein production...................................................144 
7.1.7  Transformation of competent bacteria and plasmid isolation ..................................145 
7.1.8  Sequencing...................................................................................................................146 
7.2  Zebrafish.............................................................................................................................147 
7.2.1  Zebrafish care..............................................................................................................147 
7.2.2  Injection of mRNA into fish embryos........................................................................147 
7.2.3  Whole-mount in situ hybridisation of fish embryos .................................................147 
7.3  Transgenic mice.................................................................................................................148 
7.3.1  Electroporation of embryonic stem cells (ESC)........................................................148 
7.3.2  DNA extraction from mouse ear biopsies..................................................................149 
7.3.3  Genotyping of transgenic mice...................................................................................149 
7.3.4  PCR Screening of embryonic stem cell clones (ESCCs)..........................................150 
7.3.5  Southern blot screening...............................................................................................152 
7.3.6  Establishing transgenic mouse lines...........................................................................154 
7.3.7  Skeleton preparation....................................................................................................154 
7.3.8  Whole-mount in situ hybridization ............................................................................155 
7.3.9  Whole-mount Notch intracellular domain (NICD) antibody staining .....................156 
7.3.10  Quantitative reverse transcriptase PCR (qRT-PCR) from embryonic mouse tail 
tissue………….........................................................................................................................157 
7.4  Cell culture .........................................................................................................................157 
7.4.1  Handling of cell lines..................................................................................................157 
7.4.2  Transfection.................................................................................................................158 
7.4.3  Viral gene transfer.......................................................................................................158 
7.4.4  Luciferase reporter assay ............................................................................................160 
7.4.5  Activation of ER-fusion proteins in cultured cells....................................................160 
7.4.6  Immunofluorescence and confocal microscopy........................................................160 
7.5  Biochemistry.......................................................................................................................162 
7.5.1  Glutathione-S-Transferase (GST) protein purification.............................................162 
7.5.2  Protein gel electrophoresis..........................................................................................163 
7.5.3  Western blotting ..........................................................................................................163 
7.5.4  Preparation of whole cell lysates................................................................................164 
7.5.5  Crude nuclear extract preparation ..............................................................................164 
7.5.6  Protein concentration determination..........................................................................165 
7.5.7  Binding to streptavidin beads.....................................................................................165 
7.5.8  Streptavidin protein pull-down from mouse embryos..............................................165 
7.5.9  Mass spectrometry.......................................................................................................166 
7.6  Protein-DNA interaction studies.....................................................................................169 
7.6.1  bioChIP experiments...................................................................................................169 
7.6.2  Electrophoretic Mobility Shift Assay (EMSA).........................................................175 
7.6.3  DNaseI footprinting assay ..........................................................................................178 Table of contents
 
 
8 
7.6.4  Hes7 promoter comparison.........................................................................................179 
CHAPTER 8:  REFERENCES....................................................................................................180 
Books..............................................................................................................................................201 
 
 
 Table of figures
 
 
9 
Table of figures 
Figure 1.1 The core principle of the Notch signalling pathway................................... 18 
Figure 1.2 Formation of the Notch transactivation complex....................................... 25 
Figure 1.3 Domain structure of bHLH proteins Hes and HERP.................................. 29 
Figure 1.4 Segmentation of the vertebrate embryo..................................................... 32 
Figure 1.5 A model for somitogenesis: The clock and wavefront model..................... 33 
Figure 2.1 Cloning strategy to generate BAP-tagged Hes7 and NICD cDNAs............ 44 
Figure 2.2 Luciferase reporter assay in C3H10T½ cells to validate Hes7
BAP (A) and 
NICD
BAP (B) fusion proteins...................................................................................... 47 
Figure 2.3 Hes7
BAP and NICD
BAP proteins are biotinylated upon co-expression of BirA 
in HeLa cells.............................................................................................................. 49 
Figure 2.4 Islet1 in situ hybridisation of 15 hpf zebrafish embryos injected with either 
control, NICD or NICD
BAP mRNA.............................................................................. 51 
Figure 2.5 Targeting strategy for homologous recombination in embryonic stem cells to 
generate transgenic Hes7
BAP and Notch1
BAP mice.. ...................................................... 53 
Figure 2.6 PCR screening strategy and results from Hes7
BAP (A) and Notch1
BAP (B) 
homologous recombination events.............................................................................. 55 
Figure 2.7 Southern blot screening strategy of Hes7
BAP/+ (A) and Notch1
BAP/+ (B) 
recombined loci.......................................................................................................... 57 
Figure 2.8 Notch1
BAP/BAP mice are homozygous viable, show no obvious phenotype and 
Notch1
BAP can be biotinylated by BirA in vivo ........................................................... 62 
Figure 2.9 Phenotypes of Hes7
BAP/+ (BAP/+) and Hes7
BAP/BAP (BAP/BAP) adults....... 65 
Figure 2.10 Western blot analysis of presomitic mesoderm tissue (PSM) from 
Rosa26
BirA (BirA) and Hes7
BAP/BAP;Rosa26
BirA (Hes7
BAP;BirA) E9.5 embryos to detect 
biotinylated Hes7
BAP................................................................................................... 66 
Figure 3.1 Enrichment of EKLF basic promoter and enhancer sites after bioChIP from 
MEL [GATA-1
BAP; BirA] cells................................................................................... 74 
Figure 3.2 Evaluation of C3H10T½ and MCF10A stable cell lines expressing [BirA], 
[NICD
BAP; BirA] and [ER-NICD
BAP; BirA]................................................................ 78 
Figure 3.3 NICD bioChIP results from MCF10A [NICD
BAP; BirA] and C3H10T½ 
[NICD
BAP; BirA] cell lines......................................................................................... 81 
Figure 3.4 More stringent washing conditions do not improve bioChIP experiments 
from MCF10A [NICD
BAP; BirA] cells........................................................................ 83 Table of figures
 
 
10 
Figure 3.5 Application of the BAP/biotin-avidin system for intracellular localisation of 
the biotinylated NICD
BAP protein................................................................................ 86 
Figure 3.6 Strategy to identify novel in vivo targets of Notch signalling in the postnatal 
retina of Notch1
BAP;BirA mice.................................................................................... 90 
Figure 3.7 Streptavidin protein pull-down from Notch1
BAP;BirA E10.5 crosslinked 
embryos does not purify CSL, a direct protein partner of NICD.................................. 92 
Figure 3.8 Application of the BAP/biotin-avidin system to identify novel protein 
binding partners of NICD in Notch1
BAP;BirA embryos................................................ 96 
Figure 4.1 Analysis of BAP/+, BAP/BAP and Hes7
-/- (-/-) E18.5 foetuses.................104 
Figure 4.2 Genetic analysis of the Hes7
BAP allele in BAP/+ and BAP/- E18.5 foetuses
..................................................................................................................................107 
Figure 4.3 Uncx4.1 in situ hybridisation detects irregular somite compartmentalisation 
in BAP/BAP E11.5 and E9.5 embryos........................................................................109 
Figure 4.4 Recessive overexpression of Hes7 mRNA in BAP/BAP E10.5 embryos...111 
Figure 4.5 Deregulation of Notch and Fgf signalling targets in BAP/BAP E10.5 
embryos.....................................................................................................................113 
Figure 4.6 Notch signalling, but not Wnt signalling is affected in BAP/BAP embryos
..................................................................................................................................114 
Figure 4.7 Somite segmentation and maturation defects in BAP/BAP embryos..........116 
Figure 4.8 Model for differential axial requirements of oscillating Hes7...................119 
Figure 5.1 Sequence conservation of Hes7 promoter regions ....................................122 
Figure 5.2 Predicted Hes7 repressor binding sites in the Hes7 promoter....................124 
Figure 5.3 Identification of Hes7 binding sites in the Hes7 promoter by EMSA........127 
Figure 5.4 DNaseI footprinting analysis reveals two Hes7 binding sites on the Hes7 
promoter fragment F1................................................................................................128 
 
 
 List of tables
 
 
11 
List of tables 
Table 2.1 Statistics of PCR screening process............................................................ 54 
Table 2.2 Results from the injection of the homologous recombinant ES cell clones 
(ESC) Hes7
BAP 4E7 and 3C7 as well as Notch1
BAP 6A12 and 3E3 into blastocyst 
embryos and chimera production................................................................................ 59 
Table 2.3 Adult viability of the transgenic lines as determined through inter-crosses of 
heterozygous BAP/+ animals...................................................................................... 61 
Table 2.4 Adult viability of the transgenic lines as determined through inter-crosses of 
double heterozygous BAP/+;BirA/+ animals.............................................................. 61 
Table 2.5 Comparison of Hes7
BAP/+ (BAP/+) and Hes7
BAP/BAP (BAP/BAP) adult 
skeletons. ................................................................................................................... 64 
Table 3.1 Proteins identified in Notch1
BAP/BAP;Rosa26
BirA/BirA embryonic nuclei......... 97 
Table 4.1 Comparison of Hes7
BAP/+ (BAP/+), Hes7
BAP/BAP (BAP/BAP), Hes7
-/- (-/-) and 
Hes7
BAP/- (BAP/-) E18.5 foetal skeletons....................................................................105 
Table 7.1 Standard PCR thermal cycling conditions..................................................138 
Table 7.2 PCR primer sequences to generate Hes7
N-BAP, Hes7
C-BAP and NICD
BAP vectors 
for expression in cell culture......................................................................................140 
Table 7.3 PCR primer sequences to construct Hes7
BAP and Notch1
BAP targeting vectors
..................................................................................................................................142 
Table 7.4 PCR primer sequences for cloning of BAP-tagged constructs for viral gene 
transfer......................................................................................................................144 
Table 7.5 PCR primer sequences to amplify Hes7
ORF, Hes7
N-terminus and Hes7
bHLH 
constructs for Hes7 antibody production....................................................................145 
Table 7.6 Sequencing primers to verify TOPO cloning reactions...............................146 
Table 7.7 Thermal cycler conditions for sequencing reactions...................................146 
Table 7.8 Primer sequences for genotyping of Hes7
BAP/BAP, Notch1
BAP/BAP and 
Rosa26
BirA/BirA mice. ..................................................................................................150 
Table 7.9 PCR programme for screening of electroporated ESCCs. ..........................151 
Table 7.10 PCR screening primers to identify homologous recombinant ESCC. .......151 
Table 7.11 Primer sequences for the generation of Southern blot probes...................153 
Table 7.12 Restriction digests and RNA polymerases used for transcription of 
riboprobes. ................................................................................................................156 List of tables
 
 
12 
Table 7.13 Primer sequences for quantification of Hes7 mRNA levels in wildtype, 
Hes7
BAP/+ and Hes7
BAP/BAP embryos by qRT-PCR......................................................157 
Table 7.14 Cell lines used in this thesis.....................................................................158 
Table 7.15 Antibodies used for Immunohistochemistry.............................................161 
Table 7.16 Antibodies used for western blotting........................................................164 
Table 7.17 Gradient for NanoLC-MS/MS.................................................................168 
Table 7.18 Primer sequences for amplification of EKLF (see Figure 3.1 for diagram of 
the EKLF promoter) and necdin promoter fragments. ................................................170 
Table 7.19 Mouse (m) and human (h) qPCR primer sequences for validation of NICD 
bioChIP experiments from mouse C3H10T½ [NICD
BAP; BirA] and human MCF10A 
[NICD
BAP; BirA] cell lines. .......................................................................................171 
Table 7.20 Samples from Notch bioChIP experiment for sequencing........................173 
Table 7.21 PCR primer sequences for amplification of Hes7 promoter fragments for 
EMSA.......................................................................................................................176 
Table 7.22 Primer sequences to generate mutations in N-boxes of Hes7 promoter 
fragments F1 and F10................................................................................................177 
Table 7.23 Oligonucleotide sequences of Hes7 promoter fragment F1 for EMSA. ....177 
 
 CHAPTER 1: Introduction
 
 
13 
CHAPTER 1:  Introduction 
1.1  Cell-cell signalling – A concept for communication 
Development of a multicellular organism starts with a single cell, the fertilised 
egg. Subsequent cell proliferation and specification generate multiple cell types, and 
eventually functional tissues and organs (Alberts et al., 2007). One key question of 
developmental  biology  concerns  the  mechanism  by  which  cellular  diversity  arises. 
Although each cell contains the same set of genes, the cellular function varies when 
different subsets of genes are expressed. This differentiation is achieved by regulated 
procedures involving complex communication networks between cells. Cells within the 
mitotically dividing embryo need to establish contacts with each other in order to ensure 
proper differentiation, morphogenesis and growth.  
Cell-cell communication is an essential feature of all metazoan animals and is 
critical for the co-ordination of development, maintenance of tissue homeostasis and to 
fend off invaders that enter the system (Alberts et al., 2007). One form of cell-cell 
communication is mediated by signalling molecules. The signal-sending cell expresses a 
secreted or transmembrane ligand that binds its receptor on the surface of the signal-
receiving cell. The signal is transmitted into the nucleus to mediate further responses.  
Remarkably,  there  are  relatively  few  signalling  pathways  directing  cell  fate 
decisions during the development of a multicellular organism: Wingless related (Wnt), 
Hedgehog  (Hh),  Transforming  growth  factor-β  (TGF-β),  receptor  tyrosine  kinase 
(RTK),  Janus  kinase  (JAK)/signal  transducer  and  activator  of  transcription  (STAT), 
nuclear hormone pathways and the Notch signalling cascade (reviewed in Pires-daSilva 
and Sommer, 2003). These pathways are used many times during development in many 
different combinations and contexts, and provide highly flexible mechanisms by which 
distinct responses in different tissues and species are generated.  
The various components of such signalling pathways can act through different 
modes  and  combinations  thereof  in  order  to  generate  a  variety  of  outcomes.  Five 
mechanisms to fine-tune cell signalling have been described. Firstly, in different tissues 
the  same  receptor  can  function  through  various  intracellular  transducers,  e.g.,  in 
Caenorhabditis  elegans  lethal-23  (LET-23)  RTK  signalling  is  transduced  through 
RAS/mitogen-activated  protein  kinase  (MAPK) in  the  vulva  (Aroian  and  Sternberg, CHAPTER 1: Introduction
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1991)  whereas  it  is  transduced  through  inositol-1,4,5-triphosphate  in  the  germline 
(Clandinin et al., 1998).  
Second,  the  strength  of  receptor-ligand  interaction  can  also  contribute  to 
determine  tissue  specificity.  Within  the  Wnt  signalling  cascade,  the  affinity  of  the 
receptor for its ligand can lead to the activation of different intracellular pathways. For 
example,  the  Drosophila  Frizzled2  (Fz2)  receptor  has  a  tenfold  higher  affinity  for 
Wingless (Wg) than its structurally related Frizzled (Fz) receptor. Interaction of Fz2 
with Wg results in activation of the transcription factor Tcf, whereas interaction of Fz 
with Wg results in cytoskeletal remodelling (Rulifson et al., 2000).  
A third mode of tuning communication responses is the integration of several 
signalling pathways at the level of target genes. The enhancer of the Drosophila even-
skipped (eve) gene depends on activation by Wnt, TGF-β and RTK signalling (Halfon et 
al., 2000). Thereby, mutation of any of these sites within the enhancer abolishes eve 
expression. 
Fourth, when exposed to the same signals, cells can respond differently due to the 
expression of tissue-specific target genes. For example, specification of the vulva in C. 
elegans  is  achieved  through  RTK-RAS-MAPK  signalling  and  activation  of  the 
transcription factor lineage-defective-31 (LIN-31) in vulval precursor cells but not in 
other tissues (Tan et al., 1998).  
Lastly,  compartmentalisation  of  the  signal  through  the  formation  of  specific 
protein  complexes  can  confer  signalling  specificity.  For  example,  the  Glycogen 
synthase  kinase-3  (GSK-3)  mediates  Wnt  signalling  when  complexed  with  the 
cytoplasmic protein complex adenomatous polyposis coli (APC)-axin. However, in an 
unbound state, GSK-3 responds to RTK signalling and regulates glycogen metabolism 
(Cohen and Frame, 2001). 
Once  the  information from  the  signal-sending  cell  has  been  transduced  to  the 
nucleus a response is triggered, often by the activation of transcription factors. This 
transcriptional  switch  can  be  controlled  in  three  different  ways:  in  ‘type  I’ 
transcriptional switching, the transcription factor responding to the signal functions as 
both repressor in the absence of the signal and activator of transcription upon ligand-
induced signalling. Thus signalling can lead to a repressor becoming an activator. This 
is  the  case  for  Tcf/Lef  during  Wnt  signalling,  Gli/Ci  (Cubitus  interruptus)  in  Hh 
signalling and Suppressor of Hairless (Su(H)) in Notch signalling. In contrast, TGF-β CHAPTER 1: Introduction
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and  RTK  signalling  pathways  can  achieve  a  transcriptional  switch  through  separate 
repressor and activator proteins. In this type of transcriptional regulation repressors and 
activators can recognise the same (type II transcriptional switching) or distinct DNA 
binding  sites  (type  III  transcriptional  switching)  (reviewed  in  Pires-daSilva  and 
Sommer, 2003). 
In  conclusion,  cell-cell  signalling  pathways  act  in  a  non-linear  and  highly 
integrative  way  to  confer  reproducibility  and  flexibility  during  the  development  of 
metazoan organisms. Further robustness of the system is achieved through the assembly 
of positive and negative feedback loops promoting or limiting signalling, respectively 
(Freeman, 2000). The coordinated use and fine-regulation of different communication 
pathways, enable the development of a complex organism. This thesis focuses on one of 
these cell-cell communication pathways, the Notch signalling pathway, which is in the 
focus of subsequent chapters.  
1.2  The Notch signalling pathway  
The Notch signalling pathway is involved in regulating many cellular processes 
throughout development and renewal of adult tissue in metazoans. It functions in cell 
proliferation,  maintenance  of  stem  cells  and  their  niche,  cell  fate  specification  and 
differentiation, and even in regulating cell survival, making it an extremely versatile 
pathway (reviewed in Artavanis-Tsakonas et al., 1999; Bray, 2006; Lai, 2004). 
1.2.1  Key player and core principle of Notch induced signalling 
Almost 90 years ago, the Notch gene in the fruit fly Drosophila melanogaster was 
discovered through the observation that heterozygosity results in notches at the wing 
margin (Mohr, 1919). It took 70 more years until the appearance of Notch protein as a 
receptor (Johansen et al., 1989) and its function in cell-cell signalling was revealed 
(Fehon et al., 1990). The early work was done using Drosophila as a model organism, 
but  soon  it  became  apparent  that  Notch  also  has  important  roles  in  vertebrate 
development and that domains within the receptor are highly conserved throughout the 
animal kingdom (Coffman et al., 1990; Del Amo et al., 1992; Ellisen et al., 1991; Kidd 
et al., 1986; Stifani et al., 1992; Weinmaster et al., 1991; Wharton et al., 1985).  
Mutations  in  this  evolutionary  highly  conserved  cascade  have  fascinated 
researchers around the world ever since. One of the first phenotypes described, resulting CHAPTER 1: Introduction
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from  loss-of-function  mutations  of  Notch  pathway  components,  is  the  neurogenic 
phenotype,  where  cells  switch  their  fate  from  epidermal  to  neuronal  (Artavanis-
Tsakonas  et  al.,  1999;  Poulson,  1937).  Furthermore,  loss-of-function  mutations  of 
pathway  components  can  lead  to  inherited  genetic  diseases  such  as  spondylocostal 
dysostosis  (SCD),  Alagille  syndrome  and  cerebral  autosomal  dominant  arteriopathy 
with subcortical infarcts and leukoencephalopathy (CADASIL) (Gridley, 2003). On the 
other  hand,  activating  mutations  of  Notch  signalling  cause  T  cell  acute  lymphatic 
leukaemia  (T-ALL)  (Demarest  et  al.,  2008;  Jundt  et  al.,  2008;  Weng  et  al.,  2004). 
During  tumorigenesis  Notch  not  only  acts  as  an  oncogene  as  seen  within  the 
haematopoietic  compartment  but  also  functions  as  tumour  suppressor  in  the  skin 
(reviewed in Radtke and Raj, 2003).  
In mammals there are four Notch receptors (Notch1-4). Other organisms can have 
fewer,  like  C.  elegans  with  two  (LIN-12  and  GLP-1)  and  one  in  D.  melanogaster 
(Notch)  (Artavanis-Tsakonas  et  al.,  1995).  The Notch  receptor  is  a  trans-membrane 
protein  with  an  extracellular  domain  encompassing  29-36  epidermal  growth  factor 
(EGF)-like and three cysteine-rich Notch/Lin-12 repeats (LNR). It is present on the cell 
surface as heterodimer following a furin cleavage in the Golgi apparatus at position S1 
(Logeat et al., 1998) (Figure 1.1A). Pathway activation is mediated by ligand binding 
through EGF repeats 11 and 12 (Rebay et al., 1991). The Notch intracellular domain 
(NICD)  consists  of  a  RBP-jκ-associated  molecule  (RAM)  domain,  seven  tandem 
ankyrin repeats (Zweifel and Barrick, 2001a; Zweifel and Barrick, 2001b), a glutamine-
rich domain (opa), and a C-terminal PEST (rich in proline, glutamate, serine, threonine) 
sequence as well as nuclear localisation signals (Wharton et al., 1985) (Figure 1.1A).  
There are two classes of Notch ligands, Delta-like (Dll) and Jagged (Delta and 
Serrate in Drosophila) depending on the absence or presence of a cysteine rich domain 
(Kiyota and Kinoshita, 2002). All Notch ligands are characterised by a N-terminal DSL 
(Delta, Serrate and LAG-2) domain that is essential for interactions with the Notch 
receptor. The extracellular domain consists, like in the Notch receptor, of EGF repeats 
(Figure 1.1A). In mammals there are five different Notch ligands, Delta-like 1, 3 and 4, 
and Jagged 1 and 2 (D'Souza et al., 2008). 
All  of  the  Notch  receptors  and  ligands  are  required  during  embryonic 
development and the loss of one, cannot be compensated for by the other members. 
Generation of transgenic mice lacking either Notch1, Notch2, Delta-like 1 or Jagged1 CHAPTER 1: Introduction
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results in an embryonic lethal phenotype (Gale et al., 2004; Hrabe de Angelis et al., 
1997; Shimizu et al., 1999; Swiatek et al., 1994; Xue et al., 1999) suggesting that each 
member exerts specific effects during metazoan development.  
Binding of the receptor to its ligand on the neighbouring cell initiates the Notch 
signalling cascade. Subsequently, two proteolytic cleavages release the intracellular part 
of  the  Notch  receptor  (NICD),  which  translocates  into  the  nucleus  and  activates 
transcription  of  targets  through  CSL  (named  after  CBF1,  Su(H)  and  LAG-1,  the 
mammalian, D. melanogaster and C. elegans orthologues) (Figure 1.1). Although some 
organisms encode several different receptors and ligands there is usually only a single 
CSL nuclear effector. This protein is highly conserved between different species, for 
example  up  to  84%  identity  between  D.  melanogaster  and  humans  (Kovall,  2007; 
Kovall  and  Hendrickson,  2004).  CSL  is  not  only  involved  in  Notch  target  gene 
activation but also in repression of Notch targets in the absence of NICD (Pursglove and 
Mackay, 2005) mediating a ‘type I’ transcriptional switch of Notch pathway regulation. 
In summary, the Notch pathway follows a linear principle: binding of the receptor 
to the ligand on the adjacent cell leads to a downstream response with various outputs 
ranging from developmental contexts to tumorigenesis (Figure 1.1B). In the following 
paragraphs, I will describe the different modes of regulating the Notch message at the 
level  of  receptor  and  ligand maturation  to  the  assembly  of  an  active  transcriptional 
switch. 
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Figure 1.1 The core principle of the Notch signalling pathway. (A) Schematic structure of the Notch 
receptor (top) and its ligands Delta-like and Jagged. The extracellular domain of the receptor consists of 
29-36 EGF repeats and 2 LNRs. EGF repeats 11 and 12 are essential for ligand binding (pink rectangles). 
The NICD consists of a N-terminal RAM domain, 7 ankyrin repeats and a PEST sequence. Red arrows 
indicate cleavage positions for receptor maturation. Furin-like convertase cleaves receptor at S1 in the 
Golgi apparatus. Ligands are transmembrane proteins containing a DSL motif and various EGF repeats. 
Ligands of the Jagged family additionally include a cysteine-rich domain (CR; yellow rectangles). (B) 
Interaction of the Delta ligand (purple) on the signal-sending cell with the Notch receptor (green) on the 
signal-receiving cell initiates two proteolytic cleavages of the receptor. The metalloprotease ADAM10 or 
TACE (yellow) catalyses the cleavage at S2. The remaining substrate is cleaved at S3 by the γ-secretase 
complex  (brown)  and  results  in  the  release  of  NICD.  NICD  translocates  into  the  nucleus,  where  it 
interacts with the DNA-binding factor CSL (blue). This triggers the release of the co-repressor complex 
(Co-R;  red  and  grey)  and  recruitment  of  the  co-activator  Mastermind  (MAM;  lime  green)  and  other 
transcription factors.  
 CHAPTER 1: Introduction
 
 
19 
The core of Notch signalling is the same in all Notch dependent processes but the 
fine-tuning  of  the  pathway  and  ultimate  effects  on  the  cell  differ. Post-translational 
modifications of ligands and receptors, as well as their trafficking and abundance on a 
cell have great impact on the duration of signalling and commitment to target genes, and 
thus regulate the outcome of pathway activation (reviewed in Bray, 2006). Here, I will 
give  an  outline  of  different  modes  of  post-translational  regulation,  ranging  from 
glycosylation,  ubiquitylation  and  localisation,  to  modulate  both  Notch  ligands  and 
receptors. 
1.2.1.1  Maturation of the Notch receptor 
The first post-translational modification of the Notch receptor is the addition of 
O-fucose to serine or threonine residues to the EGF repeats of the extracellular domain 
(Panin  et  al.,  2002).  The  process  of  O-fucosylation  is  catalysed  by  Protein  O-
fucosyltransferase, which is encoded by Pofut1 in mammals and Ofut1 in Drosophila. 
(Okajima and Irvine, 2002). 
The corresponding Drosophila glycosyltransferase has been shown to be located 
in  the  endoplasmatic  reticulum (Luo  and  Haltiwanger,  2005;  Okajima  et  al.,  2005). 
More strikingly, Ofut1 appears to work as a Notch chaperone that associates with folded 
EGF domains of Notch1 to keep it in shape for export (Okajima et al., 2005). Okajima 
et al. showed recently that the fucosyltransferase activity of Ofut1 is not essential for 
Notch signalling in Drosophila. They have generated a mutant version of the protein 
that lacks the fucosyltransferase activity but still possesses the chaperone function and 
concluded  that  this  mutant  of  Ofut1  is  sufficient  to  enable  Notch  signalling  during 
embryonic  neurogenesis  as  well  as  during  wing  disc  development  in  Drosophila 
(Okajima et al., 2008).  
Loss of function of Ofut1/Pofut1 in Drosophila as well as in mammals leads to 
severe  Notch  pathway  defects  and  embryonic  lethality  (Okajima  and  Irvine,  2002; 
Sasamura et al., 2003; Shi and Stanley, 2003). Moreover, a requirement for different 
Pofut1 levels during mammalian development was demonstrated using a hypomorphic 
Pofut1 mutant. Schuster-Gossler et al. showed that early mouse development is highly 
sensitive to reduced levels of Pofut1 resulting in defective somite patterning and thus 
axial skeleton development, whereas other processes such as neurogenesis and left-right 
patterning were not affected (Schuster-Gossler et al., 2009). CHAPTER 1: Introduction
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Once the receptor has been fucosylated on its EGF repeats it serves as a substrate 
for  a  glycosyltransferase,  Fringe  (Fng),  which  catalyses  the  transfer  of  N-
acetylglucosamine  (GlcNAc)  onto  O-fucose  (Bruckner  et  al.,  2000;  Moloney  et  al., 
2000).  Fng  is  a  secreted  protein  that  resides  in  the  Golgi  apparatus  and  was  first 
identified in Drosophila because of its role in modulating Notch signalling during wing 
development (Irvine and Wieschaus, 1994). Genetic studies in Drosophila led to the 
observation that Fng functions cell-autonomously to potentiate Delta-dependent Notch 
activation  and  to  inhibit  Serrate/Jagged-dependent  Notch  activation  (Fleming  et  al., 
1997; Klein and Arias, 1998; Panin et al., 1997). These opposing effects of Fng on 
ligand mediated Notch signalling lead to Notch activation in boundary cells along the 
dorsal-ventral  compartment  border  of  the  wing  (Irvine  and  Wieschaus,  1994).  In 
contrast to the fly wing, the vertebrate homologue Lunatic Fringe (Lfng) negatively 
regulates Delta-dependent Notch signalling in the presomitic mesoderm of vertebrate 
embryos (Dale et al., 2003). 
In mammals there are three Fringe paralogues, Lunatic Fringe, Manic Fringe and 
Radical Fringe (Johnston et al., 1997), whereas there is no Fringe in C. elegans. The 
most  notable  Fringe  gene  is  Lfng,  which  plays an  important  role  in  the  process  of 
vertebrate  somitogenesis  (section  1.3).  The  loss  of  function  of  Lfng  shows  severe 
defects in somitogenesis in mammals (Dunwoodie, 2009; Sparrow et al., 2006) affects 
female meiosis (Hahn et al., 2005) and male fertility (Hahn et al., 2009) as well as T-
cell development in mice (Visan et al., 2006). 
Taken together, the extracellular domain of the Notch receptor can be modified 
with  different  sugar  residues,  such  as  O-fucose,  O-glucose  and  complex  N-glycans, 
which  are  proposed  to  modulate  the  level  of  Notch  signalling  (Stanley,  2007).  In 
particular the conserved O-fucose site at EGF repeat 12 within the Notch receptor has 
been shown to contribute to decreased Notch-ligand interaction when mutated in flies 
(Lei  et  al.,  2003)  and  mice  (Ge  et  al.,  2008).  Thus,  disruption  of  glycosylation  or 
inactivation of enzymes performing the modification reactions leads to Notch signalling 
defects in Drosophila (Haines and Irvine, 2003), zebrafish (Appel et al., 2003) and 
mammals (Lu and Stanley, 2006). Glycosylation therefore provides an important level 
by which Notch signalling can be modified and allows fine-tuning of the message. CHAPTER 1: Introduction
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1.2.1.2  Notch  receptor  trafficking  and  endosomal  sorting  –  degradation  and 
recycling 
In order to allow directed activation of the signalling pathway, steady-state levels 
of  the  Notch  receptor  need  to  be  controlled  through  mechanisms  that  involve 
degradation and recycling (Nichols et al., 2007). Several E3 ubiquitin ligases have been 
shown to be associated with Notch and to label the receptor for endocytic pathways 
(Lai,  2002b).  The  modification  of  Notch  by  the  Itch/Nedd4/Suppressor  of  deltex 
(Su(dx)) family of HECT (homologous to E6-associated protein C-terminus) E3 ligases 
target the receptor for degradation (Qiu et al., 2000). The target and interaction motif for 
the ligase to attach the ubiquitin to the receptor is not the PEST domain but the ankyrin 
repeats in the N-terminal part (Qiu et al., 2000).  
Another class of E3 ubiquitin ligases shown to interact with the ankyrin repeats 
within NICD is the RING (really interesting new gene) finger domain protein Deltex 
(Matsuno  et  al.,  2002).  Deltex  can  promote  Notch  signalling  in  a  CSL-independent 
manner in the Drosophila wing through enhanced endocytosis of the receptor (Hori et 
al., 2004). These data show that Notch signalling from the same receptor can occur 
through activation in different membrane-bound compartments. The regulation of the 
amount  of  Notch  receptor  by  ubiquitination  and  endocytosis  provides  a  powerful 
mechanism to modulate pathway activity. 
1.2.1.3  Modulation of DSL ligand activity 
Differential  and  dynamic  expression  of  Notch  ligands,  as  well  as  post-
transcriptional  modifications  during  development  contribute  to  determine  the 
assignment  of  the  signal-sending  cell.  DSL  ligands  like  Notch  receptors  (section 
1.2.1.1) can be modified by O- and N-linked glycans (Panin et al., 2002) although it is 
not clear yet whether these glycosylations have an impact on ligand activity. However, 
ubiquitination of DSL ligands regulates cell-surface expression and plays an important 
role in ligand signalling activity (reviewed in D'Souza et al., 2008). Multiple lysine 
residues in the intracellular domain of Drosophila Delta and Serrate ligands, as well as 
Dll1, Dll4, Jagged1 and Jagged2 have been shown to be target sites for E3 ligases. The 
RING-containing E3 ubiquitin ligases Neuralized (Neur) and Mind bomb (Mib) directly 
interact with the Notch ligands and further promote ligand activation through enhanced 
endocytosis (Chitnis, 2006; Le Borgne and Schweisguth, 2003). CHAPTER 1: Introduction
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Neur and Mib have been shown to ubiquitinate both Delta and Serrate and despite 
their structural differences show redundant functions (Le Borgne et al., 2005; Pitsouli 
and Delidakis, 2005). Genetic studies in mice indicate that loss of Neur1 and Neur2 as 
well  as  Mib2  gene  expression  is  dispensable  for  normal  development.  However, 
additional  removal  of  Mib1  leads  to  a  Notch-like  phenotype  including  embryonic 
lethality (Koo et al., 2005). While Neur1 and Neur2 are not required for neurogenesis in 
mice, Mib1 knock-out mice show a severe neurogenic phenotype in the neural tube and 
the brain (Koo et al., 2005; Koo et al., 2007).  
In  contrast  to  the  mouse  phenotype,  zebrafish  mutants  lacking  Mind  bomb1 
(mib1) are severely compromised with somite, neural crest and vascular defects (Jiang 
et al., 2000; Koo et al., 2005; Lawson et al., 2001). These studies show that Mib1 is 
absolutely required during zebrafish development for ubiquitination of multiple ligands 
(Itoh et al., 2003). 
Endocytosis of the ligand was shown to be accompanied by endocytosis of the 
Notch extracellular domain (trans-endocytosis) in Drosophila imaginal tissues, which 
leads to the dissociation of the receptor and probably induces cleavage at S2 (Parks et 
al., 2000). Altogether, ligand modulation by Neur and Mib regulates internalisation and 
trafficking events of the ligand and thus fine-regulates Notch signalling.  
1.2.2  Regulated proteolysis triggers Notch pathway activation 
The Notch receptor is synthesised as a ~300 kDa precursor that undergoes three 
distinct proteolytic cleavages resulting in the active transcriptional activator. The first 
cleavage occurs in the trans-Golgi network and results in a heterodimeric molecule of 
120 kDa and 180 kDa joined through non-covalent interactions which is the main form 
detected  on  the  cell  surface  (Blaumueller  et  al.,  1997;  Logeat  et  al.,  1998).  This 
constitutive processing is carried out by a furin-like convertase (S1 cleavage; Figure 
1.1A) and occurs C-terminal to the RQRR sequence (amino acids 1651-1654) (Logeat 
et al., 1998).  
There is evidence that the full-length Notch receptor is also present on the cell 
surface and can mediate ligand-induced signalling in a CSL-independent manner (Bush 
et al., 2001). In Drosophila the predominant form of Notch is the full-length version, 
which might not undergo S1 cleavage (Kidd and Lieber, 2002). Mutations in furin1 do 
not lead to Notch signalling defects, however there is a second furin-like paralogue, CHAPTER 1: Introduction
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which  might  act  redundantly.  Although  mammalian  and  Drosophila  Notch  proteins 
show great homology, the proteolytic processing as well as their appearance on the cell 
surface greatly differs (Kidd and Lieber, 2002).  
Once the Notch receptor has reached the cell surface it stays in an inactive state 
until interaction with its ligand is initiated. Endocytosis of the ligand generates a pulling 
force, which frees the proteolytic cleavage site at S2 within the heterodimer domain of 
Notch (Gordon et al., 2007). Once the S2 site is accessible, a proteolytic cascade is 
initiated  leading  to  Notch  pathway  activation  (S2  cleavage;  Figure  1.1A).  The  a 
disintegrin  and  metalloprotease  ADAM10  (also  known  as  Kuzbanian;  Kuz)  and  the 
tumour-necrosis factor-α (TNF-α)- converting enzyme (TACE or ADAM17) have been 
implicated in the S2 cleavage (Brou et al., 2000; Jarriault and Greenwald, 2005; Mumm 
et al., 2000). It has been demonstrated that Kuz and TACE have individual functions to 
modulate Notch activation at the receptor level during development. Moreover, Kuz and 
TACE have the ability to promote ligand-independent Notch activation (Delwig and 
Rand, 2008). 
The  S2  cleavage  generates  a  membrane-tethered  carboxy-terminal  fragment, 
which is recognised as a substrate for the transmembrane γ-secretase protease complex, 
which cleaves the receptor at the transmembrane site (reviewed in Fortini, 2002). The γ-
secretase complex consists of presenilin, nicastrin and other putative components. Upon 
removal of presenilin (Donoviel et al., 1999; Guo et al., 1999; Shen et al., 1997; Struhl 
and Greenwald, 1999; Wong et al., 1997) and nicastrin (Hu et al., 2002; Kopan and 
Goate,  2002;  Lopez-Schier  and  St  Johnston,  2002)  flies,  mice  and  worms  develop 
Notch-like phenotypes. The cleavage at the conserved valine residue (Val1744) releases 
Notch intracellular domain and initiates the  signalling cascade (S3 cleavage; Figure 
1.1A) (Schroeter et al., 1998). 
1.2.3  Notch mediated transcriptional switch 
Once freed from the plasma membrane, NICD travels into the nucleus and forms 
a ternary complex with the DNA binding factor CSL and the transcriptional coactivator 
Mastermind (Sel-8/Lag-3 in C. elegans) (Petcherski and Kimble, 2000a; Petcherski and 
Kimble, 2000b; Wu et al., 2000). Complex formation initiates the displacement of CSL-
associated co-repressors, such as CtBP, SMRT, SHARP, CoREST, Sin3A, CIR, histone 
deacetylases  and  MeCP2  (Lai,  2002a;  Stancheva  et  al.,  2003)  (Figure  1.2).  The CHAPTER 1: Introduction
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formation of the ternary complex is a prerequisite for the recruitment of the additional 
transcription factors CBP/p300 and PCAF, which through direct interaction with NICD 
and Mastermind lead to acetylation of the chromatin (Fryer et al., 2002; Kurooka and 
Honjo, 2000; Wallberg et al., 2002).  
So far, six crystal structures of the CSL-mediated transcriptional complex have 
been determined in C. elegans, human and mouse (Friedmann et al., 2008; Kovall and 
Hendrickson, 2004; Nam et al., 2006; Wilson and Kovall, 2006). CSL proteins consist 
of three conserved domains: N-terminal domain (NTD), β-trefoil domain (BTD) and C-
terminal domain (CTD) whereby NTD and BTD recognise specific DNA sequences and 
establish contacts in the major and minor groove (Kovall and Hendrickson, 2004). In 
vitro  oligonucleotide  enrichment  experiments  have  identified  the  sequence  5’-
C/TGTGGGAA-3’ as the target DNA sequence motif (Chung et al., 1994; Tun et al., 
1994) which agrees with known in vivo binding sites albeit not all are located close to 
promoters (Nellesen et al., 1999).  
For the interaction of NICD with CSL and Mastermind, the RAM as well as the 
ankyrin  domains  are  required  (Nam  et  al.,  2003).  Around  20  residues  of  the  RAM 
domain interact with the BTD of CSL whereas the ankyrin repeats mediate complex 
stabilisation by binding to the N-terminal domain of Mastermind (Kovall, 2008). The C-
terminal domain of Mastermind has been shown to be important for interaction with 
CBP/p300 and further transcriptional activation (Fryer et al., 2002). Deletions of the C-
terminal part results in a dominant-negative phenotype in vivo, which allows the ternary 
complex to form but abolishes transcriptional activation (Wu et al., 2000).  
Once the ternary complex has assembled it is already targeted for degradation. 
Nuclear transcription factors need to have a short half-life in order to respond to rapidly 
changing  activity  levels.  Mastermind  can  initiate  complex  destruction  by  recruiting 
cyclin-dependent  kinase-8  (CDK8),  which  directly  phosphorylates  NICD  within  its 
transactivation  domain  and  C-terminal  PEST  domain,  thereby  targeting  it  for 
degradation  through  the  ubiquitin  ligase  Fbw7/Sel10  (Fryer  et  al.,  2004).  NICD 
harbouring C-terminal deletions results in a gain-of-function allele and thus can lead to 
oncogenic transformation in vivo (Weng et al., 2004).  
Once NICD is degraded, the complex dissociates and recruitment of corepressors 
is initiated by CSL. The CSL-corepressor-complex is further associated with the DNA CHAPTER 1: Introduction
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but in contrast to the activation complex only confers a low stability DNA-interaction 
with a fast exchange rate (Krejci and Bray, 2007) (Figure 1.2). 
 
 
Figure 1.2 Formation of the Notch transactivation complex. (A)  Repressor complex consisting of 
DNA-bound CSL (blue; B, BTD; N, NTD; C, CTD) and associated co-repressors (red and grey). (B) 
Formation  of  the  Notch  transactivation  complex  through  binding  of  NICD  (green)  to  CSL  and 
recruitment of Mastermind (lime green) and co-activators (yellow and orange) leads to acetylation (Ac) of 
the chromatin and transcription of target genes. 
 
1.2.4  Modes of Notch signalling 
Several different modes of Notch signalling have been described during metazoan 
development  and  within  self-renewing  tissues.  The  most  prominent  role  for  Notch 
signalling is lateral inhibition. This mechanism is based on studies from Drosophila 
neurogenesis and C. elegans vulva development (Artavanis-Tsakonas et al., 1999). At 
the beginning, progenitors are similar and express equivalent amounts of Notch ligands. 
Through lateral inhibition, Notch signalling amplifies small differences within the cell 
population leading to two neighbouring cells being different.  
Contrary to lateral inhibition, Notch is also able to exert lateral induction in the 
Drosophila wing margin (Bray, 1998; de Celis and Bray, 1997) and in some vertebrate 
cells. Thereby, Notch activation in one cell has a cooperative effect on its neighbouring 
cells leading to sharply defined gene expression boundaries (Lewis, 1998) 
Notch  can  also  function  as  a  gate-keeper: for  example,  in  the  intestine  where 
Notch keeps crypt progenitor cells in an undifferentiated state (Stanger et al., 2005). On 
the other hand, Notch is capable of inducing differentiation, as in the skin (Wilson and 
Radtke, 2006). Another mechanism includes binary cell fate decisions such as in the 
lymphoid system where Notch can specify the T cell lineage at the expense of the B cell CHAPTER 1: Introduction
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lineage, which arise from one single precursor (Radtke et al., 2004). Its function as an 
oncogene or tumour suppressor has further increased the interest in research of Notch 
signalling (Radtke and Raj, 2003). 
1.2.5  Notch signalling targets  
The  assembly  of  the  Notch  transactivation  complex  mediates  a  transcriptional 
switch and leads to the activation of target genes. Although Notch plays an important 
role in numerous processes throughout metazoan development only relatively few direct 
target genes have been identified.  
1.2.5.1  Basic helix-loop-helix (bHLH) family of Notch targets 
The best characterised family of Notch targets is the Hes family in mammals, and 
the genes of the Enhancer of Split (E(spl)) complex in Drosophila (referred to as Hes 
proteins) (reviewed in Artavanis-Tsakonas et al., 1999; Iso et al., 2003). Hes proteins 
are classified as bHLH-type transcriptional repressors and act by negatively regulating 
downstream  target  genes  (Ishibashi  et  al.,  1995;  Ohtsuka  et  al.,  1999).  In  the 
mammalian genome, seven members of the Hes family (Hes1-7) were characterised, 
however, mice do not have a Hes4 gene. In Drosophila, the E(spl) complex comprises 
11 genes which are activated in response to Notch signalling (Bailey and Posakony, 
1995;  Cooper  et  al.,  2000;  Lai  et  al.,  2000;  Lecourtois  and  Schweisguth,  1995) 
including  seven  members  of  the  Hes  family  of  bHLH  transcriptional  regulators 
(Jennings et al., 1994). 
Hes  factors  contain  three  conserved  domains,  which  confer  transcriptional 
activity:  bHLH,  orange  and  WRPW  tetrapeptide  (tryptophan,  argenine,  proline, 
tryptophan) (Figure 1.3). The basic region mediates DNA binding whereas the HLH 
structure is responsible for dimerisation. In contrast to other bHLH factors, Hes proteins 
contain  a  distinctive  proline  residue  in  the  centre  of  the  basic  region  (Figure  1.3). 
Heterodimer  partners  are  recruited  and  stabilised  via  binding  to  the  orange  domain 
(Dawson et al., 1995; Taelman et al., 2004). The C-terminal WRPW tetrapeptide is not 
only  important  for  interaction  with  corepressors  and  thus  transcriptional  repression 
(Fisher  et  al.,  1996)  but  also  acts  as  poly-ubiquitination  signal  (Kang  et  al.,  2005). 
Altogether,  these  domains  are  indispensable  for  the  function  of  Hes  proteins  in 
transcriptional repression. CHAPTER 1: Introduction
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Two modes of repression have been described for Hes proteins: active and passive 
repression acting on conserved sequences in target promoters (Kageyama et al., 2007b). 
While most bHLH factors bind to the class A and B E-box consensus sequences (5’-
CANNTG-3’), Hes proteins recognise class C sites (5’-CACG(C/A)G-3’) or the N-box 
element in their target promoters (5’-CACNAG-3’) (Akazawa et al., 1992; Ohsako et 
al., 1994; Sasai et al., 1992). However, most of these studies were done in vitro and it is 
not clear yet whether these sites are recognised in vivo. Drosophila E(spl) proteins were 
shown to bind to class B E-box sequences but the surrounding base pairs were more 
critical than the core E-box sequence (5-‘CACGTG-3’) (Jennings et al., 1999).  
So far, nobody has systematically characterised the target sites of the vertebrate 
Hes proteins. During active repression, Hes proteins form homo- or heterodimers with 
Hey1  and  bind  to  the  N-box  or  class  C  site.  This  mechanism  is  dependent  on  the 
interaction  of  the  WRPW  domain  with  corepressors  of  the  Transducine-like  E(spl) 
(TLE) family, which are evolutionary conserved homologues of Drosophila Groucho. 
However, the modes by which Groucho mediates target gene repression are not fully 
understood yet. Groucho is able to bind to chromatin directly which subsequently is 
converted in a closed conformation thereby repressing transcription (Sekiya and Zaret, 
2007). Groucho has also been shown to interact with histone deacetylases, which in turn 
inactivate the chromatin (reviewed in Jennings and Ish-Horowicz, 2008). 
During  passive  repression,  Hes  proteins  form  heterodimers  with  other  bHLH 
proteins. These complexes do not bind the DNA but rather (exhibit a dominant-negative 
effect on the E-box within the target promoter) neutralise those bHLH proteins and 
prevent their binding to E-boxes (reviewed in Kageyama et al., 2007b). This leads to 
sequestration  of  bHLH  factors,  which  would  normally  form  functional  activating 
heterodimers binding to the E-box. bHLH proteins, other than Hes proteins, can also act 
as activators when bound in heterodimers and enhance expression of targets via the E-
box (Johnson et al., 1992). Drosophila E(spl) proteins have additionally been shown to 
repress  proneural  target  genes  in  a  DNA-binding-independent  mechanism  through 
protein-protein  interactions  with  proneural  activators  (Giagtzoglou  et  al.,  2003).  In 
conclusion,  bHLH  proteins  can  act  as  activators  or  repressors  thereby  leading  to  a 
concerted regulation of cell proliferation and differentiation in many organs (reviewed 
in Kageyama et al., 2007b). 
In mammals, Hes genes are expressed in the central nervous system where they 
are implicated in maintaining the neural stem cell fate as well as in regulating boundary CHAPTER 1: Introduction
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formation.  They  are  also  involved  in  binary  cell  fate  decisions  mediating  astrocyte 
versus neuronal cell fate specification (Kageyama et al., 2008). Stem cell maintenance 
and binary cell fate decision in the digestive organs is also regulated to some extend by 
Hes genes (reviewed in Kageyama et al., 2007b). Another function of Hes proteins 
involves the oscillator mechanism of Hes1 and Hes7 in the presomitic mesoderm (PSM) 
of  the  mouse  embryo  (section  1.3).  Hes1,  Hes5  and  Hes7  are  regulated  by  Notch 
signalling (Bessho et al., 2001a; Ohtsuka et al., 1999) whereas Hes2, Hes4 and Hes6 
seem to act in a Notch-independent manner (Koyano-Nakagawa et al., 2000; Nishimura 
et al., 1998).  
Another class of bHLH proteins has been classified as Notch target genes, the 
Hey/Hesr/HRT/CHF/gridlock/HERP  family  (hereafter  referred  to  as  HERP).  HERP 
proteins are closely related to the Hes proteins but instead of the proline in the basic 
region, they carry a glycine residue (Figure 1.3). Moreover, HERP family members 
have a YRPW (tyrosine, arginine, proline, tryptophan) or related tetrapeptide signal 
instead of WRPW (Iso et al., 2001b). HERP proteins also have an additional conserved 
region  TE(V/I)GAF  (threonine,  glutamic  acid,  valine/isoleucine,  glycine,  alanine, 
phenylalanine) C-terminal of the tetrapeptide that is absent in Hes proteins (Iso et al., 
2003).  
Notch  activity  is  able  to  activate  expression  of  HERP1  and  Hes1  in  a  CSL-
dependent manner in cultured cells, whereas HERP2 shows a tissue-specific regulation 
through NICD when expressed in smooth muscle cells derived from the thoracic aorta 
(Iso  et  al.,  2002;  Iso  et  al.,  2001a).  Hes  and  HERP  proteins  can  both  repress 
transcription through formation of homodimers or heterodimers with each other. The 
mode of repression, however, differs between the two classes of bHLH factors: HERP 
proteins  do  not  recruit  TLE/Groucho  but  instead  engage  with  the  mSin3  complex, 
another major corepressor complex (Iso et al., 2001b).  
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Figure  1.3  Domain  structure  of  bHLH  proteins  Hes  and  HERP.  Hes  and  HERP  proteins  are 
characterised by 4 distinct domains: basic domain (green, with class-defining residues P or G indicated); 
HLH domain (blue); orange domain (orange) and tetrapeptide motif at C-terminus (red). 
 
1.2.5.2  Targets of Notch signalling after oncogenic transformation 
All  members  of  Notch  have  been  implicated  in  cancer  either  acting  as  an 
oncogene or tumour suppressor (reviewed in Radtke and Raj, 2003). Initially, Notch1 
was identified in human T cell acute lymphoblastic leukaemia (T-ALL), with activating 
mutations within the extracellular heterodimerization domain and/or the PEST region 
(Ellisen  et  al.,  1991;  Weng  et  al.,  2004).  Gene  expression  profiling  and  ChIP-chip 
(Chromatin immunoprecipitation combined with microarrays) analysis from T-ALL cell 
lines identified c-Myc as a transcriptional target of Notch1 (Palomero et al., 2006; Weng 
et al., 2006).  
Similarly, the constitutive expression of NICD using a mouse mammary tumour 
virus leads to the development of lactation-dependent mammary tumours (Klinakis et 
al., 2006). ChIP analysis and electrophoretic mobility shift assay also revealed c-Myc as 
a Notch target gene during mammary tumourigenesis in mice and humans (Efstratiadis 
et al., 2007).  
1.2.5.3  Targets of Notch signalling in other systems 
Notch  does  not  only  cause  T  cell  leukaemia  when  deregulated,  but  is  also 
involved  in  normal  T  cell  development  (Hasserjian  et  al.,  1996).  Using  cDNA 
Representational Difference Analysis (RDA) in murine thyoma cell lines Deftos et al. 
identified Deltex, Meltrin β (ADAM family metalloprotease), Pre-Tα (a component of 
the Pre-TCR complex involved in thymocyte development), Hes1, and members of the CHAPTER 1: Introduction
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Ifi-200 gene family (involved in transcriptional regulation and cell cycle control) as 
Notch1 target genes in T cells (Deftos and Bevan, 2000). 
Moreover, the cell cycle regulator of G1 to S-phase transition and proto-oncogene 
cyclinD1 was shown to be a Notch transcriptional target in rat kidney epithelial (RKE) 
cells (Ronchini and Capobianco, 2001). Other genes have been reported as being Notch 
targets,  including  Notch1  itself  (Kimble  and  Simpson,  1997),  CDKN1A  (gene  for 
cyclin-dependent kinase inhibitor 1A (p21, Cip1)) in primary keratinocytes (Rangarajan 
et al., 2001) and the bHLH protein E47 in the B-lymphocyte lineage albeit in a CSL-
independent  manner  (Ordentlich  et  al.,  1998).  The  Nrarp  (Notch  regulated  ankyrin 
repeat  protein)  gene  was  first  identified  as  Notch  target  gene  in  Xenopus  embryos 
(Lamar et al., 2001) and recently as Notch effector within the developing mouse retina 
(Phng et al., 2009).  
Many of the experiments that were carried out to identify Notch targets, do not 
distinguish between a direct and an indirect response to Notch signalling. This can lead 
to the identification of genes that are not direct targets but are activated as a secondary 
effect.  
A  genome-wide  study  to  identify  Notch  signalling  targets  in  the  Drosophila 
DmD8 muscle progenitor cell line using temporally controlled pathway activation and 
subsequent ChIP array analysis revealed several novel target genes (Krejci et al., 2009). 
In vivo validation confirmed an involvement of these targets in the maintenance of adult 
muscle  progenitors  and  cell  morphogenesis.  There  is  also  a  considerable  overlap 
between targets from the muscle specific cell line with targets from blood-related Kc 
cells.  Notably,  direct  target  genes  were  in  most  cases  part  of  signal  transduction 
pathways, such as the RTK (EGFR), Notch, TGF-β and Wnt pathways. This implies 
that the Notch signalling pathway has the ability to modulate other signalling pathways. 
Moreover, identified targets were from both categories, positive and negative regulators, 
suggesting a differential activation mechanism through Notch, depending on the context 
(Krejci et al., 2009).  
The most difficult part in addressing novel Notch signalling targets to my mind is 
the establishment of a controllable system, which allows temporally regulated pathway 
activation in order to identify direct target genes. Krejci et al. have been successful in 
creating a tissue culture system that upon addition of ethylenediaminetetraacetic acid 
(EDTA) leads to cleavage of the Notch receptor and subsequent pathway activation CHAPTER 1: Introduction
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(Krejci and Bray, 2007). In their study, targets of Notch were identified 30 minutes after 
pathway activation using ChIP directed against CSL combined with a genome-wide 
array approach (Krejci et al., 2009). Previous studies have relied on long-term effects of 
blocking or increasing pathway activity in cultured cells. The challenge so far has been 
the realisation of a similar system in an animal model. 
1.3  Vertebrate somitogenesis 
One well-studied role of the Notch pathway in metazoan development is during 
the establishment of the repeated pattern of the vertebrate body axis. Epithelial blocks 
of  mesoderm,  called  somites,  are  generated  sequentially  during  embryogenesis  and 
serve as precursors for vertebrae, ribs and attached skeletal muscles (Tam, 1986). They 
form one after another from the anterior part of the unsegmented presomitic mesoderm 
(PSM), which is located at the posterior tail end in vertebrate embryos (Figure 1.4). The 
periodicity by which somites are laid down is characteristic for each species, ranging 
from 30 min in the zebrafish, 90 min in the chicken and 120 min in the mouse, to 4-5 h 
in human embryonic development (reviewed in Dequeant and Pourquie, 2008). Pairs of 
somites are generated in a head-to-tail fashion and the number is regulated within each 
species, from 30 pairs in zebrafish, to several hundred in snakes (Gomez et al., 2008).  
Strikingly, the period of the formation of one pair of somites matches the period 
of dynamic or oscillatory gene expression in the PSM. It has thus been proposed that the 
process  of  somitogenesis  underlies  the  function  of  a  “segmentation  clock”,  which 
generates an oscillatory signal and leads to somite formation. This oscillator mechanism 
is joined by opposing fibroblast growth factor (Fgf)/Wnt and Retinoic acid gradients, 
which  position  the  determination  front.  When  cells  reach  this  front,  which  is 
characterised by a signalling threshold, they become defined to the future segment. An 
initial model of the segmentation process was proposed by Cooke and Zeeman and was 
termed the “clock and wavefront model” (Cooke and Zeeman, 1976) (Figure 1.5).  
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Figure 1.4 Segmentation of the vertebrate embryo (adapted from Dequeant and Pourquie, 2008). 
Dorsal view of an early human embryo demonstrating vertebrate segmentation: I) paraxial mesoderm 
production  from  the  progenitor  pool  within  the  tail  bud  (bent  arrows  show  movement  of  paraxial 
mesoderm  cells  into  the  presomitic  mesoderm  (PSM)),  II)  segmental  determination,  III)  rostrocaudal 
patterning of presumptive somites and IV) somite formation. Anterior-most somites will be part of the 
occipital bone whereas subsequent somites give rise to the vertebrae. Numbering of prospective somites 
in the PSM in negative roman numerals according to (Pourquie and Tam, 2001). Newly-formed somites 
are  labelled  with  increasing  roman  numerals  according  to  Ordahl  (1993).  Straight  arrow  indicates 
direction of axial elongation. CHAPTER 1: Introduction
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The first oscillatory gene was identified in chicken, c-hairy1, a homologue of 
Drosophila hairy (Palmeirim et al., 1997). More recently, a genome-wide approach has 
uncovered approximately 30 genes with oscillatory transcription at a periodicity similar 
to somitogenesis in the PSM of mouse embryos (Dequeant et al., 2006). These genes 
were known targets of the Notch and Fgf signalling pathways on the one hand and the 
Wnt pathway on the other hand. All genes belonging to the Notch and Fgf pathways 
were found to oscillate in phase, but out of phase with genes of the Wnt pathway. 
However, the nature of the actual pacemaker, which drives oscillation of these genes 
and thus somite formation, still remains elusive. In the following paragraphs, I will 
discuss  possible  roles  of  the  three  cycling  pathways,  Notch,  Wnt  and  Fgf  in  the 
segmentation clock. 
 
 
Figure 1.5 A model for somitogenesis: The clock and wavefront model. Sections of the posterior part 
of the vertebrate embryo are shown, including the presomitic mesoderm (PSM) as well as presumptive 
(S0) and already formed somites (SI and SII). The yet unidentified nature of the segmentation clock 
drives a wave of cyclic gene expression (blue) in the PSM whereas opposing retinoic acid (RA; green) 
and Wnt (purple)/Fgf gradients set the determination front. One cycle of the segmentation clock (T=1) 
leads to the formation of a new pair of somites and thereby promotes axis extension (arrow).  CHAPTER 1: Introduction
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1.3.1  Role of Notch signalling during vertebrate somitogenesis 
The  anterior-posterior  segmented  body  pattern  is  a  hallmark  not  only  of 
vertebrates  but  also  of  arthropods  and  annelids  (Damen,  2007).  A  common  genetic 
network  defining  the  origin  of  segmentation  is  still  debated.  Segmentation  in 
Drosophila has been demonstrated to depend on a hierarchical cascade of transcription 
factors and does not involve Notch signalling (Ingham, 1988; Nusslein-Volhard and 
Wieschaus,  1980;  Pankratz  et  al.,  1990;  St  Johnston  and  Nusslein-Volhard,  1992). 
However, Notch/Delta signalling has been shown to be required for segmentation in the 
spider Cupiennius salei, which suggests an evolutionary conservation of the pathway in 
the generation of the reiterated body pattern (Stollewerk et al., 2003). 
Oscillating gene expression within the PSM of the vertebrate embryo is driven by 
the segmentation clock, which sets the pace for the periodic formation of somites. In 
order  to  generate  oscillations,  downstream  signalling  targets  need  to  feedback 
negatively  on  the  system  including  a  delay  resulting  from  transcriptional  and 
translational timings (Lewis, 2003). Targets of the Notch pathway have been shown to 
fulfil these criteria (Giudicelli et al., 2007; Henry et al., 2002; Holley et al., 2002; Oates 
and Ho, 2002; Ozbudak and Lewis, 2008).  
The bHLH transcriptional repressor and direct Notch target gene Hes7 can inhibit 
its own transcription and has therefore been suggested to be a good candidate to act at 
the core of the mouse segmentation clock (Bessho et al., 2001a). Hes7 knock-out mice 
show a severe skeletal phenotype with no regular vertebrae or ribs, which almost always 
results in post-natal lethality (Bessho et al., 2001b). Moreover target gene oscillations, 
such as of Lfng or Dusp4, are arrested in Hes7 mutants and expressed throughout the 
PSM  (Bessho  et  al.,  2001b;  Niwa  et  al.,  2007).  Since  Hes7  also  represses  its  own 
expression, Hes7 dynamics are abolished as well (Bessho et al., 2003; Bessho et al., 
2001b).  
Stabilisation of Hes7 protein also disrupts Notch oscillations and suggests that a 
short  half-life  of  Hes7  is  crucial  for  the  segmentation  clock  (Hirata  et  al.,  2004). 
However,  upon  blockage  of  Notch  signalling  through  knock-out  of  CSL,  Hes7 
oscillations are still observed in the posterior PSM (Niwa et al., 2007). This, along with 
the observation that Wnt oscillations are still present in the absence of Hes7 (Hirata et 
al.,  2004)  implies,  that  the  Hes7  regulatory  feedback  loop  might  not  act  as  the 
pacemaker.  Furthermore,  regulation  of  Hes7  transcription  is  not  only  dependent  on CHAPTER 1: Introduction
 
 
35 
Notch signalling but also on Fgf signalling, which initiates Hes7 oscillations in the 
posterior PSM. Notch is responsible for the propagation of Hes7 transcription in the 
anterior PSM (Niwa et al., 2007). 
A  second  potential  mechanism  for  a  segmentation  clock  driven  by  Notch 
signalling involves a Lfng negative feedback loop regulating periodic Notch activation 
(Dale et al., 2003). Lfng is a target of Notch in both mouse and chicken and upon 
deletion  in  mouse  or  overexpression  in  chick  embryos,  the  regulatory  function 
impinging  on  Notch  signalling  is  lost  (Dale  et  al.,  2003;  Morimoto  et  al.,  2005). 
Mutations in Lfng have always been associated with defects in vertebrate segmentation 
and Lfng knock-out mice are born with severe axial deformations (Evrard et al., 1998; 
Zhang and Gridley, 1998).  
Lfng is characterised by a striking expression pattern, with oscillatory expression 
in the posterior PSM and anterior non-oscillatory stripe transcription, which have been 
related to distinct enhancer elements in the Lfng promoter (Cole et al., 2002; Morales et 
al., 2002). Recently, Shifley et al. have generated transgenic mice lacking the promoter 
block, which is responsible for oscillatory expression of Lfng, and thereby driving Lfng 
transcription  only  in  the  stripe  domain  (Shifley  et  al.,  2008).  These  mice  show  a 
regionalised skeletal phenotype with severely disorganised anterior cervical, thoracic 
and lumbar vertebrae and ribs, whereas sacral and tail vertebrae are only minimally 
affected. This suggests a differential role of Notch signalling in the formation of the 
anterior and posterior body halves (Shifley et al., 2008).  
Results from our lab’s studies driving chicken Lfng (cLfng) stripe expression in a 
Lfng null background recapitulate the data from Shifley et al. to some extent and shows 
dose-dependent rescue of the tail vertebrae and somites (Stauber et al., submitted). The 
sacral  and  to  some  degree  adjacent  lumbar  areas  also  form  regular  vertebrae  and 
somites. This is consistent with Lfng knock-out mice which are able to form regular 
patterned sacral vertebrae suggesting that Lfng and thus modulated Notch signalling is 
not required for the formation of the sacrum (Stauber et al., submitted). In conclusion, 
both investigations propose a differential regulation of the segmentation clock during 
the establishment of the vertebrate length axis.  
One argument against the Lfng feedback loop as master oscillator in the vertebrate 
segmentation clock is the observation that the  Notch target gene Hes7  continues to 
oscillate upon loss of Lfng (Niwa et al., 2007) or when Lfng is overexpressed in the CHAPTER 1: Introduction
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mouse (Serth et al., 2003). Our studies show that these oscillations are perturbed and 
superimposed on uniform Hes7 expression, suggesting that Lfng null embryos do not 
experience dynamic Hes7 expression (Stauber et al., submitted).  
Constitutive activation of Notch signalling in the mouse PSM does not abolish 
somite  border  formation,  although  Notch  target  genes,  such  as  Hes7  and  Lfng,  are 
expressed  constitutively  (Feller  et  al.,  2008).  These  transgenic  mice  still  show 
oscillating  expression  of  the  Wnt  target  Axin2  (Feller  et  al.,  2008)  placing  Wnt 
signalling upstream of Notch signalling. Altogether, these studies argue against Notch 
signalling being the primary pacemaker of the segmentation clock.  
A new model for the role of Notch within the segmentation clock comes from 
studies in zebrafish, where all known cyclic components are part of the Notch pathway 
(Holley, 2007). In this system, Notch is responsible for synchronising cell-autonomous 
oscillations  of  neighbouring  PSM  cells  rather  than  setting  the  pace  for  dynamic 
transcription (Jiang et al., 2000). The observed delayed disruption of somite boundaries 
in zebrafish Notch mutants, as well as after blockage of the pathway (by the γ-secretase 
inhibitor DAPT), may be due to a loss of cell-to-cell coupling (reviewed in Ozbudak 
and  Pourquie,  2008).  It  has  also  been  shown  that  boundary  formation  and  thus 
segmentation can recover after removal of the γ-secretase inhibitor DAPT (Ozbudak 
and  Lewis,  2008;  Riedel-Kruse  et  al.,  2007).  Thus,  at  least  in  the  zebrafish,  Notch 
signalling acts as a coupling device for synchronisation of oscillations within PSM cells 
rather than as a pacemaker. 
1.3.2  Wnt pathway oscillations within the segmentation clock 
In  mouse  embryos,  in  contrast  to  zebrafish,  several  components  of  the  Wnt 
signalling pathway exhibit oscillatory expression, such as the targets Axin2, dickkopf 
homolog  1  (Dkk1),  c-Myc  and  dapper  homolog  1  (Dact1)  (Dequeant  et  al.,  2006). 
Evidence for a role of Wnt signalling during segmentation comes from the hypomorphic 
Wnt3a  mutant  vestigial  tail  (vt),  which  exhibits  loss  of  Notch  and  Wnt  oscillations 
(Aulehla et al., 2003). This observation places the Wnt pathway upstream of the Notch 
signalling pathway in the generation of the repeated somites (Nakaya et al., 2005; Satoh 
et al., 2006).  
Activation  of  the  Wnt  pathway  leads  to  stabilisation  and  accumulation  of  β-
catenin, which in turn translocates to the nucleus and activates target genes (Barker, CHAPTER 1: Introduction
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2008).  A  dynamically  activated  β-catenin  loop  was  suggested  to  exert  pacemaker 
functions in mouse embryos (Aulehla et al., 2003). As predicted, conditional loss-off 
function of β-catenin in the PSM leads to a loss of Notch and Wnt oscillations (Dunty et 
al., 2008). However, in a constitutively expressed β-catenin background, Notch and 
Wnt target oscillations are still observed, arguing against a pacemaker function of Wnt 
within the segmentation clock (Aulehla et al., 2008; Dunty et al., 2008). These results 
suggest that Wnt signalling, like Notch signalling, is not at the core of the segmentation 
clock. 
1.3.3  Oscillatory expression of Fgf targets during somitogenesis 
The same microarray study that identified oscillating Notch and Wnt genes also 
uncovered a novel class of dynamic genes within the Fgf pathway (Dequeant et al., 
2006). Sprouty homologue 2 (Spry2), dual specificity phosphatase 6 (Dusp6) and Dusp4 
(Niwa et al., 2007) as well as snail homologue 1 (Snai1) (Dale et al., 2006) are targets 
and negative feedback inhibitors of the Fgf pathway and contribute to periodic Fgf 
signalling  activity.  This  notion  is  also  supported  by  periodic  phosphorylation  of 
extracellular signal-regulated kinase (ERK) mediated through Dusp4 or Dusp6, which 
establishes a negative feedback circuitry essential for oscillations (Chu et al., 1996; Li et 
al., 2007).  
Fgf signalling was proposed to lie upstream of Wnt and Notch signalling within 
the mouse segmentation clock, because a conditional knock-out of the Fgf receptor 1 
(Fgfr1) ceases oscillations in Fgf, Wnt and Notch pathway components (Niwa et al., 
2007; Wahl et al., 2007). When blocking Fgfr1 with a chemical inhibitor (SU5402), 
Lfng oscillations are abolished with one cycle of delay, suggesting that Fgf signalling 
regulates Notch signalling indirectly (Niwa et al., 2007). The loss of Fgf signalling and 
thus Lfng oscillations can be rescued by elevated Wnt signalling through constitutive 
expression  of  β-catenin  (Aulehla  et  al.,  2008). This  leads  to  a  restoration  of  Notch 
oscillations in the absence of Fgf signalling and indicates that Fgf cannot act as the 
central pacemaker of the segmentation machinery, either. 
According to the evidence provided, neither Notch, nor Wnt nor Fgf signalling 
acts  independently  at  the  heart  of  the  segmentation  clock  to  control  the  periodic 
formation of somites. Either these oscillating signalling pathways act redundantly, or 
they represent the output of a yet unidentified pacemaker.  CHAPTER 1: Introduction
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1.4  Aim of this thesis  
The Notch signalling pathway is an essential part of the communication system 
that  supports  and  governs  metazoan  development.  Although  the  pathway  seems  to 
follow a linear principle, fine-tuning can occur at many steps, leading to diverse outputs 
within various tissues or at different times.  
In this introduction, I have highlighted several aspects of the Notch signalling 
cascade: its participants and modulation thereof, as well as a few biological functions 
and mechanisms. However, there are numerous processes involving Notch, which are 
not mentioned here, perhaps more are still to be discovered. While we are beginning to 
understand how the signal is initiated, modified and transmitted we know little about the 
nature of target genes and how they respond to the Notch signal. For example, what 
makes a gene a Notch target in one tissue and developmental context but not in another? 
Several  attempts  have  been  made  towards  this  direction,  mainly  within  a  tightly 
regulated tissue culture system (see sections 1.2.5.2 and 1.2.5.3).  
This work describes a novel approach, making use of a mouse-model combined 
with high-throughput sequencing, to find Notch signalling targets at any given time 
during development and in any tissue. To achieve this goal I have chosen to make use of 
a knock-in approach to attach a high-affinity tag to the endogenous Notch1 locus. This 
tag is biotinylatable and thus the biotinylated NICD protein and its in vivo binding 
partners can be purified using the biotin-avidin system.  
The same strategy can also be applied to unravel the mechanics of the vertebrate 
segmentation clock. Up to now we do not have an idea of what drives the periodic 
formation of somites in vertebrate embryos. The Notch signalling pathway has been 
shown to play an important role during segmentation, with its targets Lfng and Hes7 at 
the core of feedback loops capable of generating oscillations (section 1.3.1). Through 
purifying targets of Hes7 during mouse embryogenesis (using the same approach) I am 
aiming to identify novel components within the segmentation clock circuitry, which 
might contribute to setting the pace of somite formation.  
I will describe the use of two different strategies to investigate the nature of Notch 
target genes in vivo: the first looks at targets of Notch itself and the second searches for 
targets of Hes7. In the case of the direct Notch approach, targets would be identifiable 
in virtually any tissue Notch is expressed in, whereas the Hes7 strategy specifically CHAPTER 1: Introduction
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aims to broaden our understanding on somitogenesis. In this thesis, I present the first in 
vivo  analysis  to  examine  the  specific  properties  of  Notch  target  genes  in  different 
developmental contexts in vertebrates. 
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CHAPTER 2:  Establishing  a novel technique to  identify in 
vivo targets of Notch signalling 
2.1  Introduction 
Chromatin immunoprecipitation (ChIP) is a widely used method to identify DNA 
binding sites of transcription factors and to explore the dynamics of gene regulation. In 
recent years genome-wide approaches combining ChIP with microarrays (ChIP-chip) or 
high-throughput sequencing (ChIP-seq) have led to a new area in understanding global 
transcriptional networks (Robertson et al., 2007).  
Conventional ChIP experiments are often limited by the availability and quality of 
antibodies  against  the  protein  of  interest.  In  order  to  circumvent  these  limitations, 
several technologies have been developed which usually involve the fusion of a peptide 
to the protein of interest and the use of antibodies with high affinity to these so called 
“tags”. To study protein-protein and protein-DNA interactions several tags are available 
such as the maltose binding protein, the Haemagglutinin (HA)-tag, the FLAG-tag, the 
Tandem  Affinity  Purification  (TAP)-tag,  the  Histidine  (His)-tag  and  the  Biotin 
Acceptor Peptide (BAP)-tag (Rigaut et al., 1999; Terpe, 2003).  
The BAP-tag is biotinylatable and biotin is then recognised by avidin/streptavidin 
(instead of an antibody). The biotin-avidin system stands out among the affinity-based 
purification methodologies because of the exceptionally high affinity of its bond. With a 
KD of 10
-13 to 10
-15 M the dissociation constant is several orders lower than that of an 
antibody (average KD of antibodies is between 10
-7 – 10
-11 (Larvor et al., 1994)). It 
represents one of the strongest non-covalent interactions, allowing for more stringent 
washing conditions in the purification step. Moreover, the BAP-tag comprises of only 
14 amino acids and is therefore unlikely to affect folding of the tagged protein (Beckett 
et al., 1999; Schatz, 1993). 
Biotin, also known as vitamin H or B7, is an essential coenzyme synthesized by 
plants, most bacteria and some fungi and is required for all forms of life (Chapman-
Smith  and  Cronan,  1999).  Specific  biotin-ligases  (or  biotinylases),  of  which  most 
organisms have only one paralogue, add biotin to the epsilon amino group of the lysine 
residue within the acceptor sequence (Chapman-Smith and Cronan, 1999). CHAPTER 2: Establishment of the BAP/biotin-avidin system
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BirA from Escherichia coli is the best-studied biotinylase and has in vivo only a 
single target, the biotin carboxyl carrier protein subunit of the acetyl-CoA carboxylase. 
BirA is a 35.3 kDa multifunctional protein that not only catalyses biotinylation but also 
acts as the transcriptional repressor that regulates biotin biosynthesis in E. coli (Cronan, 
1989). The biotinylation reaction is very specific and biotin-dependent carboxylases are 
the only known substrates in vivo (Barker and Campbell, 1981; Choi-Rhee et al., 2004).  
In  eukaryotes,  biotin  serves  as  a  covalently  bound  coenzyme  for  acetyl-CoA 
carboxylase, pyruvate carboxylase, propionyl-CoA carboxylase and 3-methylcrotonyl-
CoA carboxylase (Zempleni, 2005). These enzymes use biotin as a cofactor and mobile 
carboxyl carrier in processes like gluconeogenesis, lipogenesis, amino acid degradation 
and energy transduction (Samols et al., 1988).  
Because of the advantages pointed out above, I decided to use the BAP/biotin-
avidin system in transgenic mice to find novel targets of Notch signalling in vivo. This 
approach  has  been  used  before  successfully  in  tissue  culture  cells  to  identify  novel 
protein complex partners of the haematopoietic transcription factor GATA-1 (de Boer et 
al., 2003; Hamlett et al., 2008; Rodriguez et al., 2005). So far, there have been no 
records on the use of this method in vivo. My project describes the establishment of the 
BAP/biotin-avidin technique for the first time in a mouse model. 
This chapter describes the step-wise set-up of the BAP/biotin-avidin system from 
cell culture assays to establishing the transgenic mouse lines. After first validating the 
BAP-tagged proteins in cell culture, I generated transgenic mice, which express BAP-
tagged  Notch1  and  Hes7,  respectively  (see  1.2  for  an  introduction  on  the  Notch 
signalling pathway). Biotinylation is achieved through inter-crosses of the BAP-tagged 
mice with mice expressing the BirA biotinylase from E. coli (Driegen et al., 2005). 
2.2  Results 
This chapter is divided into three parts: The first describes experiments in cell 
culture, including tests for functionality of tagged proteins and biotinylation of the fused 
BAP-tag. The second and the third part deal with the generation and the phenotypic 
analysis of knock-in mice carrying biotinylated alleles of Notch1 or Hes7, respectively. CHAPTER 2: Establishment of the BAP/biotin-avidin system
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2.2.1  Validation of BAP-tagged Hes7 and Notch1 intracellular domain 
(NICD) in cell culture 
2.2.1.1  Construction  of  BAP-tagged  alleles  of  Hes7  and  Notch1  intracellular 
domain (NICD) for expression in tissue culture cells 
I  have  generated  BAP-tagged  cell  culture  constructs  of  cDNAs  from  Hes7 
(Hes7
BAP) and NICD (NICD
BAP) in order to test functionality of the proteins as well as 
biotinylation in cell culture based assays. The Hes7 tagging approach will be described 
first, followed by the NICD strategy.  
Since I had no information on previous tagging approaches for Hes7, I decided to 
construct  N-  and  C-terminally  tagged  Hes7
BAP  fusion  proteins,  trying  to  avoid 
functionally important sequence motifs. In the N-terminal fusion, the BAP sequence 
(Figure 2.1A) (Beckett et al., 1999) was inserted at the translation start site of Hes7 
cDNA. The BAP peptide sequence is preceded by the dipeptide MA - methionine and 
alanine -, which ensures efficient translation of the protein. For the C-terminally BAP-
tagged  Hes7,  I  inserted  the  14-mer  tag  12  amino  acids  upstream  of  the  conserved 
tetrapeptide motif (tryptophan, arginine, proline, tryptophan; WRPW) that is essential 
for TLE/Groucho mediated repression (Buscarlet and Stifani, 2007). I expected, that 
placing the BAP-tag further upstream should not interfere with this action.  
To generate a NICD
BAP expression vector, I attached the 14-mer BAP-tag (Figure 
2.1A) via a di-glycine linker to the C-terminal end. For the cell culture experiments, I 
chose to BAP-tag and express only the constitutively active form of Notch1 (NICD), 
which does not need to undergo maturation. However, the knock-in mice will express 
the  full  length  Notch1  receptor  with  the  BAP-tag  and  after  maturation  NICD
BAP 
translocates into the nucleus and activates target genes. Previous tagging strategies of 
Notch1 with an enhanced green fluorescent protein (EGFP) suggest, that the C-terminus 
provides an acceptable position for the tag (Jack et al., 2001). Moreover, the BAP-tag 
has to be within the cleaved C-terminal NICD part, which goes to the nucleus upon 
activation of the pathway.  
Briefly, the cloning involved the amplification of two parts, 5’ and 3’ (referred to 
as upper and lower, respectively), by PCR with primers containing parts of the BAP 
sequence. Subsequently these products were cloned into a TOPO expression vector for 
sequencing.  Once  the  sequence  was  confirmed,  the  two  parts  were  ligated  via  the CHAPTER 2: Establishment of the BAP/biotin-avidin system
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EcoRV  restriction  site,  which  was  generated  within  the  BAP  sequence  through 
introduction of a silent mutation. The BAP-tagged cDNAs were further excised from 
the TOPO vector backbone and introduced into a mammalian expression vector, which 
drives high level expression from the human cytomegalovirus (CMV) immediate-early 
promoter/enhancer (see Figure 2.1B for the cloning strategy; section 7.1.3 for a detailed 
description of the cloning). 
Using this split-construct technique described above, I was able to introduce the 
BAP-tag into various positions of mouse Hes7 and NICD cDNAs efficiently, resulting 
in  the  construction  of  pCI-Hes7
C-BAP,  pCI-Hes7
N-BAP  and  pcDNA3.1
+-NICD
BAP  for 
expression in cultured cells. CHAPTER 2: Establishment of the BAP/biotin-avidin system
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Figure  2.1  Cloning  strategy  to  generate  BAP-tagged  Hes7  and  NICD  cDNAs.  (A)  Nucleotide 
sequence of BAP-tag with highlighted position of the through silent mutation introduced EcoRV site 
(orange font). Specific lysine (K) residue for attachment of biotin is marked as red letter. (B) Outline of 
the cloning strategy to generate BAP-tagged cDNA. Asterisk indicates position for inserting BAP-tag 
(blue rectangle). The BAP sequence (blue line) is included in the upper reverse and lower forward primer 
sequences to generate upper and lower parts each harbouring a stretch of the BAP-tag. PCR products are 
subcloned individually into a TOPO cloning vector and subsequent EcoRV digest and ligation joins the 
BAP tag. The BAP-tagged cDNA is further cloned into a mammalian expression vector.  
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2.2.1.2  Validation of BAP-tagged proteins in a cell culture based assay 
In order to check functionality of Hes7
N-BAP, Hes7
C-BAP and NICD
BAP proteins I 
performed luciferase reporter assays in tissue culture cells. Hes7 is a transcriptional 
repressor of the basic helix-loop-helix (bHLH) family and was previously shown to 
bind to a hexameric N-box sequence when expressed in cultured cells (Bessho et al., 
2001a; Chen et al., 2005) For the Hes7
BAP functionality test, the firefly luciferase is 
driven by the β-actin promoter, which contains six N-box repeats as binding sites for 
Hes7 (Ishibashi et al., 1994). Co-expression of this reporter with wildtype Hes7 in the 
mouse  fibroblast  cell  line  C3H10T½  leads  to  a  90%  decrease  in  luciferase  activity 
(Figure 2.2A; (Bessho et al., 2001a)). Similar results were obtained when expressing the 
Hes7
C-BAP instead of wildtype Hes7 (Figure 2.2A). This suggests, that Hes7
C-BAP is able 
to function as a repressor in cell-based assays and might exhibit full activity in vivo. In 
contrast, Hes7
N-BAP is only able to reduce reporter activity by 40% (Figure 2.2A). These 
results show, that inserting the BAP-tag at the N-terminus of Hes7 impairs the function 
of  Hes7,  while  inserting  it  17  amino  acids  upstream  of  the  C-terminus  retains  full 
repressor activity. Therefore, I chose to insert the BAP-tag at the C-terminal position 
within the Hes7 locus to establish transgenic mice. In subsequent experiments, I refer to 
the Hes7
C-BAP fusion as Hes7
BAP. 
NICD is a transcriptional activator, which upon Notch pathway activation and 
subsequent proteolytic cleavage translocates into the nucleus and activates transcription 
of  target  genes  (section  1.2.3).  This  is  achieved  through  binding  of  NICD  to  CSL 
(CBF1  or  RPB-jκ  in  vertebrates,  Su(H)  in  Drosophila,  Lag-1  in  Caenorhabditis 
elegans;  collectively  referred  to  as  CSL)  thereby  promoting  the  formation  of  a 
transactivation  complex  (Figure  1.2).  CSL  has  been  shown  to  recognise  5’-
C/TGTGGGAA-3’ as the target DNA sequence motif, which is present in Notch target 
gene promoters (Chung et al., 1994; Tun et al., 1994). To test, whether NICD
BAP is 
functional as a transcriptional activator, I co-expressed it with a 509 bp Hes1 promoter 
fragment  driving  firefly  luciferase  activity  (Nishimura  et  al.,  1998).  The  promoter 
fragment stretches from -758 bp to -249 bp and contains three CSL binding sites, which 
are  bound  by  a  complex  of  CSL  and  NICD  and  subsequently  activate  transcription 
(Nam  et  al.,  2006;  Wilson  and  Kovall,  2006).  Upon  co-expression  of  the  wildtype 
NICD  protein  in  C3H10T½  mouse  fibroblasts  the  luciferase  reporter  shows  30-fold 
activation confirming Hes1  as  a Notch target gene (Figure 2.2B) (Nishimura et al., CHAPTER 2: Establishment of the BAP/biotin-avidin system
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1998). NICD
BAP is able to activate the reporter to the same extent, suggesting that the 
tagged protein retains its full function. In order to generate in vivo Notch
BAP fusion 
protein the transgenic mice will carry the BAP-tag at this C-terminal position. 
These results were obtained using the C3H10T½ mouse cell line. Other cell lines, 
such as NIH3T3 or L-cells did not replicate the data, suggesting that these results are 
cell-line  specific  (data  not  shown).  Although  the  reporter  assays  in  C3H10T½  cells 
indicate that Hes7
C-BAP and NICD
BAP are functional, it does not imply that this will also 
be  the  case  in  vivo.  These  experiments  simply  give  a  hint  how  the  proteins  might 
function in vivo.  
 CHAPTER 2: Establishment of the BAP/biotin-avidin system
 
 
 
47 
 
Figure 2.2 Luciferase reporter assay in C3H10T½ cells to validate Hes7
BAP (A) and NICD
BAP (B) 
fusion proteins. 100 ng of the firefly luciferase reporter, driven either by the β-actin promoter containing 
six N-box repeats (A) or a 509 bp Hes1 promoter fragment (B) was co-transfected with 200 ng of pCI 
(Control),  pCI-Hes7,  pCI-Hes7
N-BAP  (Hes7
N-BAP)  or  pCI-Hes7
C-BAP  (Hes7
C-BAP)  (A)  and  pcDNA3.1
+ 
(Control), pCDNA3.1
+-NICD or pcDNA3.1
+-NICD
BAP (NICD
BAP), respectively (B). 4 ng of the Renilla 
luciferase were added to each well for reference reading. After 24 h of incubation the assay was analysed 
and relative luciferase activities (shown as mean ± standard deviation for three experiments) determined. 
Drawings above the diagrams show schematic outline of the constructs used. The binding site for Hes7 or 
NICD is indicated by a brown box upstream of the luciferase reporter (yellow). Hes7 and NICD proteins 
are drawn as red and green rectangles, respectively. The BAP-tag is shown as a blue box. CHAPTER 2: Establishment of the BAP/biotin-avidin system
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2.2.1.3  Biotinylation of BAP-tagged proteins in cell culture 
After having shown that Hes7
BAP and NICD
BAP perform as well as the wildtype 
proteins in the luciferase reporter assays, I examined if the BAP-tag can be biotinylated 
efficiently  in  cells  by  the  E.  coli  biotinylase  BirA.  Therefore  I  co-expressed  equal 
amounts of either Hes7
BAP or NICD
BAP  with BirA in the mouse fibroblast cell line 
C3H10T½.  Using  streptavidin  coated  magnetic  beads,  I  was  able  to  show  that  the 
biotinylated proteins Hes7
BAP and NICD
BAP can bind efficiently the streptavidin matrix 
(Figure 2.3). 
In contrast, untagged Hes7 and NICD are not biotinylated and do not bind the 
streptavidin beads when co-expressed with the BirA biotinylase (Figure 2.3). I further 
tested if Hes7
BAP and NICD
BAP proteins can be biotinylated by endogenous biotinylases 
present in the cells. Expression of Hes7
BAP or NICD
BAP proteins in the absence of BirA 
did not lead to a signal on the western blot when developed with streptavidin and this 
suggests, that they are not biotinylated by endogenous biotinylases (Figure 2.3).  
There are two prominent high-molecular weight bands, around 100 and 170 kD, 
that appear in each lane on the western blot in Figure 2.3 (asterisks). They represent 
endogenous biotinylated proteins, which mainly reside in the mitochondrial matrix and 
were identified as biotin-dependent carboxylases (Beckett, 2007). The presence of these 
carboxylases (pyruvate and propyonyl CoA carboxylases) was confirmed by protein 
identification through mass spectrometry (Figure 3.8C). CHAPTER 2: Establishment of the BAP/biotin-avidin system
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Figure 2.3 Hes7
BAP and NICD
BAP proteins are biotinylated upon co-expression of BirA in HeLa 
cells.  HeLa  cells  were  transfected  with  either  pCI-3xHA-BirA  (BirA),  pCI-Hes7
BAP  (Hes7
BAP)  or 
pcDNA3.1
+-NICD
BAP (NICD
BAP) or BAP-tagged and untagged constructs together with equal amounts of 
pCI-3xHA-BirA (BirA). Crude nuclear extracts were prepared 24 h after transfection and 20 µg loaded 
onto 20 µl of blocked streptavidin beads for 1 h at 4 ºC. The beads were boiled at 95ºC for 5 minutes in 
20 µl of loading buffer and samples run on a 4-12% Bis-Tris gel. Biotinylated proteins were detected with 
a streptavidin-probe (1:25,000). Red rectangle highlights biotinylated Hes7
BAP in input (I) fraction and 
after binding to streptavidin beads (B). Biotinylated NICD
BAP in I and B fractions are marked with a 
green box. Asterisks label endogenous biotinylated proteins.  
 
2.2.2  Validation of Hes7
BAP and NICD
BAP in vivo 
The BAP-tagging of Hes7 and NICD proved successful in that the proteins retain 
full functionality upon tagging, and biotinylation of the BAP-tag is specific in cell-
based assays. However, before trying the system in the mouse, I asked the question if 
Hes7
BAP  and  NICD
BAP  are  functional  in  a  different  biological  system  such  as  the 
zebrafish Danio rerio. Overexpression of Notch in the zebrafish has previously been 
associated with a neurogenic phenotype leading to a massive decrease in neurons (Gray 
et  al.,  2001; Schier  et  al.,  1996).  Moreover,  heat-shock  mediated  overexpression  of 
her7, the zebrafish Hes7 orthologue and Notch target gene, has been shown to disrupt 
somitogenesis  leading  to  irregularly  spaced  segments  (Giudicelli  et  al.,  2007).  The CHAPTER 2: Establishment of the BAP/biotin-avidin system
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bHLH type repressors Her7 and Her1 were shown to act cooperatively to regulate the 
formation  of  somites  in  the  zebrafish  through  autoregulatory  feedback  inhibition 
(Holley et al., 2002; Oates and Ho, 2002). 
I prepared mRNA of NICD, NICD
BAP, Hes7 and Hes7
BAP and injected each into 
two-cell stage fish embryos (section 7.2.2). In the case of the NICD and NICD
BAP in 
vivo functionality test, the embryos were fixed 15 hours after post fertilisation (hpf) and 
subsequently hybridised with an islet1 probe, a marker for a subset of primary neurons 
(Inoue et al., 1994; Korzh et al., 1993). An excessive loss of neurons as described 
previously (Gray et al., 2001; Schier et al., 1996) was recapitulated upon injection with 
NICD or NICD
BAP mRNAs (Figure 2.4). This suggests that  NICD
BAP still acts as a 
functional activator in vivo and is able to induce ectopic expression of Notch signalling 
in the zebrafish.  
For the Hes7 and Hes7
BAP mRNA injections, embryos were analysed 24 hpf in 
respect of a segmentation phenotype. However, upon injection of Hes7 and Hes7
BAP 
mRNAs no obvious defects in the segmentation process were observed (not shown). 
Although both injection efficiency, as seen by co-expression of a fluorescent reporter, 
and mRNA quality were similar to the NICD injection experiment, the fish established 
regular somite patterns. The reason for this outcome is probably the fact that Hes7 
mRNA is degraded in vivo due to a lack of conservation between her1 or her7 and 
Hes7. Alternatively, Hes7 might not have a function within the zebrafish segmentation 
clock. From these experiments it is impossible to infer the affect of the BAP-tag on 
Hes7 in the zebrafish. 
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Figure 2.4 Islet1 in situ hybridisation of 15 hpf zebrafish embryos injected with either control (n=6), 
NICD (n=17) or NICD
BAP (n=13) mRNA. Dorsal views (anterior at the top) of 15 hpf zebrafish embryos 
hybridised with islet1 probe. Primary motoneurons (pmn) normally form two rows in the median neural 
plate and Rohon Beard (RB) sensory neurons are visible at the lateral edges of the neural plate (control). 
 
2.2.3  Establishing transgenic Hes7
BAP/BAP and Notch1
BAP/BAP mouse lines 
2.2.3.1  Generation of Hes7
BAP and Notch1
BAP targeting constructs for homologous 
recombination in embryonic stem cells 
The  pre-experiments  to  validate  BAP-tagged  Hes7  and  NICD  in  cell  culture 
suggested  that  both  proteins  retain  their  function  upon  fusion  with  the  BAP-tag. 
Moreover,  in  vivo  experiments  confirmed  that  NICD
BAP  is  still  able  to  activate 
transcription in the zebrafish embryo. The functional analysis of the tagged proteins as 
well as the confirmation of biotinylation in cultured cells is an essential requirement 
before setting up an in vivo system. 
The goal of my thesis is to find novel targets of Notch signalling in vivo using 
transgenic mouse lines that express either Hes7
BAP or Notch1
BAP. I used a knock-in 
strategy to integrate into sites of the open reading frame, tested above (section 2.2.1). 
The advantage of this method over the pro-nuclear injection technique (resulting in 
random integration) is, that - in homozygous knock-in mice - no endogenous, untagged 
protein would compete with the BAP-tagged proteins; and the use of the endogenous 
promoter leads to physiological levels of expression.  
The targeting construct for homologous recombination comprises of two parts, the 
5’  and  the  3’  homologous  regions  (HR),  which  flank  a  neomycin  resistance  (neo
r) 
cassette. I made use of the pFloxR1-modified (pFloxR1-mod) vector (Christine Laclef, CHAPTER 2: Establishment of the BAP/biotin-avidin system
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unpublished), which contains two multiple cloning sites for insertion of the HRs, and in 
between the neo
r gene with flanking LoxP sites for site-specific excision of neo
r (Figure 
2.5). 
Briefly, for the Hes7
BAP targeting construct, I PCR-amplified three parts, Hes7-
BAP  5’-homology  region  (Hes7
BAP  5’HR),  Hes7-BAP  3’-homology  region  upper 
(Hes7
BAP 3’HR upper) and Hes7-BAP 3’-homology region lower parts (Hes7
BAP 3’HR lower). 
The reason for having two stretches of the 3’HR was to facilitate the introduction of the 
BAP-tag through an EcoRV restriction site, which was created in the sequence as a 
silent mutation (Figure 2.1). I first tried a strategy using a 4 kb 5’HR and a 2.2 kb 3’HR, 
however I did not succeed to identify embryonic stem cell clones that had integrated the 
targeting construct after electroporation. Therefore, I cloned a new targeting construct 
with modified length of the HRs. I chose 1 kb for the 5’HR and 5.1 kb for the 3’HR 
(pFloxR1-mod_Hes7
BAP Figure 2.5; section 7.1.4). This strategy was successful and led 
to the identification of embryonic stem cells (ESC) that had integrated the Hes7
BAP 
targeting construct.  
The targeting construct to insert the BAP-tag sequence into the Notch1 locus was 
constructed similarly and consisted of a 3.3 kb 5’HR and a 2.5 kb 3’HR (pFloxR1-
mod_Notch1
BAP,  Figure  2.5B;  section  7.1.4).  Both  constructs  were  further 
electroporated into ESCs by the Cancer Research UK Transgenics Facility in Clare Hall 
(section  7.3.1).  The  process  of  generating  transgenic  mice  by  homologous 
recombination involves the replacement of some parts of the gene with the targeting 
construct resulting in the recombined allele. The removal of the neomycin resistance 
cassette using Cre-specific excision at LoxP sites produces a floxed recombined allele 
harbouring one LoxP site (Figure 2.5). 
2.2.3.2  Screening of embryonic stem cell clones (ESCC) 
In  order  to find  embryonic  stem  cells  (ESC)  that  had  integrated  the  targeting 
cassette,  cells  were  selected  for  neomycin  resistance  (neo
+).  Only  0.1  –  1%  of 
integrations are correct for homologous recombination (Joyner, 1991; Templeton et al., 
1997).  In  order  to  identify  homologous  recombinants,  neo
+  ESCs  were  picked 
individually, placed into 96 well plates and grown to clones (section 7.3.1). Genomic 
DNA  of  these  clones  was  prepared  and  analysed  using  PCR  (section  7.3.4)  and 
subsequently Southern blot analysis (section 7.3.5). CHAPTER 2: Establishment of the BAP/biotin-avidin system
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Figure 2.5 Targeting strategy for homologous recombination in embryonic stem cells to generate 
transgenic  Hes7
BAP and Notch1
BAP  mice. Strategy  to replace parts of the  endogenous Hes7 (A) and 
Notch1  (B)  loci  with  a  BAP-tagged  version  resulting  in  Hes7
BAP  (A)  and  Notch1
BAP  (B)  recombined 
alleles. Targeting vectors contain a 5’ and a 3’HR flanking a neomycin resistance cassette (neo
r, yellow 
box) and two LoxP sites (open rectangles) for site-specific excision. Homologous regions were inserted 
into the targeting vector pFloxR1-mod using the resctriction sites indicated. Subsequent expression of the 
Cre recombinase (purple) leads to excision of the neo
r cassette and results in Hes7
BAP (A, bottom) and 
Notch1
BAP floxed recombined alleles (B, bottom). The BAP-tag is shown in blue. CHAPTER 2: Establishment of the BAP/biotin-avidin system
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2.2.3.2.1  Polymerase chain reaction (PCR) screening of ESCC  
In the first instance, the genomic DNA was  screened by PCR (section 7.3.4), 
using  primers  in  the  BAP  sequence  or  the  neo
r  cassette  in  combination  with  gene-
specific primers outside the homology region covered by the targeting construct (Figure 
2.6). These primer combinations amplify only the homologous recombinant alleles. At 
least two different primer pairs were used to confirm a positive clone (Table 7.10 for 
primer sequences) covering both 3’ and 5’ flanking regions for Notch1
BAP and only 5’ 
flanking region for Hes7
BAP because of the long 5’HR. 
Altogether, I screened 864 clones for Hes7
BAP homologous integration (including 
the  first  attempt)  and  576  clones  for  Notch1
BAP  homologous  integration.  For  each 
targeting experiment two positive clones were found, which corresponds to 0.2% and 
0.3%  success  rate,  respectively  (Table  2.1).  This  outcome  lies  within  the  expected 
frequency  of  0.1  –  1%  for  homologous  recombination  in  ES  cells  (Joyner,  1991; 
Templeton et al., 1997).  
 
Construct  Number of screened 
ESCCs 
Positive clones confirmed 
pFloxR1-mod_Hes7
BAP  864  3C7, 4E7 
pFloxR1-mod_Notch1
BAP  576  3E3, 6A12 
Table 2.1 Statistics of PCR screening process. 
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Figure 2.6 PCR screening strategy and results from Hes7
BAP (A) and Notch1
BAP (B) homologous 
recombination events. Hes7
BAP (A) and Notch1
BAP (B) recombined loci are shown with primer pairs in 
the BAP sequence (blue arrow) or the neo
r cassette (yellow arrow) combined with primers outside the 
homology  region  (black  arrow).  Primer  combinations  are  named  in  brackets.  Homology  regions  are 
shown as red (Hes7
BAP) or green (Notch1
BAP) rectangles. (A) PCR products of Hes7
BAP ESCCs in 96-well 
plates III and IV using one primer pair combination (Hes7
BAP 5’ flanking region alternative; 3013 bp) are 
separated on an agarose gel. Red arrows point to positive clones, 3C7 and 4E7. (B) Similarly, results from 
the PCR reaction (with primer combination NICD
BAP 5’ flanking region; 1364 bp) of embryonic stem cell 
clones in 96-well plates III and VI of NICD
BAP electroporated ESCCs reveal two positive clones. Green 
arrows show position of individual clones, 3E3 and 6A12 on the agarose gel.  CHAPTER 2: Establishment of the BAP/biotin-avidin system
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2.2.3.3  Southern blot screening of PCR-positive ESCCs 
Since  the  PCR  screening  procedure  can  lead  to  false  positives  due  to  over-
amplification  of  the  target  sequences,  mis-priming  or  contamination,  additional 
Southern  blot  screening  is  indispensable  to  verify  candidate  clones.  Southern  blot 
analysis is a useful technique to identify specific DNA sequences, like the integrated 
targeting cassette, within a mixture of genomic DNA fragments (Southern, 1975). For 
that purpose, the genomic DNA needs to be digested with specific restriction enzymes 
that cut the locus at informative positions (e.g. in the resistance cassette as well as 
outside  the  homology  region).  This  leads  to  distinct  patterns  of  signals  on  the 
autoradiograph,  which  allows  to  distinguish  between  wildtype  and  homologous 
recombinant loci (section 7.3.5).  
In order to analyse the four clones, Hes7
BAP 3C7 and 4E7 and Notch1
BAP 3E3 and 
6A12, by Southern blotting I chose to use two different restriction digests in each case 
and further hybridisation with specific probes binding 5’ and 3’ of the targeting cassette 
within the genomic DNA (Figure 2.7). This strategy verifies if integration had occurred 
on both sides. The Southern blot analysis shows, that all four clones, Hes7
BAP 3C7 and 
4E7 and Notch1
BAP 3E3 and 6A12, have the targeting construct integrated at the correct 
position (Figure 2.7). 
Hes7
BAP clones 3C7 and 4E7 were digested either with EcoRI or with XhoI and 
KpnI resulting in both cases in two signals on the autoradiograph (at 7.3 kb and 3.8 kb 
as well as at 14 kb and 7.7. kb; Figure 2.7A) confirming the integration of the targeting 
construct  (Figure  2.7A).  Genomic  DNA from  Notch1
BAP  clones  3E3  and  6A12  was 
digested with either StuI or EcoRV and XhoI resulting in 5.8 kb and 4.5 kb or 12.9 kb 
and 9.9 kb, respectively (Figure 2.7B). In each case the larger fragment represents the 
wildtype fragment, which can be separated from the smaller homologous recombinant 
fragment (WT and HR in Figure 2.7). Using the Southern blot strategy, integration of 
the targeting cassette by homologous recombination can be easily distinguished from 
non-homologous  and  tandem  or  multiple  integration  sites  through  the  distinct 
fragmentation pattern. CHAPTER 2: Establishment of the BAP/biotin-avidin system
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Figure 2.7 Southern blot screening strategy of Hes7
BAP/+ (A) and Notch1
BAP/+ (B) recombined loci. 
Two different restriction digests are used to test incorporation of the targeting cassette on both integration 
sides  (orange  and  blue  text).  Homology  regions  are  shown  as  red  (Hes7
BAP)  or  green  (Notch1
BAP) 
rectangles. Each Southern blot result shows the agarose gel of the digested genomic DNA (left) and an 
autoradiograph of the developed result (right). (A) EcoRI digest of Hes7
BAP clones 3C7 and 4E7 (1 and 3) 
and hybridisation with Hes7
BAP 5’ probe (orange oval) leads to a 7.3 kb wildype (WT) and a 3.8 kb 
homologous recombinant (HR) signal. Lane number 2 shows clone 4D6 (as a control), which is negative 
and only shows the WT fragment. The double digest with XhoI and KpnI and subsequent hybridisation 
with Hes7
BAP 3’ probe (blue oval) indicates two fragments (14 kb and 7.7 kb) for the positive clones 3C7 
and 4E7. (B) Clones 3E3 and 6A12 (1 and 3) have the targeting cassette integrated correctly as seen by 
hybridisation with Notch1
BAP 5’ probe (orange oval) and resulting signals at 5.8 kb (WT) and 4.5 kb 
(HR).  Signals  at  12.9  kb  (WT)  and  9.9  kb  (HR)  are  the  results  for  positive  Notch1
BAP  clones  after 
hybridising the EcoRV/XhoI digested genomic DNA with Notch1
BAP 3’ probe (blue oval), whereas clone 
5E8 (2) only shows the WT fragment on both Southern blots. CHAPTER 2: Establishment of the BAP/biotin-avidin system
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2.2.4  Establishing homozygous Hes7
BAP/BAP and Notch1
BAP/BAP mouse lines 
co-expressing BirA and phenotypic analysis  
2.2.4.1  Mating strategy to obtain double homozygous Hes7
BAP/BAP;Rosa26
BirA/BirA 
and Notch1
BAP/BAP;Rosa26
BirA/BirA mice 
The  positive  clones  identified  in  the  screening,  Hes7
BAP  3C7  and  4E7  and 
Notch1
BAP 3E3 and 6A12, were injected into blastocyst stage embryos by the Cancer 
Research  UK  Transgenics  Facility  (section  7.3.6). These  were  implanted into  foster 
mothers  and  the  offspring  tested  for  contribution  by  recombinant  ESCs.  C57Bl/6J 
blastocysts were obtained from the C57Bl/6J mouse line, which produce black/brown 
chimeras. A high level of coat colour contribution together with a bias to male chimera 
mice (as the ES cell line is male) was indicative of an ES clone that contributed to the 
germline.  All  four  embryonic  stem  cell  clones  resulted  in  chimeric  offspring  with 
germline contribution as judged by the coat colour (Table 2.2). Chimeric mice were 
further back-crossed to wildtype C57Bl/6J mice to check for transgene transmission 
into the next generation. The integration of the BAP cassette into the Hes7 and Notch1 
loci was confirmed by genotyping PCR from mouse ear biopsies (section 7.3.3). Each 
injected ESCC resulted in a mouse line (Hes7
BAP 4E7 and 3C7; Notch1
BAP 6A12 and 
3E3),  which  showed  transmission  of  the  transgene  into  the  next  generation  as 
determined by PCR screening of chimera offspring.  
In  order  to  remove  the  neo
r  cassette,  which  has  been  shown  to  influence 
expression of adjacent genes (Muller, 1999), I crossed the transgenic mice to PGK-Cre 
mice, which ubiquitously express the Cre recombinase from the 3-phosphoglycerate 
kinase (PGK) promoter. PGK is a X-linked gene and therefore I used female PGK-Cre 
mice to remove the floxed gene from all progeny (Lallemand et al., 1998). The PGK 
promoter further drives transgene expression in all tissues, but the levels of expression 
vary  between  different  cell  types  (McBurney  et  al.,  1994).  The  Cre  recombinase 
recognises the 34 bp LoxP sites flanking the neo
r cassette and catalyses site-specific 
recombination leading to the excision of the DNA between. Using genotyping PCR to 
detect the neo
r gene (Table 7.8), I was able to confirm the removal of the floxed neo
r in 
Hes7
BAP/+ and Notch1
BAP/+ transgenic mice leaving behind one LoxP site within the 3
rd 
intron and another outside (3’) of the 3’ untranslated region (UTR). CHAPTER 2: Establishment of the BAP/biotin-avidin system
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To allow in vivo biotinylation, BAP-heterozygous mice (BAP/+) were mated to 
BirA homozygous males (kind gift of Dies Meijer, Erasmus Medical Center Rotterdam). 
These mice express the E. coli biotinylase from the Rosa26 locus, which is ubiquitously 
expressed  throughout  development  (Driegen  et  al.,  2005).  Double-heterozygous 
BAP/+;BirA/+  offspring  were  inter-crossed  to  establish  double-homozygous 
BAP/BAP;BirA/BirA mice. The primer pairs listed in Table 7.8 were used to genotype 
the pups of these breedings. 
 
ESCC  Number of 
blastocysts 
Number 
of mice 
born 
Number 
of 
Chimeras 
Contribution 
[%] 
Males 
(contribution, %) 
Hes7
BAP 4E7  11  5  3  70,70,80  3 (70,70,80) 
Hes7
BAP 4E7  33  9  7  60,75,75,75  2 (75,75) 
Hes7
BAP 3C7  26  6  2  70,80  2 (70,80) 
Hes7
BAP 3C7  8  0  0  0  0 
Notch1
BAP 6A12  13  4  2  85,65  1 (85) 
Notch1
BAP 6A12  13  0  0  0  0 
Notch1
BAP 3E3  13  0  0  0  0 
Notch1
BAP 3E3  40  10 
5  65,80,70,80, 
50 
2 (80, 50) 
Table 2.2 Results from the injection of the homologous recombinant ES cell clones (ESC) Hes7
BAP 
4E7 and 3C7 as well as Notch1
BAP 6A12 and 3E3 into blastocyst embryos and chimera production.  
 
2.2.4.2  Phenotypic analysis of Notch1
BAP/BAP;Rosa26
BirA/BirA mutant mice 
Since Notch signalling is an important key player during development of a mouse 
embryo e.g. during somitogenesis (section 1.3), I wanted to ask if Notch1
BAP retains full 
activity in vivo. Therefore, I chose to investigate the segmented pattern of Notch1
BAP/BAP 
embryos. Hybridisation of E9.5 homozygous Notch1
BAP/BAP embryos with Uncx4.1, a 
marker  for  the  posterior  somite  half,  did  not  show  any  obvious  segmentation  and 
compartmentalisation defects (Figure 2.8A). Regular Uncx4.1 stripes were seen in the CHAPTER 2: Establishment of the BAP/biotin-avidin system
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homozygous mutant, which is indistinguishable from the pattern seen in wildtype and 
heterozygous littermates (Figure 2.8A). These experiments were done in the absence of 
BirA in order to exclude a possible interference of the biotinylase resulting in false 
negative results.  
Although segmentation is not affected and Notch1
BAP/BAP embryos appear normal, 
adult viability is reduced: only 27% (8/120) of expected BAP/BAP animals survived 
after  weaning  (Table  2.3).  Examination  of  foetuses  before  birth  (E17.5)  however 
showed,  that  there  was  no  discrepancy  between  the  obtained  number  of  BAP/BAP 
animals and the expected number (3/9; 133% of expected). The BAP/BAP foetuses do 
not  seem  to  be  compromised  and  have  no  obvious  phenotype  when  compared  to 
wildtype or heterozygous littermates (Figure 2.8A).  
Initial viability issues of Notch1
BAP/BAP animals were eradicated after crossing to 
BirA  homozygous  mice  and  subsequent  breeding  of  BAP/BirA  double  heterozygous 
stock  (Table  2.4).  60%  of  the  expected  number  of  double  homozygous 
Notch1
BAP/BAP;Rosa26
BirA/BirA mice were recovered (4/107) and further used for breeding 
and expanding the line. Both, male and female BAP/BAP;BirA/BirA mice are fertile and 
produced pregnancies (as judged by the copulation plug) in 76% of cases (16/21). 
I  next  wanted  to  test  if  the  Notch1
BAP  protein  is  biotinylated  in  the 
Notch1
BAP/BAP;Rosa26
BirA/BirA mice and therefore I performed western blot analysis of 
cell lysates from different mouse tissues using  a streptavidin probe. I also chose to 
detect biotinylated Notch1
BAP within the developing retina at five days after birth (P5). 
The latter tissue provides more material for subsequent chromatin pull-downs. Upon co-
expression of Notch1
BAP with BirA, I was able to confirm biotinylation of Notch1
BAP in 
both the PSM and the retina, which is seen as a ~150 kD signal on the western blot 
(Figure 2.8B). Extracts of tissues from Rosa26
BirA/BirA mice were used as control and 
represent  the  biotinylated  background  binding  (asterisks,  Figure  2.8B).  These  data 
corroborate  the  cell  culture  validation  experiments  and  show  that  Notch1
BAP  is 
biotinylated in vivo by the BirA biotinylase in different tissues.  
Notch1
BAP/BAP;Rosa26
BirA/BirA mice do not show any phenotype and can be bred to 
expand  the  line  for  subsequent  streptavidin  chromatin  pull-down  experiments  from 
tissues like the PSM or the retina in order to find novel targets of Notch signalling 
(section 3.2.5). Since Notch signalling is implicated in a variety of processes throughout CHAPTER 2: Establishment of the BAP/biotin-avidin system
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development of the embryo and the adult these animals can be used to address the 
question of Notch target genes in virtually any tissue that expresses Notch1.  
 
Genotype  Survival rate past 
weaning 
Hes7
BAP/+  26/41 (126%) 
Hes7
BAP/BAP  2/41 (19%) 
Notch1
BAP/+  67/120 (112%) 
Notch1
BAP/BAP  8/120 (27%) 
Table  2.3  Adult  viability  of  the  transgenic  lines  as  determined  through  inter-crosses  of 
heterozygous  BAP/+  animals.  Survival  rate  past  weaning:  number  of  adults  recovered  /  total 
number of offspring (% of expected).  
 
Genotype  Survival rate past 
weaning 
Hes7
BAP/BAP;Rosa26
BirA/BirA  9/298 (48%) 
Hes7
BAP/BAP;Rosa26
BirA/+  7/298 (19%) 
Hes7
BAP/BAP  3/298 (16%) 
Hes7
BAP/+;Rosa26
BirA/BirA  50/298 (134%) 
Hes7
BAP/+;Rosa26
BirA/+  101/298 (135%) 
Notch1
BAP/BAP;Rosa26
BirA/BirA  4/107 (60%) 
Notch1
BAP/BAP;Rosa26
BirA/+  6/107 (45%) 
Notch1
BAP/BAP  1/107 (14%) 
Notch1
BAP/+;Rosa26
BirA/BirA  21/107 (157%) 
Notch1
BAP/+;Rosa26
BirA/+  25/107 (93%) 
Table  2.4  Adult  viability  of  the  transgenic  lines  as  determined  through  inter-crosses  of  double 
heterozygous BAP/+;BirA/+ animals. Survival rate past weaning: number of adults recovered / total 
number of offspring (% of expected).  
 CHAPTER 2: Establishment of the BAP/biotin-avidin system
 
 
 
62 
 
Figure 2.8 Notch1
BAP/BAP mice are homozygous viable, show no obvious phenotype and Notch1
BAP 
can be biotinylated by BirA in vivo. (A) Uncx4.1 in situ hybridisation of wildtype, Notch1
BAP/+ and 
Notch1
BAP/BAP E9.5 embryos show no differences in expression pattern (left). Notch1
BAP/BAP E17.5 foetuses 
develop  normally  and  are  indistinguishable  from  their  wildtype  or  heterozygous  littermates.  White 
rectangle represents 5 mm scale bar (B) Western blot analysis, using a streptavidin probe, (1:25,000) of 
presomitic  mesoderm  (PSM)  extracts  and  P5  pup  retina  lysates  of  Rosa26
BirA/BirA  (BirA)  and 
Notch1
BAP/BAP;Rosa26
BirA/BirA (Notch1
BAP;BirA). Green arrow points at biotinylated Notch1
BAP. Asterisks 
label endogenous biotinylated proteins. CHAPTER 2: Establishment of the BAP/biotin-avidin system
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2.2.4.3  Phenotypic analysis of Hes7
BAP/BAP;Rosa26
BirA/BirA mutant mice 
Introduction of the BAP-tag into the Notch1 locus did not disrupt the function of 
Notch1.  However,  homozygous  Hes7
BAP/BAP  mice  on  the  other  hand  are  severely 
compromised with axial truncations and fused vertebrae and ribs (Figure 2.9). Their 
adult viability is greatly reduced and only 19% of expected (2/41) animals survive past 
weaning (Table 2.3). Upon co-expression of the BirA biotinylase following BAP/BirA 
heterozygous inter-crosses 48% (9/298) of expected Hes7
BAP/BAP;Rosa26
BirA/BirA adults 
were recovered (Table 2.4).  
The  survivor’s  tails  are  truncated  by  varying  degrees  and  have  several  kinks 
(Figure 2.9). Vertebrae of the cervical and the thoracic areas are severely fused, whereas 
vertebrae of the sacrum form almost regularly (Table 2.5 and Figure 2.9B). The degree 
of severity also varies within the sacral and adjacent area and frequently, well-formed 
lumbar and tail vertebrae are observed (Table 2.5). Heterozygous littermates resemble 
wildtype although 2% show a kinked tail (Figure 2.9B). Both Hes7
BAP/BAP lines that 
were established from 3C7 and 4E7 ESCCs show the same phenotype, suggesting that 
this is indeed due to integration of the BAP sequence into the Hes7 locus.  
Although Hes7
BAP/BAP;Rosa26
BirA/BirA mice display a strong phenotype, they are 
viable (Table 2.4) and fertile (73% (19/26) of males produced a copulation plug and 
28%  (2/7)  of  plugged  females  had  a  litter). This  allowed  me  to  generate  tissue  for 
testing the biotinylation of Hes7
BAP in vivo. I collected embryos at E9.5 and subjected 
the lysate to western blot analysis using a streptavidin probe (Figure 2.10). No signal of 
Hes7
BAP was detected at ~37 kD as seen by probing with streptavidin (Figure 2.10). The 
fact that Hes7
BAP is not fully functional and apparently not biotinylated indicates that 
Hes7
BAP/BAP;Rosa26
BirA/BirA mice can not be used in streptavidin chromatin pull-down 
assays (bioChIP) to identify novel targets of Hes7 during somitogenesis. Rather, these 
mice will be analysed in respect of their segmentation defect (chapter 4). 
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  BAP/+  BAP/BAP 
Number of adult skeletons 
analysed  4  5 
Length of whole vertebral 
column (mm)  147.5±2.8  74.4±12.5 
Length of tail (mm)   87.25±4.8  32.4±10 
Total number of regular lumbar 
vertebrae  6±0  1±1 
Number of regular sacral 
vertebrae  4±0  3.2±1 
Number of regular tail vertebrae  27±1.4  4±3.4 
Number of ribs, left and right 
counted separately  13±0  9.8±0.8 
Table 2.5 Comparison of Hes7
BAP/+ (BAP/+) and Hes7
BAP/BAP (BAP/BAP) adult skeletons. 
 
 CHAPTER 2: Establishment of the BAP/biotin-avidin system
 
 
 
65 
 
Figure  2.9  Phenotypes  of  Hes7
BAP/+  (BAP/+)  and  Hes7
BAP/BAP  (BAP/BAP)  adults.  (A)  Comparison 
between BAP/+ and BAP/BAP adult mice. (B) Skeleton preparations of BAP/+ and BAP/BAP adult mice 
stained with alizarin red. Note variations in the severity of the BAP/BAP phenotype. Arrowheads point to 
kinks in the tail. t, thoracic vertebrae; l, lumbar vertebrae; s, sacral vertebrae; tail, tail vertebrae.  
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Figure 2.10 Western blot analysis of presomitic mesoderm tissue (PSM) from Rosa26
BirA (BirA) and 
Hes7
BAP/BAP;Rosa26
BirA  (Hes7
BAP;BirA)  E9.5  embryos  to  detect  biotinylated  Hes7
BAP.  BirA  and 
Hes7
BAP;BirA  embryos  were  dissected  and  the  posterior  tail  part  isolated.  Whole  cell  lysates  were 
prepared  and  run  on  a  4-12%  Bis-Tris  gel.  Detection  of  biotinylated  proteins  was  done  using  a 
streptavidin-HRP probe (1:25,000) (top blot) for biotinylated Hes7
BAP or an anti-HA antibody (1:1,000) 
combined with a secondary anti-mouse-HRP (1:5,000) antibody to visualise HA-tagged BirA. Arrows 
point at detected protein signals. Asterisks label endogenous biotinylated proteins.  CHAPTER 2: Establishment of the BAP/biotin-avidin system
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2.3  Discussion 
This chapter describes the generation of BAP-tagged alleles of Hes7 and Notch1 
for the identification of novel in vivo Notch signalling targets. Notch1
BAP is functional, 
and was used for streptavidin chromatin pull-down experiments (chapter 3), Hes7
BAP is 
not  fully  functional,  and  results  in  an  interesting  segmentation  phenotype,  which  is 
analysed in chapter 4. 
Cell culture experiments had predicted that Hes7
BAP, containing the BAP-tag 17 
amino acids upstream of the C-terminus, could still repress target genes. But this is not 
the case in vivo, as seen in the hypomorph Hes7
BAP/BAP;Rosa26
BirA/BirA strain. A possible 
explanation is that in the embryo Hes7 expression is highly dynamic and only few 
molecules  are  synthesised  and  therefore  the  in  vivo  system  is  more  fragile  than  in 
cultured  cells.  In  contrast,  in  cell  culture  experiments  Hes7
BAP  protein  was 
constitutively expressed at a very high rate, which repressed the reporter.  
Expression of Hes7
BAP in a presomitic mesoderm (PSM) specific cell line, which 
is more similar to the in vivo situation than the fibroblast cell line, would have provided 
further evidence about Hes7
BAP functionality. So far, it is not possible to establish such 
a cell line and thus these experiments were not performed. 
A further explanation for the loss of function in vivo might also be the fact that the 
BAP-tag disrupts binding of a necessary co-factor for repression. Hes proteins were 
shown to form hetero- or homodimers and down-regulation of target genes is achieved 
through recruitment of co-repressors (section 1.2.5.1). The BAP-tag could impair both, 
dimerisation and complex formation with co-repressors. However, I decided to insert 
the BAP-tag at a position, which has not been associated with an important binding site 
before. 
I chose the BAP-tag because it has only 14 amino acids, which should minimise 
folding defects and has been used successfully before (de Boer et al., 2003; Hamlett et 
al., 2008; Rodriguez et al., 2005; Stachler et al., 2008). However, these studies use the 
BAP/biotin-avidin technique in cultured cells with inducible expression of the BAP-
tagged transcription factor.  
There are several possible explanations for why Hes7
BAP is not biotinylated in 
vivo.  Firstly,  Hes7  is  a  transcription  factor,  which  mainly  acts  in  the  nucleus  and CHAPTER 2: Establishment of the BAP/biotin-avidin system
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switches  off  transcription,  while  the  BirA  biotinylase  resides  in  the  cytoplasm.  The 
short residence of Hes7
BAP in the cytoplasm during translation and further maturation 
might not be sufficient to biotinylate the protein. In future experiments one could attach 
a nuclear localisation signal (NLS) to the biotinylase in order to promote biotinylation 
within the nucleus, which is specifically important for nuclear transcription factors. In 
the  case  of  Notch
BAP  biotinylation,  the  BAP  containing  NICD  moiety  lies  on  the 
cytoplasmic side of the Notch1 receptor, which facilitates biotinylation through BirA.  
Second, there is also a possibility that the BAP-tag in Hes7
BAP is not accessible 
for the biotinylase in vivo due to protein folding. Structural analysis of the purified 
protein  would  be  needed  to  distinguish  between  these  alternatives.  However,  if 
introduction  of  the  BAP-tag  would  disrupt  protein  folding,  I  would  not  have  seen 
biotinylation of Hes7
BAP in cultured cells. Finally, I cannot exclude that Hes7
BAP is not 
biotinylated because the abundance for this highly dynamic protein might lie below 
detection in vivo.  
To  conclude,  Hes7
BAP  protein  function  is  greatly  impaired  but  not  completely 
abolished as Hes7
BAP/BAP;Rosa26
BirA/BirA mice differ from Hes7 knock-out (Hes7
-/-) mice, 
which are not viable and do not show any regular vertebrae (Bessho et al., 2001b). 
I  can  still  address  novel  Notch  signalling  targets  using 
Notch1
BAP/BAP;Rosa26
BirA/BirA  mice,  which  express  functional  and  biotinylated 
Notch1
BAP (chapter 3). Given that Notch signalling is involved in numerous processes 
throughout  development  and  disease  these  mice  can  be  used  to  identify  important 
downstream players and help understanding the complex functions of Notch. 
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CHAPTER 3:  Testing  various  applications  of  the 
Notch1
BAP/biotin-avidin  system  in  cultured  cells  and 
transgenic mouse tissues 
3.1  Introduction 
The  Notch  signalling  pathway  is  an  evolutionary  conserved  mechanism  that 
controls cell fate decisions through local cell interactions in metazoan development and 
disease (reviewed in Artavanis-Tsakonas et al., 1999) (chapter 1). Today, we have a 
considerable understanding of what triggers the activation of the cascade and leads to 
the formation of the transactivation complex in the nucleus (Kovall, 2008). However, 
the question of how different target genes are activated by Notch in different cell types 
and time frames remain less clear. To date, only a few direct targets of Notch activity 
have been characterized (section 1.2.5) but even in those cases, it is not fully understood 
what makes a gene a target in specific cells.  
With  the  help  of  genome-wide  studies,  like  chromatin  immunoprecipitation 
combined with high throughput sequencing (ChIP-seq), the number of target genes can 
eventually increase. Limitations in this procedure have been the quality of antibodies 
directed against the Notch1 intracellular domain (NICD), the extremely low abundance 
of this transcription factor in the nucleus and the fact that NICD does not bind the DNA 
itself  but  via  CSL  (named  after  CBF1,  Su(H)  and  LAG-1,  for  the  mammalian,  D. 
melanogaster and C. elegans orthologues). 
The BAP/biotin-avidin system, as outlined in chapter 2, provides an opportunity 
to  circumvent  these  problems.  First,  through  attachment  of  the  BAP-tag  epitope  to 
NICD the antibody problem can be resolved. Further biotinylation of the BAP-tagged 
protein  and  the  tight  and  specific  binding  by  avidin  (or  its  bacterial  counterpart 
streptavidin)  has  an  almost  10
3  -  10
6  times  greater  affinity  than  the  interaction  of 
epitopes with their antibodies. Once the biotin-avidin complex has formed, it remains 
stable even under very stringent washing conditions (Ford et al., 1991). This extremely 
high affinity of avidin for biotin should allow purifying low levels of biotinylated NICD 
from a restricted number of cells and efficient crosslinking can minimise the probability 
that the NICD/CSL/chromatin transactivation complex dissociates.  CHAPTER 3: Applications of the BAP/biotin-avidin system
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Streptavidin  chromatin  pull-downs  or  so  called  bioChIP  (chromatin 
immunoprecipitation of biotinylated protein and their binding partners via streptavidin) 
experiments from different tissues together with high-throughput sequencing may lead 
to a better understanding of Notch signalling targets and their activation. The utility of 
the  BAP-tag  and  streptavidin  binding  in  chromatin  immunoprecipitation  assays  has 
been used before and provided evidence that it can be used successfully in ChIP and 
ChIP-chip  assays  to  identify  genome-wide  transcriptional  targets  (Kim  et  al.,  2008; 
Kolodziej et al., 2009; van Werven and Timmers, 2006; Viens et al., 2004).  
The  BAP/biotin-avidin  system  seems  to  provide  an  alternative  opportunity  to 
address the question of Notch signalling targets in vivo in the developing and adult 
mouse. Here, I present a novel approach towards the identification of Notch target genes 
in vivo by bioChIP using the generated transgenic Notch1
BAP/BAP;Rosa26
BirA/BirA (chapter 
2) mouse line.  CHAPTER 3: Applications of the BAP/biotin-avidin system
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3.2  Results 
This chapter documents the different steps to optimise the streptavidin chromatin 
pull-down assays from cultured cells (that have been transduced with NICD
BAP and 
BirA) and Notch1
BAP/BAP;Rosa26
BirA/BirA mouse tissues. First, I established a bioChIP 
protocol using a well-studied transcription factor promoter system (section 3.2.1). Once 
I had the technique optimised I went on to perform Notch bioChIP experiments from 
stable cell lines expressing biotinylated NICD
BAP (section 3.2.2) in order to test various 
parameters  before  performing  the  experiment  on  the  mouse  tissue  (section  3.2.5). 
Additionally,  I  generated  stable  cell  lines  expressing  a  biotinylated  and  inducible 
NICD
BAP  to  identify  the  “Notch  targetome”  upon  oncogenic  transformation  (section 
3.2.2). After I tested the system in cell culture I tried to identify Notch target genes from 
transgenic Notch1
BAP/BAP;Rosa26
BirA/BirA mouse PSM and retina tissues (section 3.2.5). 
Although I was not successful in confirming known Notch target genes by quantitative 
PCR  (qPCR)  after  bioChIP,  I  decided  to  perform  high-throughput  sequencing  from 
bioChIP  samples.  Finally,  I  analysed  protein-binding  partners  of  NICD
BAP  after 
streptavidin protein purification and mass spectrometry from embryonic nuclear lysates, 
which is another application of the BAP/biotin-avidin system (section 3.2.7).  
3.2.1  Establishing a bioChIP protocol using the well-studied binding of the 
transcription factor GATA-1 to the Erythroid Kruppel-like Factor 
(EKLF) gene promoter 
Several different protocols for the bioChIP have been published previously using 
different versions of the BAP-tag (Kim et al., 2008; Kolodziej et al., 2009; van Werven 
and Timmers, 2006; Viens et al., 2004). First, I had to establish a ChIP protocol, which 
works for my tagged protein and with the instruments (e.g. type of sonicator) at my 
disposal.  Several  parameters  had  to  be  tested  beforehand  and  were  optimised 
accordingly.  These  parameters  included  the  determination  of  the  correct  amount  of 
starting  material  as  well  as  the  conditions  for  formaldehyde  fixation  (duration  and 
quality  of  formaldehyde),  the  sonication  timing  and  elution  conditions  during  the 
bioChIP procedure.  CHAPTER 3: Applications of the BAP/biotin-avidin system
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A suitable system to establish a bioChIP protocol is the well-studied binding of 
the transcription factor GATA-1 to the EKLF promoter, which has already been used in 
bioChIP experiments before (Kolodziej et al., 2009). The haematopoietic transcription 
factor  GATA-1  is  a  key  regulator  of  the  differentiation  of  the  erythroid, 
megakaryocytic,  eosinophilic  and  mast  cell  lineages  and  acts  as  both  repressor  and 
activator  of  transcription  depending  on  its  co-factors  and  the  binding  of  other 
transcription  factors  (Lowry  and  Mackay,  2006).  Previous  studies  using  the  high-
affinity binding of the biotinylated GATA-1
BAP to streptavidin beads have identified a 
number of such GATA-1 co-factors (Hamlett et al., 2008; Rodriguez et al., 2005). 
In  order  to  test  the  bioChIP  experimental  procedure  I  performed  streptavidin 
chromatin pull-downs from the established MEL cell line, which express an inducible 
GATA-1
BAP and the BirA biotinylase from E. coli (kind gift from John Strouboulis and 
Frank Grosveld, Erasmus Medical Center Rotterdam) (de Boer et al., 2003) (Figure 
3.1A). As read-out for the bioChIP I examined known GATA-1 binding sites in the 
EKLF promoter by quantitative PCR (qPCR) (Merika and Orkin, 1995) (Figure 3.1C).  
Briefly, after induction of GATA-1
BAP, cells were fixed with formaldehyde and 
chromatin  was  fragmented  by  sonication  (section  7.6.1.1).  The  average  length  of 
chromatin should be between 300 and 500 bp and was confirmed on an agarose gel 
(Figure 3.1B). In order to check the influence of the amount of starting material, I used 
either 10 x 10
6 or 1 x 10
6 cells per bioChIP experiment. The fragmented chromatin was 
mixed  with  streptavidin-coated  beads  and  washed  according  to  the  commercially 
available  ChIP  protocol  (section  7.6.1.1).  GATA-1
BAP  bound  DNA  fragments  were 
eluted  (by  reversing  the  crosslinks)  and  purified.  Enrichment  of  GATA-1
BAP  target 
DNA  sequences  was  assayed  by  qPCR  using  primer  pairs  binding  next  to  known 
GATA-1 binding sites (“enhancer” and “basic promoter”, Figure 3.1C and Table 7.18) 
and a primer pair binding in a region that lacks GATA-1 binding sites as a negative 
control (“negative”, Figure 3.1C and Table 7.18). 
The  results  from  the  qPCR  run  of  the  bioChIP  from  MEL  [BirA]  and  MEL 
[GATA-1
BAP; BirA] were normalised to an internal necdin control (Kolodziej et al., 
2009) and plotted onto a graph showing the relative enrichment of the different EKLF 
promoter fragments (Figure 3.1D). bioChIP experiments with cells that express GATA-
1
BAP and BirA show 35-40 fold enrichment of the positive EKLF promoter sites (EKLF 
basic promoter and EKLF enhancer, Figure 3.1D) but not of the EKLF negative site. CHAPTER 3: Applications of the BAP/biotin-avidin system
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bioChIP with control cells that express BirA but not GATA-1
BAP does not result in 
enrichment  of  any  of the  positive  EKLF  promoter  sites  (EKLF  basic  promoter  and 
EKLF enhancer; Figure 3.1D). These findings are consistent with previous bioChIP 
results (Kolodziej et al., 2009) and demonstrate that the parameters chosen (section 
7.6.1.1) can indeed lead to the purification of target DNA fragments. 
By contrast to the above results with 10 x 10
6 cells starting material, bioChIP on 
10 times less cells did not work: it resulted in high variations in the cycle threshold (ct) 
values  beyond  cycle  30  of  the  qPCR  and  in  an  apparent  enrichment  of  promoter 
sequences from the control cells that express only BirA (not shown).  
Using  a  well-characterised  bioChIP  system,  I  was  able  to  reproduce  previous 
results  indicating  that  -  in  principle  -  the  bioChIP  is  working  and  should  also  be 
applicable in the case of the biotinylated Notch1
BAP in cultured cells and mouse tissues. CHAPTER 3: Applications of the BAP/biotin-avidin system
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Figure  3.1  Enrichment  of  EKLF  basic  promoter  and  enhancer  sites  after  bioChIP  from  MEL 
[GATA-1
BAP;  BirA] cells. (A) Inducible GATA-1
BAP expression in  MEL cells. MEL  cells  expressing 
BirA alone or BirA and GATA-1
BAP were cultivated in DMEM supplemented with 10% FCS at 37ºC for 
4 days in the absence (-) or presence (+) of 2% DMSO. Western blot analysis of crude nuclear lysates 
probed  with  streptavidin-HRP  (1:25,000)  shows  biotinylated  GATA-1
BAP  after  DMSO  induction  in 
double stable  MEL cells (~50 kD; blue arrow). Asterisks label signals from endogenous biotinylated 
proteins. (B) 1% agarose gel of sonicated chromatin from 1 x 10
6 and 10 x 10
6 MEL cells. 1 and 5 µg 
(second  sample  only)  of  chromatin  was  loaded.  (C)  EKLF  promoter  architecture  showing  GATA-1 
binding sites (basic promoter and enhancer) and GATA-1 negative site used for analysis of GATA-1 
bioChIP experiments. Arrow, start of transcription. (D) qPCR results of GATA-1 bioChIP from 10 x10
6 
MEL [BirA] (blue columns) and [GATA-1
BAP; BirA] (red columns) cells. Each experiment shows relative 
enrichment of EKLF negative, EKLF enhancer and EKLF basic promoter sites (average of duplicates) 
over the internal control necdin.  CHAPTER 3: Applications of the BAP/biotin-avidin system
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3.2.2  Testing stable [NICD
BAP; BirA] cell lines for bioChIP 
In order to optimise the NICD bioChIP in cultured cells I established stable cell 
lines  expressing  NICD
BAP  and  BirA.  I  made  use  of  a  retroviral  gene  delivery  and 
expression system to control copy number and expression of the BirA and NICD
BAP 
constructs in different cell lines (sections 7.1.5 and 7.4.3). I chose to use the human 
breast epithelial cell line MCF10A because overexpression of NICD in that system was 
shown to lead to an oncogenic transformation (Imatani and Callahan, 2000; Robbins et 
al., 1992; Stylianou et al., 2006). NICD bioChIP experiments from stable MCF10A cell 
lines  expressing  biotinylated  NICD
BAP  before  and  after  over-activation  of  Notch 
signalling  could  provide  an  insight  into  the  mechanisms  by  which  Notch  governs 
tumourigenesis.  
In order to have a temporally regulated induction of Notch activity, I constructed a 
hormone  inducible  NICD
BAP  retroviral  vector  based  on  the  estrogen  receptor  (ER) 
fusion strategy (Littlewood et al., 1995). Thereby, addition of the synthetic compound 
4-Hydroxytamoxifen  (4-OHT)  should  lead  to  activation  of  the  ER-NICD
BAP  fusion 
protein and in that way switches on Notch signalling. As control cells I established a 
mouse fibroblast C3H10T½ cell line stably expressing ER-NICD
BAP and BirA, which 
do not undergo oncogenic transformation upon over-expression of NICD.  
After  transduction  of  MCF10A  and  C3H10T½  cell  lines  with  BirA  and  ER-
NICD
BAP constructs I checked expression of biotinylated ER-NICD
BAP on a western 
blot. In both cell lines the biotinylated ER-fusion protein was detected at ~190 kD after 
probing whole cell lysates with streptavidin (Figure 3.2A, green arrow and box). In 
contrast, MCF10A and C3H10T½ cell lines, which were transduced only with the BirA 
containing  virus,  did  not  show  a  signal  at  this  molecular  weight  (Figure  3.2A). 
However, the western blot from BirA cells detected endogenous biotinylated proteins at 
~100 and ~170 kD, which were identified by mass spectrometry as the mitochondrial 
proteins  pyruvate  and  propyonyl  CoA  carboxylases  (Figure  3.8C).  The  detection  of 
NICD
BAP  on  the  western  blot  is  consistent  with  previous  results  confirming  the 
biotinylation of NICD
BAP in cell culture (Figure 2.3), which is a prerequisite for the 
bioChIP.  
Next, I wanted to check if I could switch on the expression of the ER-NICD
BAP 
fusion by adding 4-OHT to the cells. An inducible system would have been helpful in CHAPTER 3: Applications of the BAP/biotin-avidin system
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timing  the  activation  of  Notch  signalling  but  is  not  an  absolute  requirement.  The 
luciferase reporter assay described in chapter 2 was used as a read-out and to determine 
the  strength  of  activation.  In  this  case  the  luciferase  is  driven  by  a  509  bp  Hes1 
promoter fragment containing three CSL transactivation sites (Ishibashi et al., 1995). 
The  double  stable  cell  lines  C3H10T½  [ER-NICD
BAP;  BirA]  and  MCF10A  [ER-
NICD
BAP; BirA] were transfected with the luciferase reporter construct and 24 hours 
later 4-OHT was added. After incubation of another 24 hours the cells were lysed and 
luciferase activity determined (section 7.4.4).  
There was no obvious activation of the reporter upon addition of the 4-OHT and 
reflected great variation within different experiments suggesting that the ER-NICD
BAP 
might not be functional (Figure 3.2C). Therefore, I re-cloned ER-NICD
BAP cDNA into 
the pcDNA3.1
+ expression vector and tested the construct in a transient reporter assay 
thereby comparing the activity of ER-NICD
BAP to NICD and NICD
BAP with and without 
4-OHT. 
The transient transfection assays showed that ER-NICD
BAP expression is activated 
upon transfection of the reporter even in the absence of the metabolite 4-OHT (Figure 
3.2C and D) suggesting that the ER-system is leaky. Similarly, NICD and NICD
BAP are 
both able to activate the Hes1 luciferase reporter (in the absence and presence of 4-
OHT) in C3H10T½ and MCF10A transiently transfected cell lines (Figure 3.2D and E). 
The reduced level of induction is probably due to the fact, that in this case, cells were 
assayed 48 h after transfection whereas, in the initial experiment, I measured already 
after 12 - 24 h (compare Figure 3.2D and E with Figure 2.2B). In general, the activation 
in MCF10A cells does not seem to be as high as in C3H10T½ transfected cells (Figure 
3.2D).  Also,  addition  of  4-OHT  seems  to  compromise  the  activation  of  NICD  and 
NICD
BAP while ER-NICD
BAP expression remains constant.  
This leakage of the ER-system (leading to the activation of ER-NICD
BAP even in 
the absence of 4-OHT) maybe due to the induction of the ER-domain by growth factors 
in the medium. Maybe using a more recent ER-domain (Kalaitzidis et al., 2004) would 
have circumvented this problem.  
These results led me to abandon the inducible NICD system and I went on to 
establish  MCF10A  and  C3H10T½  cell  lines  stably  expressing  NICD
BAP  and  BirA. 
Biotinylation of NICD
BAP was confirmed in both cell lines by western blot analysis with 
a streptavidin probe (Figure 3.2A). In this case, I chose a slightly longer NICD version CHAPTER 3: Applications of the BAP/biotin-avidin system
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containing  the  S3  cleavage  site  (N1∆E),  which  is  recognised  by  the  γ-secretase 
complex.  Thus  this  leads  to  a  constitutive  active  form  of  Notch,  which  is  cleaved 
continuously. This strategy is advantageous because I could make use of a γ-secretase 
inhibitor (GSI) to block Notch signalling (at cleavage site S3) in these cells. This further 
provides an adjustable system for the bioChIP experiments in order to find Notch target 
genes by comparing GSI-treated and untreated cells.  
In  order  to find  a  GSI  that  specifically  blocks  Notch  signalling  in  my  cells I 
treated C3H10T½ [NICD
BAP; BirA] stable cell lines with different compounds: DAPT 
(N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylgly  cine  t-butyl  ester,  also  called 
IX), X and XVII and performed western blot analysis of cell lysates with streptavidin or 
an α-NICD antibody. Only DAPT was able to block Notch signalling, leading to a 
stabilisation of the membrane-bound N1∆E
BAP version (IX, Figure 3.2B).  
In  control  treated  cells  (DMSO,  Figure  3.2B)  two  fragments  are  visualised 
representing the longer N1∆E
BAP protein and a shorter NICD
BAP fragment, which results 
from constitutive cleavage in C3H10T½ [NICD
BAP; BirA] cells. Detection with an α-
NICD antibody thus results only in the detection of the cleaved NICD
BAP (Figure 3.2B, 
lower  panel).  A  signal  form  the  α-NICD  antibody  is  absent  in  DAPT  treated  cells 
showing a successful blockage of S3 cleavage. These results show that NICD
BAP is 
biotinylatable in the stable C3H10T½ and MCF10A cell lines and regulation of Notch 
activity is possible by blocking the processing of the extended NICD
BAP. In conclusion I 
generated  two  different  stable  cell  line  systems,  which  were  used  for  bioChIP 
experiments in order to determine the optimal conditions. 
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Figure 3.2 Evaluation of C3H10T½ and MCF10A stable cell lines expressing [BirA], [NICD
BAP; 
BirA]  and  [ER-NICD
BAP;  BirA].  (A)  Western  blot  of  crude  nuclear  extracts  from  C3H10T½  and 
MCF10A cell lines stably expressing [BirA], [NICD
BAP; BirA] or [ER-NICD
BAP; BirA]. Detection of 
NICD
BAP  and  ER-NICD
BAP  was  done  with  a  streptavidin-HRP  probe  (1:25,000)  (green  arrows).  T, 
C3H10T½;  M,  MCF10A.  (B)  γ-secretase  inhibitor  experiment  in  C3H10T½  [NICD
BAP;  BirA]  cells 
detects two different Notch species: N1∆E
BAP and NICD
BAP. Cells were incubated with the inhibitors 
DAPT (IX), X and XVII for 3 days at 37ºC/5% CO2. Detection of cleaved Notch products was done by 
western  blot  analysis  of  cell  lysates  using  a  streptavidin  (1:25,000)  probe  or  an  α-NICD  antibody 
(1:1,000). Green arrows point at respective products. Asterisks label endogenous biotinylated proteins. 
(C, D, E) Luciferase reporter assay in C3H10T½ [ER-NICD
BAP; BirA] (C), C3H10T½ (D) and MCF10A 
(E) cell lines transiently transfected without (control) or with Hes1-reporter (C) or with the Hes1-reporter 
alone (control), NICD, NICD
BAP or ER- NICD
BAP (D, E). After 24 h of transfection, 4-OHT (+; 1 µM 
final concentration) or EtOH (-) was added and cells incubated for another 24 h at 37ºC/5% CO2. Cells 
were lysed and the luciferase activity determined. Blue columns show luciferase activity of untreated 
cells and red columns represent reporter activation upon addition of 4-OHT. CHAPTER 3: Applications of the BAP/biotin-avidin system
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3.2.3  Optimisation of NICD bioChIP experiments in established cell lines 
Enriched  promoter  sequences  after  ChIP  experiments  are  quantified  using 
quantitative  PCR  (qPCR)  assays  and  primers  flanking  potential  transcription  factor 
binding sites. It has been shown that the number and orientation of CSL binding sites 
determine the strength of activation by the Notch transactivation complex consisting of 
the  DNA-bound  CSL,  NICD  and  the  co-activator  proteins  of  the  Mastermind-like 
family  (Nam  et  al.,  2007;  Ong  et  al.,  2006).  Head-to-head  formation  of  two  CSL 
sequences has been reported to constitute high affinity binding sites whereas tail-to-tail 
CSL sites correspond to low affinity binding in cell-based assays (Ong et al., 2006). 
Also the spacing between the individual CSL sites is crucial and promotes dimerisation 
of the Notch transactivation complex in vitro (Nam et al., 2007).  
After  validation  of  the  cell  lines  C3H10T½  [NICD
BAP;  BirA]  and  MCF10A 
[NICD
BAP; BirA], I performed bioChIP experiments to confirm activation of the Hes1 
promoter, a well-characterised Notch1 target, by the biotinylated NICD
BAP. In order to 
check  for  an  enrichment  of  CSL-containing  Hes1  promoter  sequences,  I  performed 
qPCR  reactions  with  primers  flanking  the  three  CSL  sites  just  upstream  of  the 
transcription start (Figure 3.3; section 7.6.1.1 and Table 7.19). The mouse and human 
Hes1  promoters  contain  two  CSL  sequences  in  a  head-to-head  fashion,  which  are 
separated by 16 nucleotides  and an additional low affinity binding site, all in close 
arrangement  within  100  bp  upstream  of  the  transcription  start  (Figure  3.3A  for 
MCF10A human and B for C3H10T½ mouse Hes1 promoter arrangement). 
The results from the bioChIP experiments from the stably transduced human and 
mouse  cell  lines  indicated  a  slight  enrichment  (4-fold)  of  the  CSL-containing  Hes1 
promoter sequences close to the transcription start only in MCF10A [NICD
BAP; BirA] 
cells  (Figure  3.3A).  The  distal  CSL  site,  5  kb  upstream,  was  not  pulled  down  in 
MCF10A  [NICD
BAP;  BirA]  experiments  (Figure  3.3A)  demonstrating  that  this  site 
might  not  bind  the  Notch  transactivation  complex  as  strongly  or  frequently  as  the 
proximal CSL close to the transcription start site during hHes1 (human Hes1) target 
gene  activation.  The  bioChIP  from  MCF10A  [BirA]  control  cells  did  not  enrich 
significantly any promoter sequences (blue columns, Figure 3.3A) indicating that the 
background binding is low.  CHAPTER 3: Applications of the BAP/biotin-avidin system
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By contrast to the human cell line, the results from the C3H10T½ [NICD
BAP; 
BirA] bioChIP did not show enrichment for CSL-containing promoter sequences (red 
columns, Figure 3.3B). The bioChIP from BirA-transduced C3H10T½ cells seemed to 
pull-down arbitrarily DNA sequences from any promoter (Figure 3.3B). The reason for 
these different outcomes could be the fact that the transgene has an effect on the human 
MCF10A cell line whereas Notch signalling is not active in C3H10T½ cells. Moreover, 
the timing of activation might be different in both cell lines. It has been documented 
that  the  transactivation  complex  does  not  always  reside  at  the  respective  CSL 
sequences,  and  that  its  binding  and  dissociation  from  the  DNA  is  highly  dynamic 
(Krejci and Bray, 2007). 
In  summary,  bioChIP  experiments  from  MCF10A  [NICD
BAP;  BirA]  cells 
produced  an  acceptable  result,  albeit  with  a  weak  enrichment  (4-fold)  of  hHes1 
promoter  sequences,  whereas  the  analysis  of  the  C3H10T½  [NICD
BAP;  BirA] 
streptavidin chromatin pull-downs are not conclusive. Therefore, I continued my studies 
only with the MCF10A [NICD
BAP; BirA] cells. 
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Figure 3.3 NICD bioChIP results from MCF10A [NICD
BAP; BirA] and C3H10T½ [NICD
BAP; BirA] 
cell  lines. (A,  B) qPCR results of NICD bioChIP experiments from  MCF10A [NICD
BAP; BirA]  and 
[BirA] (A) and C3H10T½ [NICD
BAP; BirA] and [BirA] (B) cell lines. Fold enrichment of [NICD
BAP; 
BirA]  bioChIP  (red  columns)  versus  [BirA]  experiments  (blue  columns)  over  GAPDH  is  shown. 
Arrangement of binding sites tested within the human Hes1 (hHes1) (A) and mouse Hes1 (mHes1) (B) 
promoters  are  indicated  above  the diagrams.  Rectangles represent  CSL binding  sites and orientation. 
Colour of rectangles shows strength of binding:  light blue,  low affinity  and dark blue, high  affinity. 
Arrow, start of transcription. CHAPTER 3: Applications of the BAP/biotin-avidin system
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My  results  were  obtained  using  the  commercially  available  protocol  for 
recovering bound chromatin, which uses moderate washing conditions (section 7.6.1.1). 
In  order  to  further  optimise  the  bioChIP  protocol,  I  tested  more  stringent  washing 
conditions after chromatin binding from MCF10A [NICD
BAP; BirA] cells. Viens et al. 
found that washing with 2% SDS and subsequent high ionic strength buffer leads to a 
decreased background binding in bioChIP experiment (Viens et al., 2004). I applied 
these  washing  conditions  to  my  bioChIP  experiments  in  order  to  achieve  a  higher 
enrichment of hHes1 promoter sequences in MCF10A [NICD
BAP; BirA] cells. Also, I 
tested another Notch target gene, c-Myc, which was shown to play a role in human acute 
T cell lymphoblastic leukaemia and lymphomas (T-ALL) and mammary tumorigenesis 
(Klinakis et al., 2006; Weng et al., 2006). The human c-Myc promoter contains one 
conserved CSL binding site located around the transcription start site (Figure 3.4).  
The outcome of this bioChIP experiment showed that the increased stringency 
does not help to improve the previous results. In contrast, the qPCR data indicated an 
enrichment  of  hHes1  promoter  sequences  even  in  the  absence  of  the  biotinylated 
NICD
BAP (Figure 3.4). The activation of the human c-Myc promoter was not confirmed 
in this experiment either (Figure 3.4). A possible explanation of these results might be 
the high stringency in the washing step. Since NICD does not bind the DNA directly but 
through CSL the harsh washing could have led to the dissociation of the transactivation 
complex. This would show similar results for [NICD
BAP; BirA] and [BirA] cells (Figure 
3.4). 
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Figure 3.4 More stringent washing conditions do not improve bioChIP experiments from MCF10A 
[NICD
BAP;  BirA]  cells.  qPCR  results  of  bioChIP  experiments  from  MCF10A  [NICD
BAP;  BirA]  (red 
columns) and [BirA] (blue columns) stable cell lines. The relative enrichment of human Hes1 (hHes1) 
and human c-Myc (hc-Myc) promoter sequences is shown in relation to human GAPDH. The arrangement 
of  CSL  binding  sites  as  well  as  the  negative  sites  is  indicated  in  the  schematic  hHes1  and  hc-Myc 
promoters above. Rectangles show position and orientation of CSL sites on the respective promoters. 
Colour of rectangles indicates strength of binding: light blue, low affinity and dark blue, high affinity. 
Arrow, start of transcription.  
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3.2.4  Visualisation of NICD
BAP in cultured cells and transgenic mouse 
embryos 
An explanation for the lack of detection of NICD binding to the human Hes1 
promoter in subsequent experiments could also be due to a loss of NICD
BAP by the 
presumable stable cell lines. The NICD
BAP is expressed without antibiotic selection and 
the  cells  might  lose  the  construct.  To  check  this  possibility,  I  performed 
immunofluoresence microscopy directed against the green fluorescent protein (GFP), 
which is expressed from the NICD
BAP di-cistronic message. Streptavidin coupled to a 
fluorophor should detect the biotinylated NICD
BAP in MCF10A [NICD
BAP; BirA] cells.  
Using this approach I could show, that indeed most cells (~80%) of the double 
stable  MCF10A  [NICD
BAP;  BirA]  cell  line  had  lost  GFP  expression  and  therefore 
NICD
BAP (Figure 3.5A, arrowheads). These results were further supported by western 
blot analysis of stable cell lines, which were cultured beyond 10 passages (not shown). 
The fact, that the double stable cell lines are unable to maintain a constant NICD
BAP 
expression (due to the lack of a resistance marker) explains the inconsistent results from 
the  previous  ChIP  experiments.  This  suggests,  that  experiments  with  the  MCF10A 
[NICD
BAP;  BirA]  cell  line  do  not  reproduce  reliable  results  and  therefore  does  not 
provide a suitable system to identify Notch signalling targets. 
Another  drawback  of  the  BAP/biotin-avidin  strategy  became  apparent  in  the 
immunofluorescence assay: the streptavidin probe did not pick up biotinylated NICD
BAP 
in  MCF10A  [NICD
BAP;  BirA]  cells  but  a  structured  network  within  the  cell  body, 
presumably the mitochondria (Figure 3.5A, red channel; compare to Figure 2 in (Millar 
et  al.,  2005)).  The  same  pattern  was  visible  when  staining  embryonic  tail  sections 
(Figure  3.5B)  or  retinas  from  transgenic  Notch1
BAP/BAP;Rosa26
BirA/BirA  and 
Rosa26
BirA/BirA  and  mice  (Figure  3.5C  and  D).  In  contrast,  sections  from  transgenic 
embryos probed with an α-NICD antibody resulted in a distinct expression pattern, 
which  co-localised  with  the  DNA-specific  dye  DAPI  and  confirmed  a  nuclear 
localisation  of  NICD
BAP  (Figure  3.5B,  arrowhead).  Probing  retinas  from  mice 
expressing  only  the  biotinylase  with  streptavidin  resulted  in  the  same  cytoplasmic 
pattern as detected in cells and tissues expressing biotinylated NICD
BAP (Figure 3.5D, 
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Additional  evidence  for  an  unspecific  streptavidin  binding  comes  from 
experiments demonstrating the localisation of biotinylated Hes7
BAP in cultured cells. An 
antibody  raised  against  Hes7  was  able  to  confirm  nuclear  localisation  of  Hes7
BAP 
whereas the streptavidin probe labelled cytoplasmic structures and was identical to the 
pattern seen in MCF10 [NICD
BAP; BirA] cells and transgenic animals (not shown). This 
suggests,  that  probing  with  streptavidin  results  in  an  unexpected  high  background. 
Therefore the BAP/biotin-avidin system cannot be used to determine the intracellular 
localisation  of  the  biotinylated  NICD
BAP  protein  by  confocal  microscopy.  However, 
bioChIP  experiments  from  transgenic  Notch1
BAP/BAP;Rosa26
BirA/BirA  should  not  be 
affected by the mainly cytoplasmic noise because nuclear extracts are used for this kind 
of application.  
In conclusion the experiments on the MCF10A [NICD
BAP; BirA] and C3H10T½ 
[NICD
BAP; BirA] cell lines suggest that these systems are not suitable to address the 
question  of  Notch  signalling  targets.  First,  the  bioChIP  procedure  does  not  lead  to 
reproducible results and thus is not robust enough to perform genome-wide studies. 
Possible reasons for this are the indirect binding of NICD to the DNA and the highly 
dynamic behaviour of the transactivation complex (Krejci and Bray, 2007). Second, I 
am not able to keep double stable cell lines due to the lack of selection for the NICD
BAP, 
which leads to a reduced expression of the biotinylated NICD
BAP.  
Altogether, the optimisation of the bioChIP procedure on the stably transduced 
cell lines was useful in determining the formaldehyde fixation as well as sonication set-
up and the application of different washing conditions. However, these data are erratic, 
do not show reproducible results and lead to a high variability between different cell 
lines. I therefore decided to stop working on these cell lines and instead continue with 
the  in  vivo  bioChIP  experiments  from  transgenic  mouse  tissue,  where  NICD
BAP  is 
expressed from the endogenous Notch1 promoter. The advantages of the in vivo system 
are that there is no untagged NICD present and the stable integration of the transgene in 
the knock-in mice. 
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Figure  3.5  Application  of  the  BAP/biotin-avidin  system  for  intracellular  localisation  of  the 
biotinylated NICD
BAP protein. (A) Immunostaining of MCF10A [NICD
BAP; BirA] cells with an α-GFP 
(1:100) antibody and streptavidin conjugated Alexa Fluor 594 (1:500). Nuclei were stained with DAPI. 
Arrowhead points at a cell without GFP expression. Arrow indicates cell with GFP and thus biotinylated 
NICD
BAP  expression.  (B)  Immunostaining  of  transverse  sections  of  Notch1
BAP/BAP;Rosa26
BirA/BirA 
embryonic tails with an α-NICD antibody (1:100) and streptavidin conjugated Alexa Fluor 488 (1:500). 
DNA was visualised with DAPI. Arrowhead points at nuclear NICD staining. s, somite; nt, neural tube; t, 
tip of the tail. (C, D) Immunostaining of P5 mouse retinas from Notch1
BAP/BAP;Rosa26
BirA/BirA (C) and 
Rosa26
BirA/BirA (D) transgenic mice with Isolectin coupled to Alexa Fluor 568 (1:500) to stain the blood 
vessels or streptavidin Alexa Fluor 488 (1:500) to visualise biotinylated NICD
BAP. DAPI was used to 
stain the DNA. Arrowheads point at auto-fluorescent erythrocytes.  CHAPTER 3: Applications of the BAP/biotin-avidin system
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3.2.5  Identifying Notch target genes from Notch1
BAP/BAP;Rosa26
BirA/BirA 
transgenic mice by bioChIP and high-throughput sequencing 
I chose to investigate Notch activity by analysing binding to the Hes1 promoter by 
bioChIP  in  cells  of  the  developing  mouse  retina  in  the  Notch1
BAP/BAP;Rosa26
BirA/BirA 
transgenic  strain.  It  has  been  reported  that  inhibition  of  Notch  signalling  using  γ-
secretase inhibitors promotes vascular sprouting in the mouse retina (Hellstrom et al., 
2007). In particular the number of tip cells, which lead each vessel sprout, increases. 
Conversely, the activation of Notch signalling causes a reduced tip cell fate (Hellstrom 
et al., 2007). In collaboration with Dr. Holger Gerhardt (Vascular Biology Laboratory, 
Cancer Research UK London Research Institute) I set out to identify Notch signalling 
targets  that  mediate  the  tip  cell  fate  in  the  developing  retinal  vasculature.  bioChIP 
experiments  from  retina  tissue  of  Notch1
BAP/BAP;Rosa26
BirA/BirA  (Notch1
BAP;BirA)  and 
Rosa26
BirA/BirA (BirA) mice, with or without γ-secretase inhibitor DAPT-treatment, are 
predicted to show a difference in the target gene pool. Novel candidate targets were 
analysed  through  high-throughput  sequencing  and  their  role  in  vessel  sprouting 
investigated.  
Briefly, Notch1
BAP;BirA and BirA (control strain) five day old (P5) pups were 
injected  subcutaneously  with  DAPT.  In  order  to  check  if  the  DAPT  treatment  was 
efficient, I performed western blot analysis of skin tissue from injected Notch1
BAP;BirA 
and  BirA  pups.  A  reduced  level  of  NICD  and  NICD
BAP  expression  and  hence  the 
blockage of Notch signalling was confirmed (Figure 3.6A, middle blot). These results 
show that already after three hours a substantial decrease in NICD protein levels is 
observed (Figure 3.6A, middle blot). The duration of treatment seemed suitable for the 
bioChIP experiment because switching off target gene transcription occurs faster than 
protein degradation. 
For the bioChIP experiment I harvested eyes and dissected retinas three hours 
after DAPT injection. From a pool of retinas I prepared chromatin and sheared it to an 
average  length  of  300  bp  (Figure  3.6B).  Following  the  streptavidin  pull-down  and 
washes,  bound  chromatin  was  eluted  and  analysed  by  qPCR  in  the  first  instance. 
bioChIP pre-experiments with transgenic mouse tissue (section 7.6.1.2) using qPCR to 
assay the outcome did not result in the purification of known Notch1 target sites in the 
promoter  of  Hes1  or  Nrarp  (Notch-regulated  ankyrin  repeat  protein,  a  previously CHAPTER 3: Applications of the BAP/biotin-avidin system
 
 
 
88 
characterised  Notch  target  gene  in  the  retina,  (Phng  et  al.,  2009)  (not  shown).  I 
hypothesised that these known targets might be obscured by a high amount of either 
other  specifically  or  of  unspecifically  pulled-down  DNA  fragments.  In  order  to 
thoroughly analyse my bioChIP results, I sequenced the entire eluate of the bioChIP 
experiment from transgenic retina tissue (Figure 3.6B). 
Therefore, the bioChIP-enriched DNA was converted into a library suitable for 
high-throughput  sequencing  with  Illumina  Genome  Analyzer.  Subsequent  steps 
involved the ligation of sequencing adapters to the DNA fragments, the amplification of 
the ChIP-seq library by PCR and gel purification of the DNA. Sequencing was done 
using the Illumina chemistry as described before (Bentley et al., 2008) and carried out at 
the Cancer Research UK Leeds Institute of Molecular Medicine. 
Eight different samples, each comprising of an input (10% of starting material), a 
ChIP  (purified  chromatin)  and  two  different  treatment  conditions  (with  and  without 
DAPT; Table 7.20) were processed in the Illumina Genome Analyzer to yield 1Gbase 
of output reads. The sequencing process produces image files as raw format, which are 
processed to obtain nucleotide-base calls. The resulting 36 bp reads were subsequently 
aligned to the mouse genome using the standard Illumina pipeline.  
However, due to an imbalance in forward and reverse sequence reads it was not 
possible to call “peaks” (of enriched loci) using de facto standard approaches. Several 
different analysis strategies were undertaken in order to align the sequence reads to the 
genome and to call peaks (section 7.6.1.3).  
The  Bio-Notch  samples  were  subsequently  corrected  for  the  BirA  background 
resulting in 4 experimental conditions: input neg, ChIP neg (without DAPT) and input 
pos,  ChIP  pos  (with  DAPT)  and  an  enrichment  of  the  ChIP  sample  over the  Input 
calculated. The resulting peaks were mapped back onto the mouse genome and yielded 
a list of target genes for the two conditions (with and without DAPT). However, Hes1 
and Nrarp, two characterised target genes in the retina, were not called in the target list. 
The  predicted  outcome  would  have  been  to  detect  NICD  at  the  Hes1  and  Nrarp 
promoters  in  the  ChIP  neg  condition  whereas  NICD  should  be  absent  from  these 
promoters in the DAPT treated condition.  
These  results  mirror  the  NICD  bioChIP  experiments  from  cultured  cells 
demonstrating a challenge in detecting NICD at known Notch target promoters. Most CHAPTER 3: Applications of the BAP/biotin-avidin system
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likely  the  Notch  transactivation  complex  exhibits  a  more  dynamic  behaviour  than 
previously suggested. However, the list of identified target genes will be anlysed further 
and might contain interesting genes, which can be studied in vessel sprouting in the 
future.  
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Figure 3.6 Strategy to identify novel in vivo targets of Notch signalling in the postnatal retina of 
Notch1
BAP;BirA mice. (A) Wester blot of protein extracts from Notch1
BAP;BirA and BirA skin and retina 
tissues were probed with streptavidin (1:25,000, top), α-NICD (1:1,000; middle) or α-HA antibodies 
(1:1,000) to detect biotinylated NICD
BAP (green arrow and rectangle), endogenous NICD (green arrow) or 
3xHA-BirA (black arrow), respectively. Asterisks label signals from endogenous biotinylated proteins. 
(B)  Schematic  of  NICD
BAP  bioChIP  procedure  from  DAPT  treated  or  untreated  P5  BirA  and 
Notch1
BAP;BirA retinas. Briefly, P5 pups were injected subcutaneously with DAPT or vehicle. After 3 h 
eyes were harvested and retinas dissected. Following the formaldehyde fixation, which generates protein-
protein and protein-DNA crosslinks (red line), the chromatin was sonicated into fragments of defined 
lengths. 3 or 5 µg of DNA was loaded onto a 1% agarose gel to check average length. The crosslinked 
transactivation  complex  consistent  of  target  bound  CSL  (blue)  and  NICD
BAP  was  purified  through 
streptavdin binding (bioChIP). Bound material was eluted by reversing the crosslinks. Target genes were 
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3.2.6  Interaction of NICD with CSL in mouse embryos 
So  far,  I  could  not  show  that  the  BAP/biotin-avidin  system  is  working 
successfully in bioChIP assays to identify novel Notch target genes. One possibility 
might be the fact that NICD does not bind DNA directly but via CSL. Usually, ChIP 
(and bioChIP) experiments are designed to pull-down a transcription factor that directly 
binds its DNA target sites. A possible explanation for the failure in detection of known 
Notch  signalling  targets  such  as  Hes1  in  bioChIP  experiments  could  be  the  weak 
interaction  between  NICD  and  DNA-bound  CSL  leading  to  a  dissociation  of  the 
transactivation complex during the bioChIP procedure. 
In order to test a possible dissociation of NICD and CSL after crosslinking I 
performed  streptavidin  protein  pull-down  experiments  from  crosslinked  embryonic 
Notch1
BAP;BirA and BirA protein lysates to investigate CSL binding by western blot 
analysis (Figure 3.7). I failed to detect CSL in the bound fraction (Figure 3.7, S) of 
Notch1
BAP;BirA  embryos  after  binding  to  the  streptavidin  matrix  whereas  I  clearly 
enriched for biotinylated NICD
BAP (Figure 3.7, green rectangle). CSL protein was only 
detected in the input (Figure 3.7, I) sample of Notch1
BAP;BirA and BirA embryonic 
extracts.  
This  suggests,  that  the  interaction  between  CSL  and  NICD
BAP  despite 
formaldehyde crosslinking is lost during streptavidin purification or there might not 
have been an interaction in the first place. Proteins within the nucleus show a very 
dynamic behaviour (in protein-protein and protein-DNA interactions) because they need 
to  respond  quickly  to  cues  transmitted  by  signalling  cascades  (reviewed  in  Misteli, 
2001). Thus it is likely that NICD
BAP and CSL did not interact in my experiments or 
only transiently due to a highly dynamic environment. It has been shown previously that 
an  interaction  between  NICD  and  CSL  is  confirmed  only  upon  induction  of  Notch 
signalling (Krejci and Bray, 2007). 
Another explanation for the observed lack of interaction between NICD
BAP and 
CSL  in  embryonic  lysates  could  be  that  CSL  dissociated  during  the  washing  step. 
Although, proteins were crosslinked this might not have been sufficient to maintain a 
link between NICD
BAP and CSL.  
In conclusion these experiments are consistent with interactions between NICD 
and  CSL  being  transient  and  does  not  allow  me  to  identify  novel  targets  of  Notch CHAPTER 3: Applications of the BAP/biotin-avidin system
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signalling through the approach of the bioChIP from my transgenic mice. Although 
target genes such as Hes1 are expressed in embryonic and retina tissue my approach is 
greatly  limited  by  temporally  controlling  Notch  pathway  activation.  During  normal 
signalling in the animal, Notch activity does not occur as concerted as in experiments by 
Krejcic  et  al.,  which  profited  from  the  ability  to  control  the  timing  of  activation 
precisely in their system (Krejci and Bray, 2007).  
 
 
Figure 3.7 Streptavidin protein pull-down from Notch1
BAP;BirA E10.5 crosslinked embryos does 
not purify CSL, a direct protein partner of NICD. 500 µg of BirA and Notch1
BAP;BirA embryonic 
lysates were loaded onto streptavidin coated beads and incubated for 4 h at 4ºC. Beads were washed three 
times and bound material eluted by boiling in loading buffer. 20 µl eluate was run on a 4-12% Bis-Tris 
gel. 1% of the input fraction (I) was loaded next to the streptavidin pull-down sample (S). Western blot 
analysis with streptavidin-HRP probe (1:25,000; top) or an α-CSL antibody (1:1,000). Asterisks label 
signals from endogenous biotinylated proteins. 
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3.2.7  Identification of NICD protein binding partners in vivo via biotin-
streptavidin binding 
The BAP-biotin/avidin system has primarily been used for the identification of 
protein  interaction  partners  (de  Boer  et  al.,  2003;  Fernandez-Suarez  et  al.,  2008; 
Furuyama and Henikoff, 2006; Grosveld et al., 2005; Hamlett et al., 2008; Rodriguez et 
al., 2005). Because of the direct binding, purification of such partners might be more 
robust than of chromatin. Identification of protein binding partners of NICD does not 
only help to further evaluate the bioChIP method, but it is also of biological interest. 
For  the  activation  of  Notch  target  genes,  the  formation  of  a  ternary  complex 
consisting of NICD, the DNA-binding transcription factor CSL and the transcriptional 
co-activator Mastermind is obligatory (Kovall, 2008; Petcherski and Kimble, 2000b; 
Wu  et  al.,  2000)  (section  1.2.3).  Recruitment  of  the  general  transcription  factors 
CBP/p300 and PCAF is required for target gene activation and further factors are likely 
to be involved (Fryer et al., 2002; Kurooka and Honjo, 2000; Wallberg et al., 2002).  
Are additional nuclear components involved in vivo for promotion or dissociation 
of  the  transactivation  complex?  In  order  to  answer  this  question  I  performed 
streptavidin  protein  pull-down  experiments (section  7.5.8) from  transgenic  embryos, 
which might lead to the identification of NICD binding partners. The protein profile 
after  streptavidin  pull-down  of  nuclear  embryonic  lysates  from  transgenic 
Notch1
BAP;BirA embryos resulted in 11 proteins that were found in Notch1
BAP;BirA but 
absent in BirA and wildtype (Figure 3.8A and Table 3.1). Prominent bands that were 
enriched after streptavidin binding, and consisted of several proteins, were isolated and 
analysed by mass spectrometry (see Figure 3.8A for annotation of the proteins analysed; 
section 7.5.9).  
Pull-downs with epitope-tagged proteins normally lead to an enrichment of the 
tagged  protein  after  purification  compared  to  the  input.  Due  to  the  extremely  low 
concentration of the NICD protein I was not able to detect or to see an enrichment of 
NICD
BAP after purification on the stained gel (Figure 3.8A). However, on the western 
blot, which is a more sensitive method than protein identification by mass spectrometry 
I could visualise biotinylated NICD
BAP (Figure 3.8B, green arrow). This demonstrates, 
that the principle of the streptavidin purification is working in transgenic mouse tissues. CHAPTER 3: Applications of the BAP/biotin-avidin system
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I chose to analyse the 30 bands, which highly enrich after streptavidin purification 
compared to the input fraction (Figure 3.8A, compare lane I to S for each genotype). 
Visual examination of the protein lanes from different genotypes suggested that there 
was  no  difference  in  the  protein  profile  indicating  a  non-specific  binding  to  the 
streptavidin  matrix  (Figure  3.8A).  Mass  spectrometry  and  further  computational 
mapping of the peptides yielded 74 proteins most of which were identical in wildtype, 
BirA  and  Notch1
BAP;BirA.  However,  11  “novel”  proteins  were  identified  in  the 
Notch1
BAP;BirA lane only, likely Notch interaction partners pulled down with NICD
BAP, 
9 of them came up in the analysis from fragment 30 (Table 3.1).  
All of the 74 proteins identified were nuclear factors, mainly of the high abundant 
ribosomal protein family or proteins involved in the RNA metabolism (Figure 3.8D). 
None  of  the  analysed  proteins  was  directly  related  to  the  Notch  pathway  nor  did  I 
identify known binding partners such as CSL or Mastermind. The reason for this result 
might be that nuclear proteins arbitrarily bind the streptavidin beads and the background 
masks low abundance proteins, such as CSL.  
Previous  reports  have  indicated,  that  histones  might  be  biotinylated  as  well 
(Camporeale et al., 2007; Camporeale et al., 2004; Chew et al., 2008; Kobza et al., 
2005).  In  order  to  check  this  possibility,  I  used  a  16%  Tricine  gel  to  separate  the 
proteins after streptavidin pull-down for a better resolution in the low molecular weight 
range to detect the small histones. I identified histone cluster H1 in the protein pull-
down from wildtype, BirA and Notch1
BAP;BirA embryonic tissues (Figure 3.8A; protein 
bands 1, 2, 3). However, biotinylation of histone H1 has not been shown in previous 
studies. Histone H1 fulfils a structural function within the chromatin and so far has not 
been reported to be involved in epigenetic modifications (Happel and Doenecke, 2009).  
Since,  histone  cluster  H1  was  also  purified  with  streptavidin  from  wildtype 
protein lysate, there might be a possibility, that histone H1 is naturally biotinylated. But, 
mass spectrometry and computational motif search did not reveal a site for biotinylation 
modification. This could be due to the mass spectrometry analysis technique, which was 
not  sensitive  enough  for  this  kind  of  application.  Further  investigations  towards  a 
possible  naturally  occurring  biotinylation  of  histone  H1  were  not  pursued  due  to 
technical limitations.  
Within the identified protein pool one protein with a possible biotinylation site 
was discovered (by computational motif search analysis): mCG3370, but the function CHAPTER 3: Applications of the BAP/biotin-avidin system
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remains elusive (Mural et al., 2002). Since this protein was discovered in wildtype and 
transgenic embryonic lysates it can be excluded from the Notch target gene list.  
In summary the streptavidin protein pull-down experiments from transgenic BirA 
and Notch1
BAP;BirA embryos were not satisfactory due to the high background binding, 
suggesting that this approach is not suitable to find novel NICD interacting proteins in 
vivo. 
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Figure 3.8 Application of the BAP/biotin-avidin system to identify novel protein binding partners of 
NICD in Notch1
BAP;BirA embryos. (A) Streptavidin purification of biotinylated proteins from wildtype 
(WT), BirA and Notch1
BAP;BirA embryonic lysates. 2 mg of nuclear extracts were bound to 40 µl of 
blocked streptavidin beads and incubated for 2 h at 4ºC. Beads were washed and subsequently eluted in 
50 µl loading buffer by boiling. 20 µl was loaded onto a 16% Tricine gel. The gel was stained with 
Colloidal  Blue  and  indicated  products  (1-30),  consisting  of  several  different  proteins,  cut  out  and 
analysed by mass spectrometry. I, input; U, unbound; S, streptavidin purification. Arrowhead points at 
streptavidin  subunit  (as  identified  in  C).  (B)  Western  blot  to  detect  biotinylated  Notch1
BAP  from 
streptavidin pull-down of BirA and Notch1
BAP;BirA embryonic extracts. Visualisation of the protein was 
done by streptavidin probe (1:25,000) or an α-NICD antibody (1:1,000). Green arrows point at detected 
biotinylated NICD
BAP. (C) Streptavidin protein purification from C3H10T½ cells identified endogenous 
biotinylated proteins as seen in western blots from whole and crude nuclear cell lysates (*) as well as the 
streptavidin precursor (arrowhead). (D) Classification of proteins from bands 1-30 (A) identified by mass 
spectrometry. CHAPTER 3: Applications of the BAP/biotin-avidin system
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Protein identified  Sample 
number 
Unique 
peptides 
weight 
in kD 
DEAH (Asp-Glu-Ala-His) box polypeptide 15 isoform 2 
(NP_031865) 
30  5  89 
nucleolar complex associated 2 homolog 
(NP_067278) 
30  4  86 
tripartite motif protein 28 
(EDL38082) 
30  3  89 
RNA binding motif protein 5 
(NP_683732) 
6  3  92 
activating signal cointegrator 1 complex subunit 1 
(NP_081213 XP_483908) 
9  3  41 
small nuclear ribonucleoprotein polypeptide A', isoform CRA_c 
(EDL07232) 
30  3  25 
tuftelin interacting protein 11 
(NP_061253) 
30  2  96 
1810007M14Rik protein 
(AAH27145) 
30  2  105 
nucleolar RNA-associated protein beta (Nrap) 
(AAL74402) 
30  2  129 
similar to FtsJ homolog 3 isoform 2 
(NP_079586) 
30  2  96 
RNA-binding protein 12B-B (RNA-binding motif protein 12B-B) 
(Q66JV4) 
30  2  97 
Table  3.1  Proteins  identified  in  Notch1
BAP/BAP;Rosa26
BirA/BirA  embryonic  nuclei.  NCBI  nucleotide 
accession  numbers  are  given  in  brackets.  Sample  number  indicates  excised  protein  band  from 
Figure 3.8A. Unique peptides identify the number of distinct peptides that were found by mass 
spectrometry and matched to a single protein. 
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3.3  Discussion 
This chapter describes my endeavour to purify both Notch target chromatin and 
NICD-interacting proteins in vivo from transgenic Notch1
BAP;BirA mice. However, my 
strategy  did  not  prove  successful.  I  was  able  to  perform  bioChIP  experiments  in  a 
previously optimised system, the MEL [GATA-1
BAP; BirA] (de Boer et al., 2003) stable 
cell  line,  but  NICD
BAP  turned  out  not  to  be  an  applicable  bait  for  bioChIP  and 
streptavidin protein pull-down assays from cell lines or transgenic mouse tissue. 
3.3.1  Testing the BAP/biotin-avidin system  
Possible reasons why the GATA-1
BAP experiments worked while the NICD
BAP 
approach failed include: Firstly, identifying GATA-1 binding sites as well as protein 
complex  partners  was  done  within  a  cell  culture  system  which  allowed  a  timed 
activation (and overexpression) of the GATA-1  transcription factor. My attempts to 
create a controllable tissue culture system failed due to the constitutive activity of the 
supposedly hormone inducible ER-NICD
BAP.  
Secondly,  GATA-1  binds  transcriptional  targets  directly  and  creates  a  stable 
complex on the DNA, whereas NICD target gene activation is complex and requires the 
additional adaptor protein CSL for physical interaction with the target DNA.  
Lastly,  The  concentration  of  the  biotinylated  GATA-1
BAP  protein  lies  orders 
above  the  one  of  NICD
BAP  in  vivo  (Schroeter  et  al.,  1998)  which  facilitates  the 
purification of GATA-1
BAP associated proteins and chromatin. 
Thus, the low level of NICD
BAP (Schroeter et al., 1998), the indirect DNA binding 
as  well  as  the  complex  and  transient  interaction  between  NICD
BAP  and  its  nuclear 
partners (Krejci and Bray, 2007) impede the application of the bioChIP procedure for 
identifying novel Notch signalling targets and protein binding partners. 
Previous attempts to identify targets of NICD were limited to genomic arrays and 
comparative expression studies in tissue culture cells (Weng et al., 2006) as well as 
ChIP experiments directed against CSL in cultured Drosophila cells (Krejci et al., 2009) 
(section 1.2.5). Targeting CSL in search for novel Notch signalling targets could be a 
more  promising  approach  because  CSL  binds  DNA  directly  and  can  function  as  a 
readout  for  Notch  signalling  targets.  However,  one  needs  to  consider  the  dynamic CHAPTER 3: Applications of the BAP/biotin-avidin system
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behaviour of the different CSL complexes mediating repression and activation. It has 
been shown that a complex of CSL with its co-repressors resides on the target DNA 
only for a short time and is unstable (Krejci and Bray, 2007). Upon temporal activation 
of the Notch pathway, CSL forms a complex with NICD and co-activators, which leads 
to  high  stability  DNA  interaction  in  cultured  Drosophila  cells  (Krejci  et  al.,  2009; 
Krejci and Bray, 2007). Thus, in order to maximise target readout, a timely regulated 
Notch pathway activation can be of benefit (Krejci et al., 2009; Krejci and Bray, 2007).  
Expressing biotinylated NICD
BAP did not lead to the discovery of novel Notch 
targets.  In  the  future,  I  would  suggest  testing  a  similar  approach  using  in  vivo 
biotinylated CSL because of the fact that CSL does bind DNA directly. Pre-experiments 
to investigate an appropriate position of the BAP-tag within CSL and confirmation of 
biotinylation would be crucial. Although experiments in tissue culture cells are useful, 
they  do  not  always  predict  the  in  vivo  behaviour  as  revealed  by  my  transgenic 
Hes7
BAP/BAP mice (chapter 4). 
It has been reported, that histones are biotinylated in flies, mouse and human, 
which is mediated by the holocarboxylase synthetase (HCS) (Camporeale et al., 2006; 
Narang et al., 2004). In particular, biotinylation was shown for histone H2A (Chew et 
al., 2006) H3 (Kobza et al., 2005) H4 (Camporeale et al., 2004). Because of the high 
abundance of histones, I had to expect to pull-down these histones with my streptavidin 
beads.  However,  my  attempt  to  identify  biotinylated  histones  resulted  only  in  the 
detection of the histone cluster H1 by mass spectrometry from both embryonic wildtype 
and transgenic tissues (Figure 3.8A protein bands 1,2,3 and D). Previous studies have 
not  found  histone  1  to  be  biotinylated  nor  to  have  a  function  in  epigenetics  but  in 
chromatin structure (Happel and Doenecke, 2009). My results from the protein pull-
down and further computational analysis of a possible biotin modification concluded 
that the histone 1 is probably not biotinylated and only represents background.  
Altogether  the  BAP/biotin-avidin  system  is  not  appropriate  to  identify  novel 
Notch DNA targets and protein binding partners in vivo or ex vivo. The complex nature 
of Notch target gene activation, as well as the extremely high background binding of 
naturally unbiotinylated proteins are the major drawbacks of this strategy.  CHAPTER 3: Applications of the BAP/biotin-avidin system
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3.3.2  Decoding the mouse retina “Notch targetome”  
There is an increasing demand for the global mapping of transcription factors in 
order to gain insight into the complex gene regulatory network. However, transcription 
factors do not bind all targets in the genome, which contain their specific motif (Carroll 
et al., 2005; Rabinovich et al., 2008). Conversely, transcription factors can also bind 
non-canonical sequence motifs (Carroll et al., 2005; Cawley et al., 2004; Rabinovich et 
al., 2008) and motif patterns of a transcription factor can vary between different species 
(Borneman  et  al.,  2007;  Odom  et  al.,  2007).  ChIP-seq  provides  an  opportunity  to 
address these questions like in the context of Notch signalling in the retina. 
I decided on ChIP-seq rather than ChIP-chip (hybridisation of the purified DNA 
pool to a tiling array) because of the greater resolution, higher sensitivity and specificity 
(reviewed in Schmidt et al., 2009). Moreover, ChIP-seq reactions require less input 
material than ChIP-chip (nanograms for ChIP-seq versus micrograms for ChIP-chip) 
and  experiments  can  be  done  faster  because  they  are  not  dependent  on  design  and 
production of tiled microarrays. Another advantage of ChIP-seq is the possibility of 
detecting  low-affinity  transcription  factor  binding  sites  as  well  as  mutations  within 
binding sites.  
However, ChIP-seq analysis data can be biased by different sources, which leads 
to the enrichment of non-specific genomic regions, like unspecific immunoprecipitation, 
imprecise mapping of sequence tags as well as bias resulting through PCR. Identified 
binding sites do not have to be real transcription factor targets: there is also a possibility 
that  looping  of  the  DNA  as  well  as  protein-protein  interactions  can  lead  to  the 
identification of an enriched region. Furthermore with ChIP-seq experiments it is still 
not possible to distinguish between binding events within a whole cell population and 
an  event  in  a  single  cell  at  a  time. Technologies  towards  this  goal  still  need  to  be 
established and optimised in order to perform single cell ChIP-seq and will be able to 
give answers about target activation in time (Jothi et al., 2008). 
In  contrast  to  the  NICD  approach,  ChIP-chip  and  ChIP-seq  experiments  were 
performed successfully before with histones (Huebert et al., 2006; Negre et al., 2006; 
Robertson et al., 2008). However, core histones are the exception in the highly dynamic 
nuclear  landscape  and  reside  on  the  chromatin  for  several  hours  as  compared  to 
transcription factors which establish contact with their target sites for seconds (reviewed CHAPTER 3: Applications of the BAP/biotin-avidin system
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in Misteli, 2001). This fact greatly facilitates ChIP approaches to map histones and 
modifications thereof on the chromatin.  
Although I was not successful to identify the Notch targetome in the mouse retina 
using the NICD bioChIP-seq approach I have shown that Notch target gene activation 
might be more intricate and dynamic than previously thought. 
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CHAPTER 4:  Characterisation  of  Hes7
BAP/BAP  mice  reveal 
differential axial requirements for Hes7 transcription 
4.1  Introduction 
The basic helix-loop-helix (bHLH) transcription factor Hes7 plays an important 
role during the formation of somites in the developing mouse embryo (Kageyama et al., 
2007a; section 1.2.5.1). Both loss-of-function and persistent overexpression of Hes7, 
which normally has cyclic expression, leads to fused and irregular somites and thus 
severe malformation of vertebrae and ribs (Bessho et al., 2001b; Hirata et al., 2004). In 
order to find in vivo DNA targets of Hes7 during segmentation, I generated transgenic 
mice expressing an epitope-tagged version of Hes7 (Hes7
BAP) using a novel approach 
(chapter  2).  However,  tagging  Hes7  itself  caused  an  interesting  segmentation 
phenotype, which differs from the Hes7 null phenotype (Figure 4.1).  
4.2  Results 
This chapter deals with the analysis of the Hes7
BAP/BAP (BAP/BAP) mice: first I 
characterise  the  skeletal  phenotype  in  detail,  and  then  I  examine  the  expression  of 
putative Hes7 target genes and other key factors of somitogenesis. 
4.2.1  BAP/BAP mutant skeletons show a regionalised axial phenotype 
In order to dissect the axial phenotype of BAP/BAP mice, I analysed skeletons of 
E18.5 foetuses and compared them to wildtype, heterozygous Hes7
BAP/+ (BAP/+) and 
Hes7  knock-out  specimens.  In  Hes7
-/-  mice  most  of  the  Hes7  coding  region  was 
removed and instead, the lacZ gene was placed under the control of the endogenous 
promoter by homologous recombination in embryonic stem cells (Bessho et al., 2001b). 
The wildtype skeleton consists of 7 cervical, 13 thoracic, 6 lumbar, 4 sacral and 
around 30 tail vertebrae (from head to tail) including 13 pairs of ribs which attach at the 
thoracic vertebrae (Tam, 1986) (not shown). BAP/+ E18.5 skeletons are identical to 
wildtype skeletons in the number and size of vertebrae and will therefore be referred to 
as “control” in further experiments (Figure 4.1B; Table 4.1).  CHAPTER 4: Characterisation of the Hes7
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In contrast, Hes7
-/- foetuses show a severely disorganised axial skeleton with a 
very short tail and no regular vertebrae or ribs (Figure 4.1D; Table 4.1) (Bessho et al., 
2001b).  The  entire  length  of  the  vertebral  column  is  significantly  short  with  fused 
vertebral bodies and neural arches (Figure 4.1E; Table 4.1). The ribs are fused and the 
number of rib pairs is 7, instead of the normal 13 (Table 4.1).  
Heterozygous  BAP/+  mutant  mice  are  indistinguishable  from  wildtype  mice, 
whereas BAP/BAP mice have severe segmentation defects in the cervical, thoracic and 
lumbar area with fused vertebrae and ribs, as well as truncated tails. Nevertheless, the 
BAP/BAP mutant phenotype is not as severe as that of Hes7
-/- mice (Figure 4.1, compare 
C with E; Table 4.1). The number of ribs is reduced to 9 and left-right symmetry is 
disrupted (Table 4.1). Frequently ribs are fused and show ectopic branching.  
Upon close examination of the skeleton, one area of well-segmented vertebrae 
stands out among the deformed structures: the sacral area, which connects to the pelvic 
girdle, is normal in BAP/BAP mice. BAP/BAP foetuses always form 4 regular sacral 
vertebrae and frequently 1-3 regular lumbar and 2-10 well-patterned tail vertebrae are 
seen (Figure 4.1C, E; Table 4.1). The differences in patterning of the skeleton in this 
intermediate area distinguish the BAP/BAP mutant from the Hes7
-/- (Figure 4.1C-E; 
Table 4.1). These results indicate that in a homozygous state the BAP allele results in a 
hypomorphic phenotype due to reduced Hes7 function.  
 CHAPTER 4: Characterisation of the Hes7
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Figure 4.1 Analysis of BAP/+, BAP/BAP and Hes7
-/- (-/-) E18.5 foetuses. (A) BAP/BAP foetuses have 
shorter tails than BAP/+ foetuses but considerably longer tails than -/-. Arrowheads point at the tip of the 
tail. White scale bar: 5 mm. (B-D) Lateral (top) and dorsal views of BAP/+, BAP/BAP and -/- E18.5 
skeletal preparations. Bones are stained with alizarin red and cartilage with alcian blue. Compare the 
sacral (s) and adjacent lumbar (l) and tail (tail) areas between different skeleton preparations. C’ and D’ 
show magnifications of the sacral and surrounding area. Asterisks label vertebral bodies of the sacrum. 
(E) Average length of skeletal regions from BAP/+, BAP/BAP, BAP/- and -/- E18.5 foetuses (see Table 
4.1).  Boxes  for  each  region  are  aligned  to  the  left  (anterior)  end.  Green  box:  c+t,  cervical+thoracic 
vertebrae; yellow box: l, lumbar vertebrae; blue box: s, sacral vertebrae; orange box: tail vertebrae. Black 
bars indicate standard deviations. CHAPTER 4: Characterisation of the Hes7
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  BAP/+  BAP/BAP  -/-  BAP/- 
Number of E18.5 skeletons analysed  6  4  4  10 
Length of whole vertebral column (mm)  27.5±1.6  20±1.9  16.3±0.5  16.5±1.2 
Length of cervical plus thoracic region 
(mm)  9.3±1.3  5.5±0.6  5.6±0.8  6.3±0.7 
Length of lumbar region (mm)  4±0  3.6±0.8  4.0±0.4  3.2±0.2 
Length of sacral region (mm)  1.9±0.2  1.6±0.2  1.6±0.3  1.8±0.2 
Length of tail (mm)  11.2±0.7  6.5±2.4  4.9±0.6  4.2±0.6 
Total number of cervical vertebrae 
(normal and irregular)  7±0  4.75±0.5  4.6±0.9  5.6±0.5 
Total number of regular lumbar vertebrae  6±0  2.3±0.9  0  0 
Number of regular sacral vertebrae  4±0  3.8±0.5  0  0.4±0.7 
Number of regular tail vertebrae  28±1  6.5±4.4  0  0 
Number of ribs, left and right counted 
separately  13±0  9±0.9  7.3±0.7  5.2±0.4 
Table  4.1  Comparison  of  Hes7
BAP/+  (BAP/+),  Hes7
BAP/BAP  (BAP/BAP),  Hes7
-/-  (-/-)  and  Hes7
BAP/- 
(BAP/-) E18.5 foetal skeletons. 
 
Most  Hes7
-/-  foetuses  die  within  a  few  hours  after  birth,  probably  due  to 
respiratory failure (Bessho et al., 2001b). However, one copy of wildtype Hes7 fully 
restores viability and leaves only a mild kinked-tail phenotype in 43% of the adult 
population  (Bessho  et  al.,  2001b).  Cell  culture  functional  assays  and  phenotypic 
analysis of the BAP/BAP mutants suggest, that the BAP allele still has residual function, 
albeit  less  than  wildtype  Hes7.  Therefore,  I  asked,  is  one  copy  of  the  BAP  allele 
sufficient to rescue the null-phenotype? 
Mice containing one BAP allele and one knock-out allele (BAP/-) die at birth 
(probably  due  to  respiratory  failure  because  of  the  malformed  ribcage)  and  are CHAPTER 4: Characterisation of the Hes7
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indistinguishable from Hes7
-/- mice (compare Figure 4.1A and D with Figure 4.2A and 
C). They show a severely disorganised skeleton and do not form any regular vertebrae 
or ribs (Figure 4.2C and C’). The tail length is significantly reduced and resembles 
Hes7
-/- tails (Figure 4.1E; Table 4.1). These results show, that one copy of the Hes7
BAP 
allele does not rescue the Hes7 knock-out phenotype (compare Figure 4.1D with Figure 
4.2C; Table 4.1). This further supports the hypothesis that, the BAP allele is a strong 
hypomorph allele because a weaker allele would be able to rescue the phenotype.  
In summary, this part of the results confirms a requirement for one functional 
copy of Hes7 during regular segmentation. The introduction of the BAP-tag sequence 
into the Hes7 locus has disrupted some of the protein function. In a heterozygous state 
this partial loss-of-function can be compensated by the wildtype allele, which can still 
produce a fully functional Hes7 repressor. However, the residual function of Hes7
BAP is 
not  sufficient  to  rescue  the  phenotype  of  a  heterozygous  BAP/-  mutant.  BAP/BAP 
mutant mice on the other hand survive and do not show an as severe axial phenotype as 
Hes7
-/- or BAP/- mice. These results show that although Hes7
BAP has lost most of its 
function, it is still sufficient for survival and to form some regular vertebrae, if two 
copies are present (Table 4.1). 
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Figure 4.2 Genetic analysis of the Hes7
BAP allele in BAP/+ and BAP/- E18.5 foetuses. (A) BAP/+ and 
BAP/- E18.5 foetuses. Arrowhead points to the tip of the tail. White scale bar: 5 mm. (B–C’) lateral (top) 
and dorsal views of heterozygous BAP/+ (B) and heterozygous BAP/- (C) E18.5 foetal skeletons stained 
with alizarin red (bone) and alcian blue (cartilage). Magnifications of the sacral area are shown in (B’) 
and  (C’).  Asterisks  label  regular  (B’)  and  irregular  (C’)  vertebrae  bodies  of  the  sacrum.  c,  cervical 
vertebrae; t, thoracic vertebrae; l, lumbar vertebrae; s, sacral vertebrae; tail, tail vertebrae. CHAPTER 4: Characterisation of the Hes7
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4.2.2  Regionally disrupted somite organisation in BAP/BAP embryos 
The rescue of the sacral and adjacent lumbar and tail vertebrae in BAP/BAP mice 
could be due to the restoration of anterior-posterior compartmentalisation that leads to 
boundary formation. To test this hypothesis, I visualised the posterior somite halves 
with Uncx4.1 in situ hybridisation (Mansouri et al., 1997) in BAP/BAP and BAP/+ 
embryos.  
Heterozygous BAP/+ E11.5 embryos (~48 somite pairs formed) hybridised with 
the Uncx4.1 in situ probe display a regular and distinct stripe pattern along the length 
axis visualising the posterior somite compartments (Figure 4.3A). In E11.5 BAP/BAP 
embryos, segmentation and anterior-posterior compartmentalisation is greatly disrupted 
as  seen  by  irregular  Uncx4.1  expression  (Figure  4.3B,  black  line).  However,  some 
regular Uncx4.1 stripes are formed around the hind limb bud and tail area (somites ~28 
onwards), albeit less distinctly than in BAP/+ embryos (Figure 4.3A and B, asterisks). 
The  well-patterned  somites  are  consistent  with  the  mild  sacral  vertebral  phenotype 
observed in BAP/BAP mutants. The Uncx4.1 stripe domains get fuzzy and less regular 
towards  the  tail  end  (Figure  4.3B’)  mirroring  abnormalities  in  somite  size  and 
compartmentalisation of mutant embryos (Figure 4.3B). 
Younger BAP/BAP embryos, at E9.5, have 3-5 additional regular Uncx4.1 stripes 
in the anterior segmented region, which form the occipital bone (Figure 4.3D’ and E’, 
asterisks). This is consistent with Hes7
-/- mice, which also form some regular anterior 
somites (Bessho et al., 2001b). It has also been shown that in Notch1 knock-out mice 
the  initial  somites  are  formed,  albeit  delayed,  independently  of  Notch  signalling 
(Conlon et al., 1995; Huppert et al., 2005).  
In section 4.2.1 I showed, that segmentation is affected in BAP/BAP mice, with 
severely fused vertebrae and ribs along the length axis except in the sacral and to some 
degree in the adjacent lumbar and tail areas. The Uncx4.1 in situ hybridisation results 
point out, that the adult skeletal phenotype is reflected by patterns of gene expression in 
newly formed somites, indicating that the defects arise early and are due to irregular 
somitogenesis.  Hes7  is  an  important  player  in  the  formation  of  new  somites,  and 
disrupting its auto-inhibition loop, as in the case of the BAP/BAP mice, appears to have 
an influence on the segmentation clock.  CHAPTER 4: Characterisation of the Hes7
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Figure 4.3 Uncx4.1 in situ hybridisation detects irregular somite compartmentalisation in BAP/BAP 
E11.5  and  E9.5  embryos.  (A,  B)  Lateral  views  of  BAP/+  (A,  n=9)  and  BAP/BAP  (B,  n=9)  E11.5 
embryos  hybridised  with  an  Uncx4.1  riboprobe.  (A’,  B’)  show  magnifications  of  the  tail  end  region 
(anterior at the top). The black line marks irregular Uncx4.1 pattern, whereas asterisks indicate regular 
somites.  fl,  forelimb  bud;  hl,  hindlimb  bud.  (C-E)  E9.5  BAP/+  (C,  n=5)  and  BAP/BAP  (D,  E,  n=7) 
embryos hybridised with Uncx4.1 and Hes7 in situ probes (lateral view). (C’, D’, E’) magnified views of 
the anterior-most Uncx4.1 stripes. Blue box indicates PSM. 
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4.2.3  Hes7 does not need to oscillate when the sacral area is formed 
Oscillations  of  Hes7,  generated  through  an  auto-regulatory  negative  feedback 
loop, were shown to play an important role in the segmentation clock (Bessho et al., 
2001b).  The  mRNA  as  well  as  protein  levels  oscillate  in  wildtype  embryos,  which 
generates a distinct expression pattern (Bessho et al., 2001b; Masamizu et al., 2006).  
Hes7 oscillations are best revealed using an intron probe to detect the nascent 
transcript by in situ hybridisation  (Hirata et al., 2004; Niwa et al., 2007) (Figure 4.4C). 
Heterozygous BAP/+ E10.5 embryos show oscillations in Hes7 mRNA and nascent 
transcript levels (Figure 4.4A and C), whereas BAP/BAP embryos fail to do so (Figure 
4.4B  and  D).  Instead,  Hes7  transcription  occurs  evenly  throughout  the  presomitic 
mesoderm (Figure 4.4B, D).  
Differences  in  mRNA  levels  (dynamic  vs.  constitutive  expression)  in  E9.5 
embryonic  tails  were  quantified  using  quantitative  reverse  transcriptase  PCR  (qRT-
PCR;  section  7.3.10)  and  showed  and  eight-fold  increase  in  Hes7
BAP  mRNA  in 
BAP/BAP embryos compared to wildtype (Figure 4.4E). This recessive overexpression 
of  the  Hes7
BAP  mRNA  is  a  consequence  of  the  suggested  failure  in  the  Hes7
BAP 
feedback loop.  
Sacral segments form normally in BAP/BAP embryos, despite the non-oscillatory 
Hes7 expression. On the other hand, formation of anterior cervical, thoracic and lumbar 
as well as posterior tail somites requires oscillating Hes7. This regionalised skeletal 
phenotype has been described before in mice expressing only the non-oscillatory stripe 
domain of Lfng, a modulator of Notch signalling (Shifley and Cole, 2008; Stauber et al., 
submitted). The anterior half of the axial skeleton appears to rely on the oscillating Lfng 
domain, whereas the tail region needs mainly the Lfng stripe domain. Segmentation in 
the intermediate sacral region requires neither domain. My findings for the BAP/BAP 
hypomorph  mice  and  the  results  of  the  Lfng  mutants  imply  that  the  segmentation 
machinery changes along the anterior-posterior axis (Figure 4.8).  
 CHAPTER 4: Characterisation of the Hes7
BAP hypomorph allele
 
 
 
111 
 
Figure  4.4  Recessive  overexpression  of  Hes7  mRNA  in  BAP/BAP  E10.5  embryos.  (A,  B)  Hes7 
mRNA  levels  in  BAP/+  (A,  n=8)  and  BAP/BAP  (B,  n=9)  embryos  as  visualised  by  cDNA  in  situ 
hybridisation. These embryos are additionally stained with Uncx4.1, which marks the posterior somite 
halves. Black line indicates irregular Uncx4.1 pattern. (C, D) Hes7 nascent transcript levels are detected 
using a Hes7 intron probe for in situ hybridisation of BAP/+ (C, n=8) and BAP/BAP (D, n=9) embryos. 
Ventral views of E10.5 tail ends. Anterior at the top. (E) Quantification of Hes7 mRNA levels in wildtype 
(WT), BAP/+ and BAP/BAP E9.5 embryonic tails using qRT-PCR. Error bars show standard deviation of 
3 individual samples.  
 
4.2.4  Altered gene expression of somitogenesis key factors in Hes7
BAP/BAP 
mutants 
Hes7  belongs  to  the  bHLH  type  family  of repressors  and  reduces  target  gene 
activity  via  binding  to  the  target  promoter  (Bessho  et  al.,  2001a;  Kageyama  et  al., 
2007b). A few Hes7 target genes have been described previously: They are mainly 
effectors of Notch signalling such as Hes1, Lfng and Hes7 itself, as well as Dusp4, 
which is a component of the Fgf pathway (Bessho et al., 2003; Niwa et al., 2007).  CHAPTER 4: Characterisation of the Hes7
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Arrested Hes7 oscillations, as seen in BAP/BAP embryos (Figure 4.4B, D) point 
to  a  non-functional  feedback  circuitry  and further  suggest  that  targets  might  not  be 
repressed properly. This could lead to a loss of oscillations or an increase in mRNA 
levels of Hes7 target genes. I therefore examined expression of the known Hes7 targets, 
Lfng and Dusp4, by in situ hybridisation. 
In  BAP/+  E10.5  embryos,  the  transcript  levels  for  both  Lfng  and  Dusp4  are 
expressed dynamically (Figure 4.5A and C). Lfng is transcribed in a stationary stripe 
domain in the anterior PSM (adjacent to the boundary that is about to form between 
somitomeres S-I and S0) and within an additional oscillating domain in the posterior 
PSM (Cole et al., 2002; Morales et al., 2002) (Figure 4.5A). The Fgf signalling inhibitor 
Dusp4 is also cyclically expressed in the PSM  of BAP/+ embryos albeit in a more 
diffuse pattern (Niwa et al., 2007) (Figure 4.5C). 
In  the  PSM  of  BAP/BAP  mutant  embryos  Lfng  and  Dusp4  mRNA  levels  are 
constitutively up-regulated and staining is seen throughout the PSM (Figure 4.5B and 
D) These results are consistent with Hes7
BAP having a reduced repressor activity, and 
imply that Notch and Fgf signalling, as seen through Lfng, Hes7 and Dusp4 expression, 
are de-regulated in BAP/BAP mutants. 
To further confirm a failure in Notch oscillations, I analysed the expression of 
another Notch target gene, Nrarp. Nrarp is expressed in a dynamic expression pattern, 
which resembles Lfng transcription, in the PSM of BAP/+ embryos (Krebs et al., 2001) 
(Figure 4.5E). However, the oscillating transcription is abolished and Nrarp expression 
significantly reduced in BAP/BAP embryos corroborating a failure in Notch signalling 
(Figure 4.5F). 
I also used an antibody to detect the Notch intracellular domain (NICD) in order 
to  check  if  cyclic  Notch  activity  is  abolished  in  BAP/BAP  mice.  In  heterozygous 
littermates, NICD is seen in two distinct phases in the anterior PSM: a single defined 
stripe domain and two rather indefinite domains (Figure 4.6A, black lines). However, in 
BAP/BAP embryos, only one phase was seen, reflecting the distinct stripe (compare 
Figure 4.6A and B). These results show that Hes7 is at the core of Notch oscillations 
and that Hes7
BAP cannot maintain Notch oscillations, thereby leading to segmentation 
defects. CHAPTER 4: Characterisation of the Hes7
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Figure 4.5 Deregulation of Notch and Fgf signalling targets in BAP/BAP E10.5 embryos. (A, B) In 
situ  hybridisation  to  detect  expression  of  cycling  Lfng  in  BAP/+  (A,  n=11)  and  constitutive  Lfng  in 
BAP/BAP (B, n=7) E10.5 embryos. (C, D) Oscillating Dusp4 transcription is seen in BAP/+ (C, n=19) but 
not  in  BAP/BAP  (D,  n=7)  E10.5  embryos.  (E,  F)  Visualisation  of  Nrarp  expression  by  in  situ 
hybridisation of BAP/+ (A, n=15) and BAP/BAP (B, n=7) E10. 5 embryos. Ventral (A, B, E, F) and 
lateral (C, D) views of embryonic tails. Anterior at the top. 
 
It  is  believed  that  the  segmentation  clock  is  a  complex  interaction  network 
comprising of different signalling pathways, such as the Notch, Wnt and Fgf pathways 
(Aulehla and Pourquie, 2008; Dequeant et al., 2006; Dequeant and Pourquie, 2008; 
Ozbudak  and  Pourquie,  2008).  Notch  and  Fgf  signalling  targets  are  deregulated  in 
BAP/BAP embryos. Next, I wanted to check if Wnt signalling is affected in BAP/BAP 
mutants and therefore examined Axin2, whose expression is dynamic in the PSM but 
oscillates in the opposite phase of Notch signalling components (Aulehla et al., 2003; 
Dequeant et al., 2006) (Figure 4.6C). No obvious differences are seen in Axin2 target 
gene expression in E10.5 BAP/BAP embryos compared to BAP/+ littermates, indicating 
that Wnt signalling is, as previously suggested, upstream of Notch signalling in the CHAPTER 4: Characterisation of the Hes7
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segmentation  machinery  (Aulehla  et  al.,  2003;  Aulehla  et  al.,  2008).  The  former 
described that both the Hes7
-/-, and the Hes7
118G/118G mutant, (carrying a stabilised Hes7 
protein  through  a  lysine  to  arginine  mutation  at  position  14),  also  show  unchanged 
Axin2 oscillations in the PSM (Hirata et al., 2004). This suggests that Axin2 and Hes7 
oscillations can occur independently. 
 
 
Figure 4.6 Notch signalling, but not Wnt signalling is affected in BAP/BAP embryos. (A, B) NICD 
antibody staining to detect Notch activity in BAP/+ (E, n=8) and BAP/BAP (F, n=7) E10.5 embryos. 
Black bars indicate individual cyclic regions of Notch activity. v, ventral view; l, lateral view. (E, F) 
Axin2 expression, as seen by in situ hybridisation of BAP/+ (E, n=7) and BAP/BAP (F, n=11) E10.5 
embryos. Ventral views of embryonic tails shown. Anterior at the top. 
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Arrested oscillations in Fgf and Notch signalling components (Figure 4.5B, D, F 
and  Figure  4.6D)  result  in  de-synchronisation  of  PSM  cells.  As  a  consequence, 
segmentation is impaired and leads to fused somites and therefore vertebrae and ribs. 
I next wanted to examine somite border formation by in situ hybridisation with a 
Mesp2 probe, which is expressed at the border of the next forming somite (Saga et al., 
1997) (Figure 4.7B). Mesp2 has been shown to be regulated by Notch signalling and to 
play an important role in the border formation between adjacent somites (Morimoto et 
al., 2005; Saga, 2007; Takahashi et al., 2000). In wildtype and BAP/+ embryos, Mesp2 
is expressed in an anterior stripe next to the presumptive somite border (Figure 4.7A). 
Expression is greatly reduced, scattered and asymmetric in BAP/BAP mutant embryos 
demonstrating a failure in proper separation of the forming somites (Figure 4.7B). This 
is probably due to reduced cyclic Notch activity, leading to a deregulation of Mesp2 
expression and therefore border formation. 
As somites are not compartmentalised correctly in BAP/BAP mutant embryos, I 
investigated  if  maturation  of  somites,  such  as  skeletal  muscle  differentiation,  is 
impaired as well. To address this, I hybridised BAP/+ and BAP/BAP E10.5 embryos 
with a MyoD riboprobe to detect the myotome linage. BAP/+ embryos show a regular 
MyoD expression pattern reflecting the regular Uncx4.1 stripes (Figure 4.7C). Ectopic 
and fuzzy expression of this early myogenic marker is seen in the BAP/BAP mutant 
embryos  mirroring  the  irregular  Uncx4.1  expression  pattern  (Figure  4.7D).  These 
embryos were too young to visualise MyoD expression in the still undifferentiated and 
presumptive regular somites around somite ~28 onwards. Therefore I cannot conclude 
that MyoD expression would be regular in the sacral somite region. However, my results 
suggest that somite maturation is affected in BAP/BAP embryos due to a loss of somite 
compartmentalisation.  
Altogether, BAP/BAP mice are able to survive to some extent but exhibit severe 
defects, mainly in the axial skeleton. However, muscle differentiation is compromised, 
and it is likely that the vascular network and the peripheral nervous system are affected 
since they initiate through inter-segmental regions during development (Figure 4.7D). 
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Figure 4.7 Somite segmentation and maturation defects in BAP/BAP embryos. (A, B) Mesp2 in situ 
hybridisation of BAP/+ (A, n=4) and BAP/BAP (B, n=8) E10.5 embryos. Ventral views of embryonic 
tails shown. Anterior at the top. (C, D) Skeletal muscle differentiation as seen through MyoD in situ 
hybridisation in BAP/+ (C, n=7) and BAP/BAP E10.5 embryos (D, n=4). Lateral view. fl, forelimb bud; 
hl, hind limb bud. Arrowheads point at ectopic initiation of MyoD expression.  
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4.3  Discussion 
Here,  I  describe  the  phenotype  of  the  BAP/BAP  mouse  strain  which  exhibits 
reduced Hes7 function through insertion of the BAP-tag. Although cell-based reporter 
assays predicted a fully functional repressor upon BAP-tagging this is clearly not the 
case in vivo. The reasons for a failure in the feedback-loop system remain unclear.  
Most likely, BAP-tagging has reduced the function of Hes7
BAP leading to a failure 
in  the  auto-regulatory  feedback  loop  and  thus  over-expression  of  the  Hes7  mRNA 
(Figure  4.4E).  However,  alternative  explanations  for  the  cause  of  the  BAP/BAP 
phenotype include change of transcription timing and protein stability. 
One possible explanation for the BAP/BAP phenotype might be a more stable 
Hes7  mRNA  due  to  longer  transcription  time.  However,  in  situ  hybridisation  of 
heterozygous BAP/+ embryos with a Hes7 probe does not show an increase in transcript 
levels and excludes this hypothesis.  
Since Hes7 has a short half-life of ~20 minutes, and lengthening the half-life leads 
to similar defects (Hirata et al., 2004), I hypothesised that Hes7
BAP might be more stable 
due to introduction of the tag. I tried to estimate the half-life of Hes7
BAP by transfecting 
tissue culture cells with the Hes7
BAP construct and subsequent blockage of translation 
with cycloheximide. However these experiments were not conclusive due to technical 
difficulties (data not shown).  
The  phenotype  of  BAP/BAP  mutants  suggests  that  there  is  a  differential 
requirement for Hes7 oscillations along the length axis. Hes7 is required throughout 
segmentation  (Bessho  et  al.,  2001b)  but  it  does  not  need  to  oscillate  during  the 
formation of the sacrum. My results define at least three phases of segmentation during 
the 5 days of mouse somitogenesis (Figure 4.8): phase A (somites 1-~30; E7.75-E10) 
and  phase  C  (somites  ~35-65;  E10.5-E13.5)  require  oscillating  Hes7,  whereas  the 
transition  phase  B  (somites  ~31-~34)  is  associated  with  constitutive  Hes7  activity. 
However, the region covered by phase B is not strictly limited to the 4 presumptive 
sacral  vertebrae  and  can  be  extended  anteriorly  (1-3  regular  lumbar  vertebrae)  or 
posteriorly (2-10 regular tail vertebrae) (Table 4.1).  
Several other genes have been described, that when mutated or knocked-out, lead 
to a regional skeletal phenotype. As mentioned in section 4.2.3, Lfng mutants lacking 
the oscillating expression domain have a regularly patterned sacrum and the strength of CHAPTER 4: Characterisation of the Hes7
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the  stripe  expression  determines  the  tail  length (Shifley  et  al.,  2008;  Stauber  et  al., 
submitted).  Hemizygous  animals  (which  have  a  duplicated  stripe-enhancer  B-block 
(Cole  et  al.,  2002;  Morales  et  al.,  2002)  of  the  Lfng  promoter  integrated;  therefore 
referred to as BBL line) exactly resemble the BAP/BAP mutant phenotype (Stauber et 
al., submitted). However in a homozygous state, animals show a complete rescue of the 
tail.  
Also, in the complete absence of Lfng
-/-, mice do form a well-patterned sacrum but 
the tails are short (Evrard et al., 1998; Stauber et al., submitted; Zhang and Gridley, 
1998). Moreover, mice harbouring an in-frame insertion of lacZ in the Lef1 gene form a 
severely disorganised skeleton with a regularly patterned sacral and anterior tail region 
(Galceran  et  al.,  2004).  These  examples  suggest  that  the  architecture  of  the 
segmentation machinery changes along the length axis. 
I can only hypothesise about what triggers and positions the different phases. In 
phase A, mesodermal cells ingress through the primitive streak whereas later (at around 
30-somite stage) they are recruited from the tailbud (Wilson and Beddington, 1996). 
This change in cell movement coincides with the onset of phase B and could lead to a 
partial loss of synchronisation of PSM cells. At this point, the segmentation machinery 
might have to be modified to act against any de-synchronisation. 
The  reason  for  a  regionally  disorganised  skeletal  phenotype  could  be  the 
differential  regulation  of  mesoderm  development  along  the  length  axis.  no  tail, 
spadetail and tbx6 are zebrafish mutants that show a changing hierarchy of these T-box 
genes in the trunk versus tail (Griffin et al., 1998). A loss of function mutation of α5-
integrin (Yang et al., 1993) also exhibits regionalised effects on somite formation for 
unknown reasons.  
The BAP/BAP phenotype is probably a phenotype of reduced protein function. 
However, BAP/BAP mutants revealed the regional differences in the requirement for 
oscillating Hes7, which could not be seen before in wildtype or Hes7
-/- animals (Bessho 
et al., 2001b). In wildtype embryos, oscillations in Hes7 are seen from the onset of 
somitogenesis  at  ~E8.5  and  persist  until  E12.5.  The  expression  pattern  of  Hes7  is 
characterised through three distinct phases (Bessho et al., 2001a; Bessho et al., 2001b; 
Kageyama et al., 2007a) and moves like a wave from the anterior to the posterior PSM. CHAPTER 4: Characterisation of the Hes7
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Due to this overall dynamic behaviour it is not possible to detect differences in Hes7 
expression levels between the different phase transitions. 
Together my results indicate that Hes7 activity is required along the whole body 
axis  for  proper  segmentation,  but  that  Hes7  oscillation  is  not  essential  during  the 
formation of the sacrum and to some degree of adjacent lumbar and tail areas (Figure 
4.8). 
 
 
Figure  4.8  Model  for  differential  axial  requirements  of  oscillating  Hes7.  During  phase  A  and  C 
oscillating Hes7 is required for the formation of somites 1- ~30 and somites 35-65, respectively. Phase B 
does not require oscillating Hes7 for the generation of somites 31-35. The three Phases of somitogenesis 
are  separated  through  a  dashed  line.  Red  ovals  represent  Hes7  protein,  whereas  red  lines  show  the 
negative feedback loop. Coloured squares stand for occipital (turquoise), cervical (turquoise), thoracic 
(green), lumbar (brown), sacral (purple) and tail (blue) somites. Occipital somites will be part of the skull. 
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CHAPTER 5:  Analysis of Hes7 transcriptional regulation  
5.1  Introduction 
Mouse  Hes7  is  expressed  exclusively  in  the  presomitic  mesoderm  (PSM),  the 
caudal growth zone of the embryo that periodically generates somites (section 1.3). 
Hes7 transcription oscillates with the same periodicity as the formation of somites (~2 h 
in  mouse)  and  has  been  established  as  a  key  player  within  the  segmentation  clock 
(Bessho et al., 2003; Bessho et al., 2001a; Bessho et al., 2001b). Both homozygous 
disruption  of  the  Hes7  gene  and  non-oscillatory  overexpression  (by  Hes7  protein 
stabilisation) causes aberrant somite formation and patterning, resulting in a severely 
disorganised and truncated axial skeleton (Bessho et al., 2001b; Hirata et al., 2004). The 
establishment  of  an  autoinhibitory  Hes7  feedback  loop  sustains  oscillating  gene 
expression, and this has been suggested – among other feedback circuits – to be the 
basic mechanism of the segmentation clock (Bessho et al., 2003). 
The intricate regulation of oscillatory Hes7 transcription, which may be at the 
core of the segmentation clock, led me to analyse the Hes7 promoter using comparative 
studies of the promoter region and protein-DNA binding assays. Although Hes7 is able 
to bind both N-box and E-box sequences (via its basic domain) in cell-based reporter 
assays (Bessho et al., 2001a; Chen et al., 2005), it is not clear how the transcriptional 
feedback mechanism is regulated and what the nature of the target sequence in vivo is. 
In this chapter, I describe DNA binding studies such as Electrophoretic Mobility Shift 
Assay (EMSA) and DNaseI footprinting in order to unravel the exact binding site of 
Hes7 in the Hes7 promoter.  
5.2  Results 
It was not possible to identify target binding sites of Hes7 by bioChIP from the 
established transgenic Hes7
BAP/BAP;Rosa26
BirA/BirA mouse line (section 2.2.4.3; chapter 4) 
due to the fact that Hes7
BAP is not biotinylated in vivo. Thus, I made use of in vitro 
DNA-protein binding studies to unravel the Hes7 target motif.  
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5.2.1  Two separate blocks within 4.9 kb of the mouse Hes7 promoter are 
conserved in higher mammals 
In  order  to  identify  functionally  important  sites  in  the  mouse  Hes7  promoter, 
which  are  likely  to  be  evolutionarily  conserved,  I  compared  homologous  Hes7 
promoters  using  the  PIP  Maker  programme (Schwartz  et  al.,  2000).  Hes7  promoter 
regions are fully sequenced in mouse, rat, human, cow, opossum, and zebrafish (her1; 
(Gajewski et al., 2003)), and sequenced with presumably minor gaps in macaque, dog, 
platypus, and frog.  
Comparison  of  promoter  sequences  of  Hes7  homologues  uncovers  extended 
conservation between mouse and the other higher mammals spreading over 4.9 kb of 
the mouse Hes7 promoter (including introns and the 3’ flanking region) (Figure 5.1). 
These conserved upstream regions that are likely to harbour cis-regulatory elements, 
map to two areas separated by a gap: the proximal block (-3.0 kb – transcriptional start), 
that  directly  flanks  the  transcriptional  start  in  all  higher  mammals,  and  the  distal 
conserved  block  (-4.9  kb  –  -4.0  kb  in  mouse),  which  starts  at  different  positions 
depending on the species (-4.9 kb in mouse, -4.7 kb in rat, -6.0 kb in macaque, -8.5 kb 
in cow, -9.1 kb in human) (Figure 5.1, yellow boxes). The expression pattern of Hes7 is 
not known for most of the species compared (like dog). However, the similarities in the 
promoter  region  might  be  consistent  with  an  oscillating  transcription  in  higher 
mammals (most probably with different periodicities, e.g. 4-5 h in human, Sadler et al., 
2000).  
The  conservation  between  Hes7  of  mouse  or  human  and  lower 
mammals/vertebrates is mainly restricted to exons, exon-intron boundaries and short 
interspersed  nuclear  elements  (SINE)  (Figure  5.1).  Comparison  of  the  mouse  Hes7 
locus to more distantly related loci or non-homologous cycling genes revealed a lack of 
conservation within the promoter regions (mouse Hes5, chick hairy1 and hairy2; not 
shown; sequence of chick hairy1 and 2 promoters, Michael Stauber, unpublished) or a 
lack  of  overall  similarity  and  thus  of  alignment  (zebrafish  her1/her7,  mouse  Hes1, 
mouse Hey2, mouse Lfng, mouse Per1; not shown). 
Therefore,  the  high  level  of  conservation  of  the  Hes7  promoter  within  higher 
mammals and the lack of conservation compared to lower vertebrates does not allow 
identification of other distinct and, potentially, functionally relevant elements. CHAPTER 5: Hes7 transcriptional regulation
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Figure 5.1 Sequence conservation of Hes7 promoter regions. Percent identity plot of the mouse Hes7 
locus (also including the last Per1 exon (green) and the first Aloxe3 exon (blue); Hes7 exons underlain in 
red) compared to homologues of higher mammals (rat, human, macaque, dog, cow), lower mammals 
(opossum, platypus), and the lower vertebrate Xenopus (frog). Analysed promoter fragments include 20 
kb upstream of the first Hes7 exon and 4 kb downstream of the last Hes7 exon. Triangles on upper line 
indicate SINE positions (two well conserved ones are indicated by black arrows; for meaning of other 
symbols see pipmaker.bx.psu.edu/pipmaker/pip-instr.html). Red arrow points at a particularly long stretch 
of conserved genomic DNA. Distal and proximal conserved blocks are boxed in yellow.  CHAPTER 5: Hes7 transcriptional regulation
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5.2.2  Identification of Hes7 binding sites in the Hes7 promoter 
A crucial step in generating Hes7 oscillations and maintaining the segmentation 
clock is repression of Hes7 transcription by Hes7 protein (possibly as a dimer with a 
paralogous Hes or other bHLH protein (reviewed in Kageyama et al., 2007b). In order 
to examine Hes7 autoinhibition, I checked the Hes7 promoter for Hes7 binding sites by 
EMSA (section 7.6.2). 
In a binding assay, I tested 18 partially overlapping ~300 bp fragments covering 
4.7 kb of the Hes7 promoter (Figure 5.2A) with a truncated Hes7 protein that contained 
the basic helix-loop-helix (bHLH) domain. It was not possible to use the full-length 
Hes7 protein due to extensive degradation of the protein after glutathione-S-transferase 
(GST)-tag purification. Therefore, I tried to purify shorter versions of the protein, which 
still  contain  the  DNA-binding  domain.  Using  GST  pull-down  assays,  I  was  able  to 
purify  a  Hes7  protein,  which  lacks  aminoacids  84-226  (hereafter  referred  to  as 
Hes7
bHLH; Figure 5.4A; section 7.5.1). 
Two  fragments  (F1,  F10;  Figure  5.2A)  were  efficiently  shifted  in  the  EMSA 
experiment when incubated with the Hes7
bHLH protein (Figure 5.3A, red boxes). One of 
them (F1) showed an additional stronger shift of the fragment, indicating more than one 
occupied binding site (Figure 5.3A, red asterisks). Two more fragments were shifted 
with medium efficiency (F6, F7; Figure 5.3A). All shifted fragments lie within the 3.0 
kb “core promoter” (Figure 5.2A), which was previously shown to be sufficient for 
generating oscillations (Chetana Sachidanandan, unpublished).  
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Figure 5.2 Predicted Hes7 repressor binding sites in the Hes7 promoter. (A) Hes7 exons are shown 
as boxes; ORF filled in black. Position of the promoter fragment (4.7 kb) analysed in EMSA is shown as 
a grey bar above the locus as is the 3 kb core promoter. N-boxes/class C binding sites were predicted 
according to the consensus sites (see main text); due to degenerate consensus some of these binding sites 
are identical to sites in the E-boxes/E(spl) row. Positions of fragments F1, F6, F7, and F10 used for Hes7 
EMSA are shown in the N-box/class C site line. Distal and proximal conserved blocks are shaded in grey. 
(B) F1 and F10 sequences aligned to their homologues in higher mammals. Putative Hes7 binding sites 
(N-box/class C site, E-box/E(spl) are boxed. Position of nucleotide mutations within N-boxes of F1 and 
F10 for EMSA are shown in red letters. A red box with dashed lines highlights Hes7 footprint in F1. 
Asterisks label positions with identical bases in all species compared. CHAPTER 5: Hes7 transcriptional regulation
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Fragments F1 and F10 contain one N-box (CACNAG) each (Figure 5.2A and B). 
Additionally,  F1  and  F10  contain  class  C  sites  (CACG(C/A)G)  and  E-boxes 
(CANNTG) (Figure 5.2A and B). Hes7 has been shown to bind N-boxes and class C 
sites  more  strongly  than  E-boxes  in  vitro  (Bessho  et  al.,  2001a;  Chen  et  al.,  2005; 
Kageyama et al., 2007b).  
Next, I analysed whether the N-box, contained in each fragment, is the recognised 
Hes7 binding site. I mutated the N-boxes of F1 and F10 (marked with red letters in 
Figure  5.2B;  F1:  CTCGTG  to  1.  CACGTG  or  2.  CTCTTG;  F10:  CACAAG  to  1. 
CATAAG or 2. CACATG). The mutation 1 in the N-box of F1 retains the simple shift, 
while mutation 2 disrupts the  simple shift, yet retaining the additional shift (Figure 
5.3B).  Thus  surprisingly,  these  close  mutations  (separated  by  only  1  bp)  appear  to 
disrupt different sets of Hes7 protein bound to its promoter, one generating the simple 
shift (possibly by binding by of a single Hes7 dimer), the other generating the additional 
shift (probably by binding of two or more Hes7 dimers).  
Neither  mutations  of  F10  (F10:  CACAAG  to  1.  CATAAG  or  2.  CACATG) 
affected the bandshift (Figure 5.3B). I conclude that Hes7 is not binding the N-box of 
F10, but probably to the class C sites or an E-box (Figure 5.3B).  
To further dissect the F1 region of the Hes7 promoter fragment and to analyse the 
differential shift obtained upon mutating the N-box, I generated a new fragment with 
both mutations. However, the exchange of both nucleotides within the N-box (resulting 
in  a  CACTTG  sequence)  did  not  abolish  the  observed  shift.  Strikingly,  this  new 
fragment containing both mutations, is now shifted to the lower position resembling the 
shift of the fragment containing only mutation 1 (compare F1-M1 to F1-M1+2 in Figure 
5.3B). These data suggest that the mutation of position 1 (CACGTG) disrupts some of 
Hes7 binding, but does not abolish it completely, and that the 5
th nucleotide within the 
N-box, does not seem to be implicated in the contact of Hes7 to its promoter.  
I  hypothesised  that  there  might  be  another  binding  element  within  the  F1 
fragment,  which  still  can  bind  Hes7  upon  mutation  of  the  N-box,  producing  the 
observed shift. In order to test this possibility, I performed an EMSA assay with ~30 bp 
oligonucleotides that span the Hes7 F1 fragment. Only the oligonucleotide containing 
the N-box (gggagcCTCGTGccggggtccttgagctgg) showed a shift after incubation with 
the Hes7 protein (fragment 6; Figure 5.3C). This indicates that Hes7 might only bind 
the N-box in F1.  CHAPTER 5: Hes7 transcriptional regulation
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Next, I attempted to determine the exact binding sequence of Hes7 using DNaseI 
footprinting experiments with Hes7 protein on the F1 and F10 fragments (Figure 5.4). 
In these conditions, I found protection of the sequence ctttccgggagcCTCGTG in F1, 
which coincides with the conservation around the N-box (Figure 5.2B and Figure 5.4) 
and might represent the full binding site covered by one Hes7 dimer (or by two Hes7 
dimers creating the additional shift in the EMSA). A second 28 bp footprint is found 
directly 5’ to the E-box of F1; this might be a second, unexpected Hes7 binding site 
(which does not lead to an EMSA shift). In contrast, the DNaseI footprint analysis of 
F10 did not reveal a Hes7 binding site (Figure 5.4). 
It turned out that fragments F6 and F7 (with partial shift in the EMSA; Figure 
5.3A)  contain  at  their  overlapping  site  a  95  bp  conserved  DNA  stretch  (red  arrow, 
Figure 5.1), which lies within the proximal conserved region, 2 kb upstream in the Hes7 
promoter.  Since  the  EMSA  shifted  both  fragments  with  medium  efficiency  it  is 
probable that an additional Hes7 binding site is positioned at the overlap of F6 and F7 
within the conserved DNA region.  
Together, these results indicate that Hes7 binds at least to one site within the 3.0 
kb Hes7 core promoter. This site includes the previously suggested N-box, but seems to 
extend  beyond  the  hexamer  nucleotide  sequence.  Therefore,  this  region  most  likely 
plays an important role in the autoinhibition of Hes7 transcription. CHAPTER 5: Hes7 transcriptional regulation
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Figure 5.3 Identification of Hes7 binding sites in the Hes7 promoter by EMSA. (A) Incubation of 
Hes7 fragments F1-F10 with (+) or without (-) Hes7
bHLH protein. The two fragments with the strongest 
shifts, F1 and F10, are framed in red. For positions of F1, F6, F7, and F10 within the Hes7 locus see 
Figure 5.2A. (B) EMSA of mutated F1 and F10 with Hes7
bHLH protein. Controls are the same as above. 
The differential shift is indicated with red lines. (D) EMSA of Hes7 F1 30 bp oligonucleotides (Table 
7.23) with Hes7
bHLH protein. A six N-box repeat and arbitrarily selected vector DNA served as positive 
(Pos Co) and negative (Neg Co), respectively. Shifted fragment is boxed in red. 
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Figure  5.4  DNaseI  footprinting  analysis  reveals  two  Hes7  binding  sites  on  the  Hes7  promoter 
fragment F1. (A) GST-purification of Hes7
bHLH protein. Input (I), unbound (U), bound (B) and thrombin 
cleaved (T) protein fractions were loaded onto a 4-12% Bis-Tris gel. (B) Incubation of fragments F1 and 
F10 with increasing amounts (0/30/60/100/300 ng) of Hes7
bHLH protein in the absence (-) and presence 
(+)  of  DNaseI.  Sequencing  reactions  of  F1  and  F10  (GATC)  are  aligned  next  to  the  footprinting 
experiments. Protected sequences are indicated on the left hand side. N-box sequence is marked in red 
letters. CHAPTER 5: Hes7 transcriptional regulation
 
 
 
129 
5.3  Discussion 
The Hes7 promoter is peculiar in that its activity is limited to driving oscillating 
transcription in the PSM. It has been suggested that cyclic expression is due to the 
ability of Hes7 to bind and repress its own promoter (Bessho et al., 2003), thereby 
maintaining a negative feedback loop. The exact binding site sequence, as well as the 
regulation of the feedback inhibition, remains elusive.  
In order to unravel the mechanics of Hes7 oscillations, I have analysed the Hes7 
promoter first using computational tools. Comparison of homologous Lfng promoters of 
vertebrates has previously revealed three conserved regions in this promoter one of 
which drives its cyclic expression (Block A (Morales et al., 2002) or FCE1 (Cole et al., 
2002)).  The  same  strategy  did  not  reveal  distinct  conserved  elements  of  the  Hes7 
promoter  likely  to  mediate  cyclic  transcription  due  to  a  high  conservation  between 
higher mammals and a lack of conservation between lower vertebrates. Unlike Lfng, 
Hes7 transcription does not exhibit an anterior PSM expression domain (Bessho et al., 
2001a) suggesting a less complex array of cis-acting elements. The failure to identify 
distinct cis-regulatory features driving a dynamic Hes7 feedback loop implies a more 
intricate regulation of Hes7 oscillations.  
Although we know that a 3 kb region of the Hes7 promoter is sufficient to drive 
its oscillatory expression, and that a number of binding sequences (mediated by bHLH 
proteins) have been identified within this region, it is still not clear how Hes7 protein 
exerts the repressive action on its own promoter.  
EMSA and DNaseI footprinting assays led me to identify a N-box element (-132 
bp to -137bp) and surrounding nucleotides as a putative Hes7 binding site. In addition I 
uncovered a putative binding site ~2.4 kb upstream of the Hes7 transcription start site, 
however, I could not demonstrate an interaction with Hes7 protein by mutating the site 
or by DNaseI footprinting. This might be explained by the fact that such in vitro studies 
are  highly  susceptible  to  saturation  with  the  protein.  Increasing  amounts  of  protein 
could lead to shifts of unspecific fragments and one has to be careful in setting the 
conditions. This possibility appears unlikely since careful titration experiments were 
performed to set the correct amount of protein to be used in these experiments. In order CHAPTER 5: Hes7 transcriptional regulation
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to minimise unspecific effects, competition studies with unlabeled “cold” fragments or 
oligonucleotides could be performed.  
Mutation of bases 3 and 5 of the core N-box sequence in F10 did not lead to an 
abolishment of the observed shift of fragment F10. This might be due to the fact, that 
this  mutation  did  not  hit  important  nucleotides  responsible  for  this  interaction. 
However, DNaseI footprinting did not reveal a Hes7 binding site within F10, suggesting 
that there might not be one.  
Using EMSA and DNaseI footprinting tools, I confirmed that the N-box is a likely 
binding site for Hes7 on its own promoter. In addition, mutation of the N-box in F1 
resulted in an unexpected outcome: a differential occupation of the N-box binding site 
was evident in the EMSA assays (Figure 5.3). In contrast to previous studies, which 
have used sets of oligonucelotides including N- or E-box binding motifs (Chen et al., 
2005),  I  have  analysed  fragments  for  Hes7  binding  covering  4.7  kb  of  the  Hes7 
promoter.  
Mutation of the N-box core sequence in F1 did not abolish the shift, but rather 
uncovered  two  different  binding  conformations.  I  suggest  that  Hes7  is  able  to 
multimerise in vitro and further occupies the N-box and surrounding sequences. This 
becomes clear through mutation 1 of the N-box in F1, which abolishes the supershift to 
the second position. Nevertheless, mutating both bases of the N-box in F1 still allows 
binding of Hes7 to the fragment. Either the chosen nucleotides are not responsible for 
establishing contact with Hes7, or that nucleotides around the N-box are more important 
for the binding.  
Altogether, these experiments confirm previous studies indicating that the N-box 
is a putative Hes7 target sequence (Bessho et al., 2001a; Chen et al., 2005; Kageyama et 
al., 2007b). Furthermore, my results are consistent with previous observations showing 
that the murine bHLH proteins Hes1 (Ishibashi et al., 1993) and Hes5 (Akazawa et al., 
1992;  Sasai  et  al.,  1992)  are  also  able  to  bind  to  N-box  sequences  in  DNaseI 
footprinting assays. In contrast, studies from Drosophila have identified the E-box as 
the target for E(spl) bHLH proteins in vitro and in vivo. In particular the nucleotides 
surrounding the core E-box have been demonstrated to be  essential for establishing 
contact with the DNA sequence (Jennings et al., 1999). These findings are similar to my 
results demonstrating that nucleotides flanking the core N-box sequence are recognised 
in Hes7 binding and might have an important function. CHAPTER 5: Hes7 transcriptional regulation
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It is not clear yet which nucleotides are recognised by Hes7 in vivo, and how the 
repressive  feedback  loop  is  maintained.  Moreover,  we  do  not  have  any  evidence 
whether Hes7 acts as a homo- or heterodimer in vivo. The in vitro binding experiments 
performed here most likely lead to a multimerisation of the protein, but it is not possible 
to conclude if this is the case in vivo. Further studies are needed to investigate the nature 
of the target sequence in vivo and to unravel the autoregulatory feedback mechanism. 
Future experiments include tissue culture studies in order to test fragments F1 and F10 
as well as mutated versions thereof in reporter assays for Hes7 binding. Once ex vivo 
studies  have  confirmed  specific  Hes7  binding  sites,  transgenic  mice  could  be 
established  harbouring  mutations  within  the  Hes7  promoter  to  test  the  in  vivo 
significance of the respective Hes7 binding sites.  
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CHAPTER 6:  Concluding remarks 
The Notch signalling pathway is a multifaceted cell communication pathway and 
has  been  demonstrated  to  be  implicated  in  many  different  biological  processes  as 
diverse  as  generating  the  segmented  vertebrate  body  pattern  to  causing  oncogenic 
transformations (reviewed in Bray, 2006; section 1.2). It has been challenging to pin 
down common sets of Notch target genes within different cell or tissue systems and 
there is evidence that one target might not be a target in another context. Notch exerts 
multiple pleiotropic effects on cell proliferation, differentiation and survival but little is 
known about different targets of Notch isoforms. 
It is important to unravel the nature of Notch targets not only to understand the 
Notch communication network but also to uncover novel targets during oncogenesis 
that can serve as putative therapeutic targets. Thus certain genes might be downstream 
Notch targets only in transformed tissues. 
In this thesis, I describe a novel approach using the high affinity of the biotin-
avidin  system  in  chromatin  immunoprecipitation  (bioChIP)  assays  to  identify  novel 
targets  of  Notch1  signalling  in  vivo  by  means  of  two  different  strategies.  The  first 
strategy aimed at discovering specific DNA sequences, which are recognised by the 
Notch transactivation complex consisting of the Notch intracellular domain (NICD) and 
its  nuclear  effector  CSL.  This  direct  strategy  should  have  allowed  identification  of 
Notch  gene  targets  in  any  biological  context  in  which  Notch  signalling  is  active. 
Futhermore, it would have been feasible to induce Notch-dependant tumours in the 
mouse and to search for novel targets after oncogenic transformation.  
In contrast, the second approach made use of a previously characterised Notch 
target gene, Hes7, and aimed at identifying Notch targets in an indirect manner. This 
second system was limited to unravel the implications of the Notch pathway only within 
one model system: the vertebrate segmentation machinery.  
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6.1  Direct Notch signalling targets 
In chapter 3 I describe several applications of the BAP/biotin-avidin system in 
cultured  cells  and  from  tissues  of  the  established  transgenic  mice  expressing 
biotinylated Notch1. Although, Notch1
BAP is biotinylated, I was not able to purify novel 
targets or protein interaction partners using streptavidin.  
I  was  able  to  show  that  in  principle  the  BAP/biotin-avidin  system  works  in 
cultured  cells  by  using  a  previously  established  cell  line  expressing  the  inducible 
biotinylated  GATA-1
BAP  transcription  factor  (section  3.2.1).  However,  several 
disadvantages of the approach to identify Notch1 signalling targets became apparent 
during my experiments: First, the high background binding resulting from biotinylated 
and non-biotinylated proteins has been a major drawback of the bioChIP experiments as 
well  as  for  the  streptavidin  protein  pull-down  assays.  Although  the  biotin-avidin 
interaction is able to withstand very  stringent washing conditions I was not able to 
reduce the background. This is also an important fact when purifying dynamic and low-
level  proteins  and  targets  thereof  because  the  background  binding  does  not  allow 
detection of the protein of interest due to an unproportional ratio of background to bait 
protein.  
Second,  it  can  take  a  very  long  time  to  make  knock-in  mice  which  carry  a 
biotinylated  protein: In  my  case  it  took  2½  years  to  generate  a  targeting  construct, 
screen for homologous recombinant embryonic stem cells and to establish the double 
homozygous mouse lines after multiple breeding steps. In contrast, the generation of an 
antibody  for  ChIP  experiments  can  take  6-8  months  for  a  monoclonal,  less  for  a 
polyclonal  antibody.  Screening  for  a  good  antibody  for  a  particular  application 
additionally lasts several months and there is no guarantee that an antibody will work 
for ChIP if it can be successfully used for other applications e.g. western blot analysis. 
Usually, several different antibodies are tested for the use in ChIP experiments. In most 
cases, the affinity of an antibody for its epitope is sufficient for ChIP experiments. 
Third, the indirect binding of NICD to its targets, the low physiological levels of 
NICD as well as the dynamic behaviour of the Notch transactivation complex made it 
difficult to optimise experimental conditions.  
Possible alternative strategies to identify novel Notch target genes in vivo include 
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Additionally,  a  timed  activation  of  the  Notch  signalling  pathway  potentiates  the 
identification of direct Notch targets because CSL occupancy on target promoters is 
enhanced when NICD is available (Fryer et al., 2004; Krejci and Bray, 2007). In order 
to allow a specific activation of Notch and thus formation of the nuclear transactivation 
complex, one can make use of inducible systems like hormone receptor approach or a 
chemical-induced strategy (like EDTA, which worked in cultured Drosophila cells by 
calcium depletion induced Notch cleavage (Krejci and Bray, 2007; Rand et al., 2000)). 
Since it is not possible to establish a transgenic mouse line in the complete absence of 
Notch1, a tissue-specific Notch1 line could be generated where Notch1 is under the 
control  of  a  tetracycline-inducible  promoter.  Thus  upon  addition  of  tetracycline, 
expression of Notch is induced in the specific tissue context and allows regulated Notch 
activation. 
Similar  experiments,  using  temporal  Notch  activation  and  ChIP-chip  analysis, 
have  already  been  conducted  in  Drosophila  tissue  culture  cells  and  led  to  the 
identification of novel Notch targets, which were verified in vivo (Krejci et al., 2009). A 
comparable system needs to be established in vivo, in the mouse, to allow for a more 
regulated system, to detect target genes after an activation period. With the help of 
massive  parallel  sequencing  of  pulled-down  chromatin  (from  ChIP  with  a  CSL 
antibody), novel Notch target genes could be identified.  
This approach, directed to find targets of CSL by ChIP, however, leads to uncover 
targets only of the CSL-dependent Notch signalling cascade. In contrast to previously 
suggested  hypotheses,  there  might  be  CSL-dependent  targets,  which  do  not  show 
increased levels of CSL binding after Notch activation. There is growing evidence that 
Notch can also signal through a CSL-independent manner in a non-canonical pathway. 
This  view  was  supported  for  the  first  time  by  experiments  from  Drosophila  which 
showed that a Notch knock-out exhibits a more severe phenotype than a Su(H) (CSL of 
Drosophila)  knock-out  fly  (Rusconi  and  Corbin,  1998;  Rusconi  and  Corbin,  1999; 
Zecchini et al., 1999) suggesting that Notch might be regulated independently of CSL 
(reviewed  in  Martinez  Arias  et  al.,  2002).  In  vertebrates,  the  evidence  for  a  non-
canonical Notch signalling is still unclear and so far has mostly been demonstrated in 
cultured  cells  (reviewed  in  Martinez  Arias  et  al.,  2002).  Conversely,  CSL  can  be 
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organ  of  Drosophila  (Barolo  et  al.,  2000)  and  thus  would  also  show  a  bias  in  the 
identified target gene pool. 
Another alternative strategy to find novel Notch targets could be the tagging of 
Notch with a different tag e.g. FLAG, HA or the TAP-tag and to use antibodies against 
the  tag  in  ChIP  experiments.  However,  it  is  unclear  if  this  approach  would  work 
because  the  Notch  transactivation  complex  most  likely  turns  out  to  be  unstable. 
Alternatively,  antibodies  against  Notch  itself  could  be  raised  and  tested  for  their 
application  in  ChIP  experiments.  The  ChIP  approach  combined  with  large  scale 
sequencing still seems to be the best and directed approach to find novel nuclear Notch 
targets. Therefore the ChIP technique must be improved in order to detect NICD at 
physiological levels. 
6.2  Indirect Notch signalling targets during vertebrate somitogenesis  
The second approach to identify targets of Notch signalling in an indirect fashion 
via Hes7 signalling during vertebrate segmentation did not lead to novel nuclear targets 
either. Although Hes7
BAP was functional in ex vivo experiments, BAP-tagging resulted 
in a strongly hypomorphic allele in vivo. Moreover, biotinylation of Hes7
BAP could not 
be  detected  in  vivo  even  though  cell  culture  experiments  showed  successful 
biotinylation.  
Several studies on identifying Hes7 targets in the mouse presomitic mesoderm 
(PSM) have been conducted before this study:  ChIP experiments using an antibody 
against  Hes7  were  performed  and  confirmed  a  predicted  interaction  (based  on 
computational motif analysis) of Hes7 with the Lfng, Hes1 and Hes7 promoters (Bessho 
et al., 2003). Another approach used microarray analysis to compare Hes7
-/- with Hes7 
transgenic mice (expressing Hes7 persistently in the PSM) and found among others (15 
genes >2.0-fold expression in Hes7
-/- than Hes7 transgenic mice) Dusp4, a negative 
regulator of Fgf signalling (Niwa et al., 2007). Althought the latter approach confirmed 
Dusp4 as a direct Hes7 target gene, this strategy most likely can lead to false positives 
i.e. artefacts resulting from the overexpression.  
To my mind, ChIP experiments combined with high-throughput sequencing, is the 
only  way  to  identify  real  Hes7  targets  in  the  PSM  of  mouse  embryos.  In  order  to 
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high-quality antibody directed against Hes7 raised. The first option will be challenging 
in  order  to  find  and  place  a  tag  which  does  not  disrupt  Hes7  protein  stability  and 
integrity.  The  BAP-tag,  although  very  small,  appears  not  to  provide  a  satisfactory 
solution  due  to  the  high-background  binding  during  purification.  Another  challenge 
when purifying Hes7 is the fact that it is a dynamic protein with a fast turn-over rate and 
very low abundance in the PSM. Different ChIP conditions will need to be tested e.g. 
different antibodies (directed against Hes7 or the tag), amount of PSM material and 
washing conditions. 
A ChIP-seq strategy would also allow to unravel the exact binding site of Hes7 in 
its target promoters. Previous studies including the one in this thesis (chapter 5) have 
used in vitro (Chen et al., 2005) (Figure 5.3 and Figure 5.4) and ex vivo (Bessho et al., 
2001a) (Figure 2.2A) studies and showed binding of Hes7 to the N-box and E-box 
sequences with a stronger preference for the N-box. However, we are still far from 
understanding the Hes7 autoinhibitory feedback loop and further studies are needed to 
confirm that the N-box is indeed the recognised target site within the Hes7 promoter in 
vivo.  
6.2.1  Differential transcription of Hes7 
The hypomorph Hes7
BAP allele, however, led to the discovery of a differential 
regulation of Hes7 transcription. Homozygous Hes7
BAP/BAP embryos and adults show a 
disorganised skeletal phenotype albeit not as severe as in Hes7
-/- mice with a rescue 
around the sacral and adjacent tail region (Figure 4.1). I have proposed a model for this 
differential transcription of Hes7 whereby Hes7 does not need to oscillate when the 
sacrum is formed but does show cyclic transcription during the establishment of the 
anterior cervical, thoracic and lumbar as well as posterior tail somites (Figure 4.8). My 
results  are  consistet  with  previous  studies  in  transgenic  mice  lacking  the  cyclic 
expression domain of Lfng and have suggested that the architecture of the segmentation 
machinery changes during the establishment of the vertebrae precursors (Shifley et al., 
2008; Stauber et al., submitted). CHAPTER 6: Concluding remarks
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6.3  Final conclusion 
Altogether, this thesis was aiming to contribute to the understanding of the target 
gene network that is regulated by Notch signalling in vivo. However, it turned out that 
the strategy chosen is not applicable for highly dynamic and low abundance proteins 
(such as Notch1 and Hes7) and that further information on the formation and dynamics 
of the Notch transactivation complex is needed in order to establish a suitable system.  
The actual question of how cell diversity arises by the action of different cell 
communication networks still remains to be answered. Identifying Notch targets will 
only be a piece of the jigsaw puzzle. Target gene activation is not only limited to one 
single transcription factor but involves multiple transcription factors interacting with 
cis-regulatory sequences within the enhancer region. This suggests that there is a need 
for a complex transcription factor network, which determines the regulation of a certain 
gene and thus the cellular outcome. 
 
 
 CHAPTER 7: Materials and Methods
 
 
 
138 
CHAPTER 7:  Materials and Methods 
7.1  Molecular Biology 
7.1.1  Polymerase Chain Reaction (PCR) 
PCR reactions (Saiki et al., 1988) were carried out in 200 µl thin-walled 8 tube 
and  flat  cap  strips  (Thermo  Scientific)  or  Thermo  Fast  96  well  plates  (Thermo 
Scientific)  using  a  Peltier  (PTC-200,  DNA  Engine)  thermal  cycler.  For  cloning  of 
expression  constructs  either  PfuTurbo  (Stratagene)  or  TaKaRa  LA  Taq  (TaKaRa) 
polymerase was used. Genotyping PCR reactions were carried out with the Taq PCR 
Master Mix system (Qiagen). Reactions were performed in 50 µl with 10 µM of each 
primer  (synthesised  by  Sigma-Aldrich),  20  mM  dNTPs  (deoxyribonucleotide 
triphosphates, Pharmacia Biotech), 2-10 ng of template DNA in 1 x polymerase buffer. 
The thermal cycling conditions were based on the basic settings listed in Table 7.1. The 
annealing  temperature  was  adjusted  to  the  melting  temperatures  of  oligonucleotide 
primers and the extension time adjusted to the length of the product. PCR products were 
confirmed by electrophoresis in a 1% agarose gel (Ultra Pure, Invitrogen) with TAE 
(Tris-acetate, EDTA) running buffer.  
 
  94ºC  3 minutes 
  94ºC  30 seconds 
40 cycles of  60ºC  30 seconds 
  72ºC  1 minute/kb 
  72ºC  10 minutes 
  12ºC  forever 
Table 7.1 Standard PCR thermal cycling conditions. 
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7.1.2  Ligation 
Site-directed ligation was performed as previously described by Sambrook et al., 
2001. Briefly, vector and insert DNA were digested from constructs using two different 
restriction enzymes (New England Biolabs) and their supplied buffers for at least 2 
hours  at  37ºC.  Vector  DNA  was  dephosphorylated  with  calf  intestinal  alkaline 
phosphatase (New England Biolabs) at 37ºC for 30 minutes. Both DNA fragments were 
purified through agarose gel electrophoresis and extracted from the gel matrix with the 
help of the QIAquick Gel Extraction Kit (Qiagen). Elution was into 50 µl of ultra pure 
water and ligations were done with T4 DNA Ligase (New England Biolabs) using a 
molar ratio of vector DNA to insert DNA of 1:3 in 20 µl. The reaction was incubated at 
16ºC overnight and 2 µl used for subsequent transformation into chemically competent 
bacteria (section 7.1.7). 
7.1.3  Cloning of BAP-tagged constructs for expression in cell culture 
The cloning of the mouse Hes7
BAP constructs was done in three steps: The first 
step involved the PCR-amplification of two parts: Hes7
N-BAP upper and Hes7
N-BAP lower for 
the N-terminal fusion and Hes7
C-BAP upper and Hes7
C-BAP lower generating the C-terminal 
fusion,  each  harbouring  a  portion  of  the  BAP-tag.  An  EcoRV  restriction  site  was 
generated through introduction of a silent mutation so as to split the BAP sequence in 
two  parts,  which  could  then  be  easily  reunited  with  blunt  end  ligation.  Using  this 
strategy greatly facilitated the introduction of the BAP-tag. Fusion of both sequences, 
Hes7
N-BAP upper and Hes7
N-BAP lower as well as Hes7
C-BAP upper and Hes7
C-BAP lower resulted in 
a correctly tagged Hes7
N-BAP or Hes7
C-BAP, respectively. The primers were synthesised 
(Sigma-Aldrich) to include the BAP sequence and as template for the PCR reaction 
served the pCI-Hes7 vector containing 790 bp of Hes7 cDNA (Table 7.2, EcoRV sites 
in bold). The upper and lower parts were each subcloned into the pCRII-TOPO vector 
using the TOPO cloning strategy (Invitrogen) for sequencing with M13 forward and 
M13 reverse primers (Table 7.6). After verification of the DNA sequence the lower 
fragment was digested with EcoRV and XbaI for Hes7
C-BAP or EcoRV for Hes7
N-BAP 
from the pCRII-TOPO vector backbone, purified through agarose gel electrophoresis 
and ligated into EcoRV/XbaI or EcoRV digested pCRII-TOPO-Hes7
C-BAP 
upper or pCRII-
TOPO-Hes7
N-BAP 
upper vector. The BAP-tagged Hes7 cDNAs, Hes7
C-BAP and Hes7
N-BAP, 
were digested with PstI and XbaI and cloned into the similarly digested mammalian CHAPTER 7: Materials and Methods
 
 
 
140 
expression vector pCI (Promega) to give pCI-Hes7
C-BAP and pCI-Hes7
N-BAP constructs 
for use in cell culture transfections (see Figure 2.1B for a schematic cloning strategy). 
The  construction  of  the  mouse  NICD
BAP  expression  vector  was  similar  to  the 
Hes7
BAP vectors. NICD
BAP  upper and NICD
BAP  lower parts were PCR-amplified from the 
pcDNA3.1
+-NICD  template  (Table  7.2)  followed  by  subcloning  into  pCR2.1-TOPO 
vector (Invitrogen) and sequencing as previously (Table 7.6). In this case the lower part 
was  introduced  into  EcoRV  and  XmaI  restriction  sites  in  pcDNA3.1
+  (Invitrogen). 
Following the digest of pCR2.1-TOPO-NICD
BAP 
upper with EcoRV the upper part was 
isolated and cloned into EcoRV cut pcDNA3.1
+-NICD
BAP 
lower to create a BAP-tagged 
NICD cDNA (Figure 2.1B). 
 
Amplicon  Forward primer  Reverse primer 
Hes7
N-BAP upper 
5’- GCT GCA GAA GTT 
GGT CGT GAG G -3’ 
5’- GAT ATC ATT CAG GCC 
ACC AGC CAT TGC TCC TCC 
GGA ACC CTT CGG -3’ 
Hes7
N-BAP lower 
5’- GAT ATC TTT GAG GCC CAG 
AAG ATC GAG TGG CAT GTC 
ACC CGG GAG CGA GCT GAG 
AAT AG -3’ 
5’- GAC TCT AGA GGT 
ACC ACG CGT G -3’ 
Hes7
C-BAP upper  5’- GCT GCA GAA GTT GGT CGT 
GAG G -3’ 
5’- GAT ATC ATT CAG GCC 
CCC GTC TTG TCT GTA AGG 
CGG TG -3’ 
Hes7
C-BAP lower 
5’- GAT ATC TTT GAG GCC CAG 
AAG ATC GAG TGG CAT GCG 
CCC AAG GCC CCG TCA CTC C -
3’ 
5’- GAC TCT AGA GGT ACC 
ACG CGT G -3’ 
NICD
BAP upper 
5’- GCA TTG GGC 
GGC CGC G -3’ 
5’- GAT ATC ATT CAG GCC 
ACC TCC TTT AAA TGC CTC 
TGG AAT GTG G -3’ 
NICD
BAP lower 
5’- GAT ATC TTT GAG GCC CAG 
AAG ATC GAG TGG CAT TAA 
ACA GAG ATG TGG GAT GCA G 
-3’ 
5’- GCT CCC GGG AGC TTT TTG 
C -3’ 
Table  7.2  PCR  primer  sequences  to  generate  Hes7
N-BAP,  Hes7
C-BAP  and  NICD
BAP  vectors  for 
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For the BirA biotinylase, the cDNA sequence was taken from pGEM-SD2-3xHA-
BirA (de Boer et al., 2003), which contains the biotinylase fused to three HA-tags. 
3xHA-BirA was cut with EcoRI from the pGEM-SD2-3xHA-BirA vector and subcloned 
into EcoRI digested pCI (Invitrogen), driving expression of 3xHA-BirA from the human 
cytomegalovirus (CMV) immediate-early promoter.  
7.1.4  Cloning of BAP-tagged constructs for homologous recombination in 
embryonic stem (ES) cells  
For the Hes7
BAP targeting construct, I PCR-amplified three parts, Hes7-BAP 5’-
homology region (Hes7
BAP  5’HR), Hes7-BAP 3’-homology region upper (Hes7
BAP  3’HR 
upper) and Hes7-BAP 3’-homology region lower parts (Hes7
BAP 3’HR lower). The two parts 
for the 3’HR were amplified with TaKaRa LA Taq Polymerase as 1949 bp and 3202 bp 
pieces (using primers specified in Table 7.3 and genomic DNA from the mouse 129B6 
strain as template), subcloned into pCR2.1-TOPO (Invitrogen) for sequencing (Table 
7.6) and subsequently ligated using the EcoRV site. 
The 1042 bp 5’HR was amplified with Pfu Turbo Polymerase using the primers 
listed in Table 7.3 and subcloned into the pCRII-Zero-Blunt vector (Invitrogen), for 
subsequent sequencing (Table 7.6). Both homology regions were cloned into pFloxR1-
modified: The 5’HR was cloned into SbfI/XbaI and the 3’HR into XhoI/HindIII (see 
Figure 2.5A for a schematic outline of the cloning strategy). 
The targeting construct to insert the BAP-tag sequence into the Notch1 locus was 
constructed similarly. The two homology regions were PCR-amplified as above: The 
1320 bp and 2072 bp parts of the 5’HR were ligated via the EcoRV and insterted into 
SbfI/XbaI in the targeting vector. The 2509 bp 3’HR was cloned into pFloxR1-modified 
using the ClaI/NheI sites in the multiple cloning site (see Figure 2.5B for the targeting 
strategy and Table 7.3 for primer sequences). 
The  targeting  constructs  pFloxR1-mod_Hes7
BAP  and  pFloxR1-mod_  Notch1
BAP 
were linearised with SfiI and subsequently purified by phenol-chloroform extraction. 
Briefly, 200 µl of phenol:chlorform:isoamylalcohol (25:24:1, Fluka) was added to 200 
µl of the digested DNA and vortexed. After a 1 min spin at 16,000 x g the upper phase 
was transferred into a new tube and the extraction repeated. The DNA was precipitated 
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at -20ºC for several hours. The resulting pellet was washed twice with 70% ethanol, 
dissolved in 50 µl TE (10 mM Tris/HCl pH 7.5, 1 mM EDTA) buffer and adjusted to a 
final concentration of 1 µg/µl. 
 
Fragment to be 
amplified by PCR  Forward primer  Reverse primer 
Hes7
BAP 5’HR  5’- CCT GCA GGG AGT GAG 
AGG GAA ACG AAT GG -3’ 
5’- TCT AGA GAC ACG CGC 
GGG TGT TAT TAA CC -3’ 
Hes7
BAP 3’HR lower 
5’- GAT ATC TTT GAG GCC 
CAG AAG ATC GAG TGG CAT 
GCG CCC AAG GCC CCG TCA 
CTC C -3’ 
5’- AAG CTT CCA CTG GTA  
GCA GGG AAA GTG G -3’ 
Hes7
BAP 3’HR upper  5’- CTC GAG TGT CTC TGT 
GTC TCC CTC ATT G -3’ 
5’- GAT ATC ATT CAG GCC 
CCC GTC TTG TCT GTA AGG 
CGG TG -3’ 
Notch1
BAP 3’HR  5’- ATC GAT AGA CCC CCT 
CAA AGA GTT GGG -3’ 
5’- GCT AGC TGC CTT AGA 
CGT ACA CAG TGC TG -3’ 
Notch1
BAP 5’HR lower 
5’- GAT ATC TTT GAG GCC 
CAG AAG ATC GAG TGG CAT 
TAA ACA GAG ATG TGG GAT 
GCA G -3’ 
5’- TCT AGA TAA GCA GTC 
AAC AAG CAC AG -3’ 
Notch1
BAP 5’HR upper  5’- CCT GCA GGC TTT TGG 
ATG AGT ACA ACC TG -3’ 
5’- GAT ATC ATT CAG GCC 
ACC TCC TTT AAA TGC CTC 
TGG AAT GTG G -3’ 
Table 7.3 PCR primer sequences to construct Hes7
BAP and Notch1
BAP targeting vectors (EcoRV 
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7.1.5  Cloning of BAP-tagged constructs for viral gene transfer 
For the generation of double stable cell lines, I chose to make use of the viral 
transduction  system  based  on  the  Moloney  Murine  Leukaemia  Virus  (MMLV).  To 
ensure expression of both the BirA biotinylase and either ER-NICD
BAP or N1∆E
BAP two 
selection options must be in place. Therefore the 3xHA-tagged BirA was placed under 
neomycin  selection  and  cloned  via  XhoI/NotI  into  the  retroviral  vector  pFBneo 
(Stratagene).  
N1∆E
BAP  cDNA  was  amplified  from  pcDNA3.1
+-N1∆E
BAP  by  PCR  using 
PfuTurbo DNA Polymerase and standard reaction conditions (section 7.1.1; Table 7.4) 
and further subcloned into pCR-Blunt II-TOPO for sequencing (section 7.1.8). Upon 
digestion with SalI and EcoRI, the 2584 bp fragment of N1∆E
BAP was introduced into 
similarly digested pFB-IRES-GFP (gift of Caetano Reis e Sousa, Cancer Research UK 
London  Research  Institute)  to  give  the  resulting  pFB-IRES-GFP-N1∆E
BAP  retroviral 
expression vector. This allowed for selection of GFP positive cells and hence for cells 
that had integrated the N1∆E
BAP.  
To generate the ER-NICD
BAP fusion construct, I PCR-amplified a 969 bp stretch 
of the murine oestrogen receptor (ER) from the ∆KS-βCat-ER (obtained from Fiona 
Watt,  Cancer  Research  UK  Cambridge  Research  Institute)  containing  the restriction 
sites SalI and BamHI (Table 7.4). Similarly, 2094 bp containing NICD
BAP cDNA was 
amplified by PCR (section 7.1.1; Table 7.4). Both amplicons were subcloned into pCR-
Blunt  II-TOPO  for  sequencing  (section  7.1.8).  pCR-Blunt  II-TOPO-NICD
BAP  was 
further  digested  with  BamHI/EcoRI  and  inserted  into  EcoRI  digested  pCR-Blunt  II-
TOPO-ER  to  result  in  a  functional  tagged  ER-NICD
BAP  fusion  construct.  The  ER-
NICD
BAP fusion was released from the vector through SalI/EcoRI digest and inserted 
into similar digested pFB-IRES-GFP construct. 
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Fragment to be 
amplified by PCR  Forward primer  Reverse primer 
3xHA-BirA XhoI/NotI  5’- CTC GAG ATG GCC ACC 
TAT GAC GTC C -3’ 
5’- GCG GCC GCT TAT TTT 
TCT GCA CTA CGC AGG -3’ 
N1∆E
BAP EcoRI /EcoRI  5’- GAA TTC GAC CAT GGA 
CTA CAA AGA CG -3’ 
5’- GAA TTC TTA ATG CCA 
CTC GAT CTT CTG G -3’ 
NICD
BAP BamHI /EcoRI  5’- GGA TCC CGC CGG CGC 
CAG -3’ 
5’- GAA TTC TTA ATG CCA 
CTC GAT CTT CTG G -3’ 
ER SalI/BamHI  5’- GTC GAC CGA AAT GAA 
ATG GGT GCT TCA G -3’ 
5’- GGA TCC GAT CGT GTT 
GGG GAA GCC -3’ 
Table 7.4 PCR primer sequences for cloning of BAP-tagged constructs for viral gene transfer. 
 
7.1.6  Cloning of Hes7 constructs for protein production 
Three  different  lengths  of  Hes7  constructs  were  generated,  namely  Hes7
ORF 
(aminoacids 1-226) covering the full open reading frame, Hes7
N-terminus (aminoacids 1-
129) lacking the proline-rich and WRPW sequences and Hes7
bHLH (aminoacids 1-83) 
containing  just  the  bHLH  domain.  Generating  three  different  lengths  of  protein 
maximises the chances of producing a fully functional Hes7 protein. Constructs were 
amplified  by  PCR  using  PfuTurbo  DNA  Polymerase  (section  7.1.1)  and  the  primer 
sequences listed in Table 7.5. The forward and reverse primers included the restriction 
sites  EcoRI  and  XhoI,  respectively  for  further  introduction  in  the  final  expression 
vector. Amplified fragments were subcloned into pCR-Blunt II-TOPO and verified by 
sequencing  (section  7.1.8).  Subsequent  EcoRI/XhoI  digest  and  ligation  with  similar 
digested  pGEX-4T-1  (Amersham  Biosciences)  yielded  vectors  for  expression  of 
glutathione S-transferase (GST) fusion constructs.  
Constructs were transformed into chemically competent E. coli BL21-CodonPlus 
(DE3)-RIL cells (Stratagene) according to the manufacturers’ guidelines for efficient 
high-level expression of heterologous proteins. 
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Fragment to be 
amplified by PCR  Forward primer  Reverse primer 
Hes7
ORF  5’- CGG AAT TCA TGG TCA 
CCC GGG AGC GAG C -3’ 
5’- CCG CTC GAG TCA GGG 
CCA AGG TCT CCA AAA C -
3’ 
Hes7
N-terminus  5’- CGG AAT TCA TGG TCA 
CCC GGG AGC GAG C -3’ 
5’- CCG CTC GAG TCA CGC 
TGG GAG CCC TGG ATC -3’ 
Hes7
bHLH  5’- CGG AAT TCA TGG TCA 
CCC GGG AGC GAG C -3’ 
5’- CCG CTC GAG TCA GCC 
TGG GGA CCG GGG AAC -3’ 
Table 7.5 PCR primer sequences to amplify Hes7
ORF, Hes7
N-terminus and Hes7
bHLH constructs for Hes7 
antibody production.  
7.1.7  Transformation of competent bacteria and plasmid isolation 
For  propagation  of  the  DNA  constructs,  One  Shot  chemically  competent 
Escherichia coli (Invitrogen) cells were transformed according to the manufacturers’ 
guidelines. Briefly, 2 µl of the TOPO (Invitrogen) cloning reaction was added to one 
vial  of  competent  cells  and  incubated  for  5-30 minutes  on  ice.  Bacteria  were  heat-
shocked for 30 seconds at 42ºC and immediately transferred to ice. After addition of 
250 µl of S.O.C. (Super Optimal broth with Catabolite repression, Invitrogen) medium 
cells were regenerated through incubation at 37ºC shaking (200 rpm) for 1 hour. 10-50 
µl  of  each  transformation  was  spread  onto  selective  plates  and  incubated  at  37ºC 
overnight. Positive clones from the Zero Blunt TOPO cloning reactions were selected 
on  Luria  Bertani  (LB)  agar  plates  containing  25  µg/µl Zeocin  (Invitrogen)  whereas 
positive  clones  from  the  TOPO  TA  cloning  reaction  were  selected  with  100  µg/µl 
Ampicillin  (Sigma-Aldrich)  and  40  µl  of  40  mg/ml  X-gal  (5’-Bromo-4-Chloro-3-
Inodolyl-β-D-Galactoside, Sigma-Aldrich) for blue-white screening.  
The next day colonies were picked and placed into 3 ml of LB broth containing 
the  respective  antibiotic  and  grown  overnight  at  37ºC  and  200  rpm.  Plasmids  were 
isolated  from  bacterial  pellets  using  the  Qiagen  liquid  handling  robot  based  on  the 
Qiagen plasmid purification chemistry by the Cancer Research UK Equipment Park 
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After verification of the plasmid DNA by restriction digest of the miniprep DNA 
a larger quantity of plasmid DNA was prepared. For this purpose, the QIAfilter Maxi 
Plasmid Purification Kit was used (Qiagen) according to the manufacturers’ guidelines. 
7.1.8  Sequencing 
Sequencing was performed using the BigDye Terminator v3.1 Cycle Sequencing 
Kit (Applied Biosystems). The PCR reactions were carried out on a Peltier (PTC-200, 
DNA Engine) thermal cycler using the conditions specified in Table 7.7. PCR reactions 
were purified with the DyeEx 2.0 Spin Kit (Qiagen) and dried in a speed vacuum. DNA 
sequencing  was  performed  on  an  Applied  Biosystems  3730  DNA  Analyser  by  the 
Cancer Research UK Equipment Park facility. 
 
Primer  Sequence 
M13 forward  5’- CAG GAA ACA GCT ATG AC -3’ 
M13 reverse  5’- GTA AAA CGA CGG CCA G-3’ 
Table 7.6 Sequencing primers to verify TOPO cloning reactions. 
 
  ramp to 96ºC at 2.5ºC/sec   
  96ºC   1 minute 
  96ºC  10 seconds 
  ramp to 50ºC at 1ºC/sec   
24 cycles of  50ºC   5 seconds 
  ramp to 60ºC at 1ºC/sec   
  60ºC  4 minutes 
  12ºC  forever 
Table 7.7 Thermal cycler conditions for sequencing reactions. CHAPTER 7: Materials and Methods
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7.2  Zebrafish 
7.2.1  Zebrafish care 
Zebrafish  were  raised  according  to  standard  procedures  (Westerfield,  1993)  at 
28ºC on a 14- to 10-hour light-dark cycle. 
7.2.2  Injection of mRNA into fish embryos 
pCDNA3.1
+-NICD, pCDNA3.1
+-NICD
BAP, pCI-Hes7 and pCI-Hes7
BAP as well as 
pRSET-BtdTomato were linearised with StuI (NICD constructs), NotI (Hes7 constructs) 
or EcoRI (Tomato injection control). The purified linearised DNA was further extracted 
with  phenol:cholorform:isoamylalcohol  and  precipitated  with  ethanol.  Subsequently, 
DNA was transcribed with T7 RNA polymerase for 2-3 hours at 37ºC and RNA was 
recovered  through  phenol:cholorform:isoamylalcohol  and  ethanol  precipitation.  The 
quality of the RNA was verified on a 0.8% agarose gel in TBE (Tris-borate, EDTA) and 
the  concentration  determined  using  the  NanoDrop  spectrophotometer  (Thermo 
Scientific). The injection mix contained approximately 1 µg of NICD or Hes7 mRNA 
and 1 µg of control mRNA in injection buffer. The RNA was injected at concentrations 
of 50 µg/ml up to 1 mg/ml (i.e. from 25 pg to 500 pg RNA per cell) in 2-cell stage 
wildtype fish embryos in 1 x Ringer´s solution (115 mM NaCl, 5 mM KCl, 2 mM 
CaCl2, 25 mM NaHCO3, pH 7.3) containing 0.5% phenol red. 
7.2.3  Whole-mount in situ hybridisation of fish embryos 
Embryos  injected  with  NICD  or  NICD
BAP  mRNA  were  fixed  in  4% 
paraformaldehyde  (PFA)  15  hours  after  injection  and  hybridised  with  digoxigenin-
labelled islet1 RNA probe (Inoue et al., 1994). Briefly, embryos were dehydrated in a 
graded series of methanol (25%, 50%, 75%, 100%) for 10 minutes each. Embryos were 
stored in 100% methanol at -20ºC until needed and subsequently rehydrated in a graded 
series of methanol (75%, 50%, 25%) for 10 minutes each. This was followed by a wash 
in phosphate buffered saline including Tween-20 (PBST: 37 mM NaCl, 2.7 mM KCl, 
10 mM sodium phosphate dibasic, 2 mM potassium phosphate monobasic pH 7.4, 0.1% 
Tween-20) for 10 minutes and incubation in pre-warmed hybridisation solution (50% 
formamide, 5x saline-sodium citrate (SSC) buffer: 0.75 M sodium chloride and 0.075 
mM trisodium citrate pH 7.0, 50 µg/ml heparin, 500 µg/ml yeast tRNA, 0.1% Tween-CHAPTER 7: Materials and Methods
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20, 0.0092 M citric acid) for 2 hours at 62ºC. Embryos were incubated with the probe in 
hybridisation  solution  overnight  at  62ºC.  The  next  day  embryos  were  washed  in 
2xSSC/0.1% Trition-X-100 for 5 minutes and then for 30-40 minutes at 62ºC. After 
exchange of the solution embryos were washed in 0.2xSSC/0.1% Trition-X-100 for 30-
40 minutes at 62ºC. Afterwards embryos were transferred into KTBT buffer (50 mM 
Tris/HCL pH 7.5, 150 mM NaCl, 10 mM KCl, 0.1% Triton-X-100) and incubated for 
20 minutes at room temperature before blocking in 25% sheep serum in KTBT for 1 
hour  at  room  temperature.  Embryos  were  further  incubated  with  anti-digoxigenin 
antibody conjugated to alkaline phosphatase (Roche) 1:5,000 in KTBT including 25% 
sheep serum at 4ºC overnight. The next day, embryos were washed in KTBT three 
times for 30 minutes at room temperature before equilibration in AP buffer (100 mM 
Tris pH 9.5, 50 mM MgCl2, 100 mM NaCl, 0.1% Triton-X-100) for 30 minutes at room 
temperature.  The  colour  reaction  was  developed  in  the  dark  with  Nitro-Blue 
Tetrazolium  Chloride/5-Bromo-4-Chloro-3'-Indolyphosphate  p-Toluidine  salt 
(NBT/BCIP, Roche: 45 µl NBT [75 mg/ml in 70% dimethylformamide] + 35 µl BCIP 
[50 mg/ml in 100% dimethylformamide] in AP buffer. When the desired colouration 
was achieved, embryos were rinsed in KTBT and post-fixed in 4% PFA. 
7.3  Transgenic mice 
7.3.1  Electroporation of embryonic stem cells (ESC) 
Electroporation of the targeting constructs pFloxR1-mod_Hes7
BAP and pFloxR1-
mod_ Notch1
BAP was performed by the Cancer Research UK Transgenics facility in 
Clare Hall, London. The ES cells used were derived from 129 inbred mice and were 
maintained on primary embryonic fibroblast cells with the addition to the media of 
Leukaemia Inhibitory Factor (LIF), at 1000 units/ml, to prevent differentiation and to 
maintain pluripotence.  
Constructs were electroporated into 5 x 10
6-10
7 ES cells. Selection was applied 24 
hours after electroporation with the addition of 200 µg/ml Geneticin G418 sulphate 
(Gibco) in ES cell medium. After 8-10 days colonies were picked and placed into wells 
of a 96 well microtitre plate. These were further cultured and, when confluency was 
reached, half of the cells were frozen and half transferred to another 96 well plate and 
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7.3.2  DNA extraction from mouse ear biopsies 
Ear biopsies of transgenic mice were dissolved in 300 µl of lysis buffer (50 mM 
Tris pH 8.0, 5 mM EDTA pH 8.0, 100 mM NaCl, 0.5% SDS) containing 20 mg/ml 
Proteinase K (Roche) with constant rolling at 56ºC overnight. The next day, 120 µl of 
saturated sodium chloride solution was added. The solution was mixed and incubated 
on ice for 20 minutes. Precipitates were eliminated by centrifugation at 16,000 x g for 
20 minutes and the supernatant transferred to a new tube. DNA was isolated by adding 
600 µl of absolute ethanol and further centrifugation at 16,000 x g for 20 minutes. The 
pellets were washed with 300 µl of 70% ethanol and centrifugation at 16,000 x g for 20 
minutes. Following the drying of the DNA it was dissolved in 100 µl of TE.  
7.3.3  Genotyping of transgenic mice 
For genotyping, 1 µl of the DNA solution prepared from ear biopsies (section 
7.3.2) was used per PCR reaction together with 10 µM of each primer (Table 7.8) and 
the Taq PCR Master  Mix (Qiagen). Thermo cycler conditions were as described in 
section 7.1.1. 
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Genotype  Forward primer  Reverse primer  Fragment size 
(bp) 
Hes7
BAP/+  5’- TCT TTG AGG CCC 
AGA AGA TCG -3’ 
5’- AGA AAG CGA TTC 
AAA GGT TGT GG -3’ 
614 bp 
Hes7
BAP/BAP  5’- CCC ATC CCA CTG 
CTC CTC TC -3’ 
5’- GGA TCC CTC TCC 
TGC CCT CT -3’ 
220 bp WT 
262 bp Homo 
Notch1
BAP/+  5’- GCA AGC TTG AAT 
GGC CAG -3’ 
5’- TTG AGG CCC AGA 
AGA TCG AGT G -3’ 
764 bp 
Notch1
BAP/BAP  5’- CAG CTC CTC CCC 
GCA TTC C -3’ 
5’- TTG GTC GCC CCA 
GCA TCC -3’ 
194 bp WT 
242 bp Homo 
BirA/+  5’- GTT ACG ATG TGC 
CCG ACT ATG C -3’ 
5’- CGC CAT CAC GAT 
ACC GAT AAC C -3’  515 bp 
BirA/BirA  5’- CTT GGA CTG GCT 
TGA CTC ATG G -3’ 
5’- CCA CTG GCT GGC 
TAA ACT CTG G -3’ 
799 bp WT or 
Het 
absent in Homo 
neo
r  5’- GAC TGG GCA CAA 
CAG ACA ATC G -3’ 
5’- GCA ATA TCA CGG 
GTA GCC AAC G -3’  620 bp 
Table 7.8 Primer sequences for genotyping of Hes7
BAP/BAP, Notch1
BAP/BAP and Rosa26
BirA/BirA mice. 
Abbreviations  for  genotypes  are  as  follows:  wildtype  (WT),  heterozygous  (Het)  or  homozygous 
(Homo). 
7.3.4  PCR Screening of embryonic stem cell clones (ESCCs) 
ESCCs were picked by the Cancer Research UK Transgenics Facility in 96 well 
plates and subsequently lysed. DNA was precipitated by adding 50 µl of isopropanol to 
each  well.  The  plates  were  incubated  at  room  temperature  for  30  minutes. 
Centrifugation at 1,500 x g for 10 minutes at room temperature generated a DNA pellet. 
The centrifugation step was repeated once to wash the pellet with 70% ethanol. The 
DNA was allowed to dry completely before dissolving in 100 µl TE. For PCR screening 
one primer was designed to bind in the targeting vector and the other to specifically 
recognise the flanking genomic region (Table 7.10). A master mix for all 96 reactions 
was  prepared  using  0.1  µl  TaKaRa  LA  Taq  DNA  Polymerase,  4  µM  of  each 
oligonucleotide primer, 8 nM dNTPs and 5 µl of DNA from ESCC for each reaction. 
The plates were sealed and reactions performed on a Peltier (PTC-200, DNA Engine) 
thermo cycler using the programme specified in Table 7.9. 
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  94ºC  2 minutes 
  94ºC  20 seconds 
40 cycles of  60ºC  30 seconds 
  72ºC  3 minutes 
  72ºC  5 minutes 
  12ºC  forever 
Table 7.9 PCR programme for screening of electroporated ESCCs. 
 
Region analysed  Forward primer  Reverse primer 
Size of 
PCR 
product 
(bp) 
Hes7
BAP 5’ flanking region 
5’- AAA GCG ACC 
CAA GGG ACT GG -
3’ 
5’- TTG AAA ACC 
ACA CTG CTC GAT 
CC -3’ 
1166 
Hes7
BAP 5’ flanking region 
(alternative) 
5’- TTG AAA ACC 
ACA CTG CTC GAT 
CC -3’ 
5’- TCC ATC CTT 
CTG AGA GGT CAT 
GC -3’ 
3013 
Notch1
BAP 5’ flanking region 
5’- TTG AGG CCC 
AGA AGA TCG AGT 
G -3’ 
5’- CAG GAG CGT 
ATG CAC CAC GAT 
A -3’ 
1364 
Notch1
BAP 3’ flanking region 
5’- GGG GCT CGA 
CTA GAG GAT CAG 
C -3’ 
5’- GAT GGT GAG 
ATT GAG GCC AAC 
C -3’ 
2845 
Table 7.10 PCR screening primers to identify homologous recombinant ESCC. CHAPTER 7: Materials and Methods
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7.3.5  Southern blot screening 
7.3.5.1  Restriction enzyme digestion of mouse genomic DNA 
Genomic DNA from ESCCs was precipitated by ethanol and centrifugation at 
16,000 x g following a wash with 70% ethanol. The pellet was dissolved in 100 µl TE. 
25 µl of the genomic DNA was digested with a suitable enzyme (Table 7.11) and the 
appropriate buffer as for plasmid DNA, except that the following components were 
added  to  the  digestion  mixture:  100  µg/ml  bovine  serum  albumin  (BSA,  Sigma-
Aldrich), 2.5 µg/ml RNaseA (Sigma-Aldrich) and 1 mM spermidine (Sigma-Aldrich). 
Digestions were allowed to proceed overnight at 37ºC with more enzyme added after 4 
hours of incubation. 
7.3.5.2  Preparation of Southern blot probes 
Southern blot probes were amplified using TaKaRa LA Taq DNA Polymerase and 
primers specified in (Table 7.11). For cycling conditions and PCR set-up see section 
7.1.1. The size of probe fragments was verified on an agarose gel after restriction digest. 
Labelling  of  DNA  probes  was  performed  using  the  Rediprime  II  Random  Prime 
Labelling System (Amersham Biosciences) and 
32P-Nucleotides [α-
32P] dCTP Redivue 
Tips  according  to  the  manufacturers’  instructions.  Unincorporated  nucleotides  were 
removed using Micro Bio-Spin P-30 Tris chromatography columns (Bio-Rad). 
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Probe  Forward primer  Reverse primer  Restriction 
enzyme 
Hes7
BAP 5’  
5’- TGA ACC ACC 
AAT GCA GAC AAG 
G -3’ 
5’- GGA TTC TAC TGG 
CTG GCT GTG G -3’ 
EcoRI 
Hes7
BAP 3’ 
5’- CTG CAG AGG 
CTT CGT GTG AGG -
3’ 
5’- TCC AAT CAG GCT 
GCT CTC ACC 
-3’ 
XhoI/KpnI 
Notch1
BAP 5’ 
5’- TCT GGC TTG 
GTC CAC CAC TAC 
C -3’ 
5’- GTC CAT GTG ATC 
CGT GAT GTC C -3’ 
StuI 
Notch1
BAP 3’ 
5’- AAC AAA AAG 
GCC GAG GAC TGG 
-3’ 
5’- GCA GGA TCC TAG 
AGG CAG AAG C -3’ 
EcoRV/XhoI 
Table 7.11 Primer sequences for the generation of Southern blot probes. Restriction enzymes to 
digest  the  genomic  DNA  are  shown  in  the  last  column.  For  position  of  probes  and  restriction 
enzymes see Figure 2.7. 
7.3.5.3  Southern blotting and hybridisation 
Digested genomic DNA was separated on a 0.7% agarose gel in TBE using the 
Flowgen  system  for  10  hours  and  transferred  on  to  Hybond-N
+  nylon  transfer 
membrane (Amersham Biosciences). Blotting was performed as follows: A tray was 
filled with alkaline transfer buffer (400 mM NaOH) and a glass plate resting on an 
inverted plastic tub placed in the middle of the tray. Three pieces of 3 MM paper soaked 
in transfer buffer were then placed on the glass and their ends allowed to dip into the 
buffer, thereby acting as a wick. The agarose gel, which was pre-soaked in the transfer 
buffer for 20 minutes, was placed onto the 3 MM paper and the Hybond-N
+ nylon 
transfer membrane was placed on top of the gel. Air bubbles were removed by rolling 
with a pipette. Three more pieces of 3 MM paper, the same size as the gel, were placed 
on top of the membrane and Saran wrap was positioned around the edges of the blot 
apparatus to isolate the wick. A stack of tissues and then a glass plate were placed on 
top of the 3 MM paper. Finally a flask containing 500 ml of water was placed on top of 
the  glass  plate  to  weigh  down  the  tissues.  DNA  blotting  was  allowed  to  proceed 
overnight. Once blotting was complete, the apparatus was carefully dismantled and the 
membrane washed in 2xSSC (300 mM sodium chloride, 30 mM sodium citrate) for 20 
minutes at room temperature. The membrane was pre-hybridised with rotation for 2 
hours at 65ºC in 20 ml Church buffer (200 mM sodium phosphate buffer pH7.2, 1 mM CHAPTER 7: Materials and Methods
 
 
 
154 
EDTA,  1%  BSA,  7%  SDS,  15%  formamide).  The  radio-labelled  DNA  probe  was 
denatured by boiling for 2 minutes and placed on ice for 1 minute before being added 
directly  to  the  pre-hybridisation  buffer.  Hybridisations  were  performed  at  65ºC 
overnight. 
Membranes were washed 3 times 30 minutes at 65ºC with Church wash buffer (40 
mM sodium phosphate buffer pH7.2, 1 mM EDTA, 1% SDS). Once the majority of 
unbound probe had been washed away, the membrane was wrapped in Saran wrap and 
exposed to Kodak X-OMAT AR film at -80ºC. 
7.3.6  Establishing transgenic mouse lines 
Transgene  constructs  were  injected  into  F1  x  F1  (CBA  x  C57Bl/6J)  mouse 
embryos, which were then implanted into pseudopregnant foster mothers. Transgenic 
founder lines were identified by screening DNA samples taken from these litters. Once 
a  founder  was  identified,  it  was  bred  to  establish  whether  the  transgene  could  be 
transmitted and was capable of expression. Transgenic mice were kept in the C57Bl/6J 
background. C57Bl/6J also served as a wildtype control. 
7.3.6.1  Chimera production 
15-20  ES  cells  were  microinjected  into  day  4  fertilised  mouse  embryos 
(blastocysts).  Following  injection,  embryos  were  transferred  into  day  3  plugged 
pseudopregnant foster mice, which gave birth 18 days later. One week after birth the 
coat colour was determined which is a read-out for the success of germline contribution.  
C57Bl/6J blastocysts produce black/brown chimeras. A high level of coat colour 
contribution together with a bias to male chimera mice (as the ES cell line is male) was 
indicative of an ES clone that contributed to the germline. 
7.3.7  Skeleton preparation 
Skeletons  were  prepared  and  stained  with  alcian  blue/alizarin  red  S following 
standard  procedures  (Nagy  et  al.,  2003).  All  photographs  were  taken  with  a  Leica 
DC500 digital camera and Leica firecam version 1.7.1 software. Several photographs 
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7.3.8  Whole-mount in situ hybridization 
Whole-mount  in  situ  hybridisation  was  performed  by  a  modification  of  the 
method  used  by  (Henrique  et  al.,  1995).  Formaldehyde-fixed,  proteinase  K-treated 
embryos were pre-hybridised in hybridisation buffer (50% formamide; 1.3xSSC, pH 
5.0, 5 mM EDTA, 0.2% Tween-20, 0.5% CHAPS, 50 µg/ml yeast RNA, 100 µg/ml 
heparin) at 70ºC for > 1h. Hybridisation with DIG-labelled RNA probes was performed 
in  hybridisation  buffer  at  70ºC  over  night.  Hybridised  embryos  were  washed  in 
hybridisation buffer at 70ºC for 1 h and in TBST (0.25 M Tris/HCl, pH7.5, 1.37 M 
NaCl,  27  mM  KCl,  1%  Tween-20)  at  room  temperature  for  several  hours,  and 
subsequently incubated in TBST/10% heat-treated goat serum for > 1h and in alkaline-
phosphatase coupled anti-DIG antibody (Roche; in TBST/10% goat serum) at 4ºC over 
night. After extensive washes in TBST, embryos were transferred to NTMT (100 mM 
NaCl,  100  mM  Tris/HCl  pH  9.5,  50  mM  MgCl2,  10%  Tween-20)  and  the  colour 
reaction performed with NBT/BCIP (Roche) at room temperature for several hours. 
RNA  probes  were  made  from  0.7  kb  Hes7  ORF  [subcloned  from  pCl-Hes7 
(Bessho et al., 2001a) into pBluescriptII KS, Stratagene], 1.2 kb mouse Lfng cDNA 
(IMAGE clone 408467), 0.7 kb Uncx4.1 cDNA (Mansouri et al., 1997), 1.9 kb mouse 
MyoD, 1.2 kb Dusp4 (Niwa et al., 2007), 2.8 kb Axin2 (Aulehla et al., 2003) and 0.8 kb 
Nrarp (Phng et al., 2009). Hes7 intron probe was synthesised from a 1 kb PCR product 
of the first intron cloned into pCRII-TOPO vector (Invitrogen) and used with the same 
hybridisation buffer as cDNA probes but at 65ºC instead of 70ºC. For generation of 
antisense riboprobes vectors were digested with an enzyme cutting 5’ of the cDNA and 
further transcribed from the 3’ end (Table 7.12). 
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Probe  Restriction digest  RNA polymerase 
MyoD  BamHI  T7 
Uncx4.1  XhoI  T7 
Dusp4  NotI  T7 
Nrarp  SalI  T7 
Lfng   HindIII  T7 
Hes7 intron  NotI  SP6 
Hes7 cDNA  SpeI  T3 
Mesp2  BamHI  T7 
Axin2  SalI  T7 
Table 7.12 Restriction digests and RNA polymerases used for transcription of riboprobes. 
7.3.9  Whole-mount Notch intracellular domain (NICD) antibody staining 
Whole-mount NICD antibody staining on E9.5 and E10.5 wildtype and transgenic 
Hes7
BAP/+  and  Hes7
BAP/BAP  embryos  was  done  as  described  by  (Feller  et  al.,  2008). 
Briefly, embryos were dissected in cold PBS, fixed in 50% DMSO in methanol for 5 
minutes  and  subsequently  washed  3  times  for  10  minutes  in  NH4Cl-PBS  (50  mM 
NH4Cl, 1xPBS). Following bleaching in 15% H2O2 in NH4Cl-PBS for 35 minutes cells 
were  transferred  into  TS-PBS  (1%  Triton-X-100,  10%  FCS,  1xPBS)  and  washed  3 
times for 10 minutes each. Incubation with the cleaved Notch1 (Valine 1744) antibody 
(Cell Signaling) diluted 1:100 in TS-PBS was performed overnight at 4ºC. The next 
day, embryos were washed 10 times 20 minutes in TS-PBS and incubated overnight at 
4ºC with an anti-rabbit biotinylated antibody (BA1000, Vector) at a 1:100 dilution in 
TS-PBS. The following day, embryos were washed again 10 times for 20 minutes in 
TS-PBS but at 4ºC. Incubation with Streptavidin-HRP (NEN) 1:100 in TS-PBS was 
done overnight and washes as previously at 4ºC were carried out the next day. Detection 
was by incubation for 10 minutes in solution A (100 mM Tris pH7.5, 0.1% Triton-X-
100,  224  nM  4-Chloro-1-Naphthol  (Sigma-Aldrich)),  3  washes  for  15  minutes  in 
solution  B  (100  mM  Tris  pH7.5,  224  nM  4-Chloro-1-Naphthol),  incubation  for  15 
minutes  in  solution  C  (40%  ethanol,  2.8  mM  4-Chloro-1-Naphthol)  and  staining  in CHAPTER 7: Materials and Methods
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solution  D  (50%  ethanol,  7.5%  H2O2,  3.5  mM 4-Chloro-1-Naphthol).  When  judged 
complete, embryos were fixed in 2% PFA in 50% ethanol. 
7.3.10 Quantitative reverse transcriptase PCR (qRT-PCR) from embryonic 
mouse tail tissue 
E9.5  embryos  of  wildtype  and  transgenic  Hes7
BAP/+  and  Hes7
BAP/BAP  were 
harvested and the posterior tail dissected. Total RNA was isolated using the RNeasy 
Mini  Handbook  (Qiagen)  and  further  treated  with  DNase  (Invitrogen).  qRT-PCR 
reactions  were  performed  with  the  SuperScript III  Platinum
  SYBR  Green  One-Step 
qRT-PCR Kit (Invitrogen) on a ABI 7500 Fast (Applied Biosystems) machine using 
primers listed in Table 7.13. Hes7 mRNA levels were quantified relative to GAPDH 
mRNA expression. 
 
mRNA  Forward primer  Reverse primer 
GAPDH  5’- GGT GCT GAG TAT GTC GTG 
GA -3’ 
5’- GCG GAG ATG ATG ACC 
CTT T -3’ 
Hes7  5’- GGA GCG AGC TGA GAA TAG 
GG -3’ 
5’- CTT CTA GGC TGC GGT 
TGA TG -3’ 
Table 7.13 Primer sequences for quantification of Hes7 mRNA levels in wildtype, Hes7
BAP/+ and 
Hes7
BAP/BAP embryos by qRT-PCR. 
7.4  Cell culture 
7.4.1  Handling of cell lines 
Cell lines were incubated in 37ºC incubators with 5% CO2 using the appropriate 
medium conditions (Table 7.14). E4 (Cancer Research UK cell service equivalent to 
DMEM  (Dulbecco’s  modification  of  Eagle’s  medium))  was  used  for  murine  cells 
supplemented  with  10%  foetal  calf  serum  (FCS)  whereas  a  combination  of  E4  and 
HAMS  F12  was  used  for  MCF10A  cells.  Cells  were  regularly  split  using 
trypsin/versene (Cancer Research UK cell services) to maintain a healthy population. 
Freezing of cells was done in full medium supplemented with 10% dimethyl sulfoxide 
(DMSO, Sigma-Aldrich). 
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Cell line  Species/ Morphology/ 
Type  Medium requirements  Source 
C3H10T½  Mouse/ Fibroblasts/ 
Monolayer  E4 + 10% FCS  CR-UK Cell 
Services 
MCF10A  Human/ Breast/ 
Monolayer 
1:1 E4:HAMS F12 
5% horse serum (Sigma-Aldrich), 10 
µg/ml Insulin (Sigma-Aldrich), 5 
µg/ml Hydrocortisone 
(Calbiochem), 20 ng/ml EGF 
(Calbiochem), 100 ng/ml Cholera 
Toxin (Quadratech) 
CR-UK Cell 
Services 
MEL [BirA] and 
[Bio-GATA-1] 
Mouse/ Spleen/ 
Suspension  E4 + 10% FCS 
Frank 
Grosveld, 
Erasmus 
Medical 
Center, 
Rotterdam 
GP2-293 
Human/ Kidney/ 
Monolayer (based on 
HEK-293 cell line) 
E4 + 10% FCS 
Pantropic 
Retroviral 
Expression 
system Kit 
(BD 
Biosciences) 
Table 7.14 Cell lines used in this thesis. 
7.4.2  Transfection 
Transfection of cell lines was done with FuGENE
 6 transfection reagent (Roche) 
according to the manufacturers’ guidelines. The ratio of DNA to FuGENE
 6 was 1:3.  
7.4.3  Viral gene transfer 
7.4.3.1  Preparation of virus-containing supernatants 
3 x 10
6 GP2-293 cells were plated in full medium in a 10 cm dish the day before 
transfection.  5  µg  of  the  plasmid  encoding  the  vesicular  stomatitis  virus  (VSV)  G 
protein, which confers a polytrophic host range together with 5 µg of the retroviral 
construct and 30 µl FuGENE
 6 transfection reagent were diluted in 500 µl E4 without 
antibiotics and serum. Viral supernatants were harvested 72 hours after transfection, 
filtered through a syringe driven filter unit (0.45 µm Millex HV syringe filter, Milipore) 
and used immediately for transduction or frozen in liquid nitrogen and stored at -80ºC.  CHAPTER 7: Materials and Methods
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7.4.3.2  Transduction of cell lines 
In order to establish stable cell lines expressing biotinylated NICD
BAP, cells were 
first transduced with the biotinylase and selected for neomycin resistant clones. Positive 
clones (as verified by western blot analysis to detect HA-tagged BirA) were further 
transduced with viral particles containing NICD
BAP and selected according to their GFP 
expression. 
C3H10T½ and MCF10A cell lines were plated at 2 x 10
5 per well of a 6 well plate 
and incubated overnight at 37ºC and 5% CO2. Virus containing the BirA biotinylase 
under  neomycin  selection  was  produced  as  described  in  7.4.3.1  using  the  retroviral 
plasmids  pVSV-G  and  pFBneo-3xHA-BirA.  Cells  were  infected  with  the  virus 
supernatant (titre ~10
8) by spin infection at 600 x g for 90 minutes at room temperature. 
Polybrene  (Sigma-Aldrich)  at  a  final  concentration  of  8  µg/ml  was  added  to  the 
infection mixture. After the centrifugation, cells were incubated for another 90 minutes 
at 37ºC and 5% CO2. The medium was changed thereafter and the cells incubated for 3 
days  at  37ºC  and  5%  CO2.  To  identify  positive  clones,  which  had  integrated  the 
biotinylase, cells were split 1:50 in 10 cm dishes and placed under Geneticin G418 
sulphate (Gibco) selection. A final concentration of 1 mg/ml G418 was used to select 
for  positive  C3H10T½  [BirA]  clones  whereas  0.5  mg/ml  of  G418  was  applied  to 
identify stable MCF10A [BirA] clones. In each case 24 clones were picked and placed 
in separate wells. Cells were grown and further checked for expression of 3x-HA BirA 
by western blot analysis using an α-HA antibody (Roche). 
Selected clones were further transduced with viral particles containing NICD
BAP 
under GFP selection. Infection was performed as described above. However cells were 
sorted for GFP expression after 3 days of infection using Fluorescence-activated cell 
sorting (FACS). 
7.4.3.3  Fluorescence-activated cell sorting (FACS) 
For FACS sorting of infected live cells, cells were harvested by trypsinisation, 
washed once with E4 + 1% FCS and taken up in E4 + 1% FCS. Around 1 x 10
5 cells 
were sorted on a MoFlo (DakoCytomation, now BeckmanCoulter) cell sorter and plated 
in rich medium for expansion.  CHAPTER 7: Materials and Methods
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7.4.4  Luciferase reporter assay 
C3H10T½ cells were plated at a density of 8 x 10
4 per well of a 24 tissue culture 
plate 24 hours before transfection. 100 ng of the firefly luciferase reporter was co-
transfected with either 200 ng of pCI (Promega) or pCDNA3.1
+ (Invitrogen) as control 
or the respective construct containing untagged or BAP-tagged Hes7 and NICD cDNAs. 
The reporter in the case of Hes7 is a synthetic β-actin promoter with a six N-box repeat 
(Ishibashi et al., 1994). To test for Notch1 activation, a 509 bp Hes1 promoter fragment 
drives luciferase activity (Nishimura et al., 1998).  
FuGENE
  6  (Roche)  was  used  as  transfection  reagent  at  a  ratio  of  1:3,  DNA: 
FuGENE
 6. 4 ng of the Renilla luciferase pRL-TK (Promega) in each sample served as a 
reference reading. After incubation for 24 hours at 37ºC and 5% CO2 the assay was 
analysed using the Dual-Luciferase Reporter Assay System (Promega) according to the 
manufacturers’ guidelines. Firefly and Renilla activities were read using the EnVision 
Multilabel Reader. The values of the reporter readings were normalised to the values of 
the  Renilla  reading.  The  resulting  luciferase  activity  alone  was  taken  100%.  Each 
experiment was done in triplicates and repeated at least three times. 
7.4.5  Activation of ER-fusion proteins in cultured cells 
4-Hydroxytamoxifen (Sigma-Aldrich) was added to the cell culture medium at a 
final  concentration  of  1  µM.  Control  cells  were  treated  with  ethanol  (1:1000). 
Activation of the ER-fusion protein was tested after incubation at 37ºC and 5% CO2 for 
24 hours by luciferase reporter assay.  
7.4.6  Immunofluorescence and confocal microscopy 
For  immunohistochemistry  MCF10  cells  stably  expressing  BirA  and  NICD
BAP 
were cultured on chamber slides coated with Poly-D-Lysine (BD Biosciences). 24 hours 
after plating, the medium was aspirated and cells washed twice with PBS and fixed in 
4% paraformaldeyhde (PFA) for 10 minutes at room temperature. Following two more 
washes with PBS, cells were treated with 0.1% Triton-X-100 in PBS for 5 minutes at 
room temperature. The first antibody was applied after another two washes with PBS 
and used at a concentration of 1:100 in TNB buffer (0.5% blocking reagent (Roche) in 
0.1 M Tris/HCl pH 7.5, 0.15 M NaCl) for an overnight incubation. The next day, cells CHAPTER 7: Materials and Methods
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were washed three x five minutes with 1xTBST (0.1 M Tris/HCl pH 7.5, 0.15 M NaCl, 
0.1% Tween-20) and the secondary antibody applied at concentration of 1:500 for 3 
hours  at  room  temperature.  This  was  followed  by  further  washes  in  1xTBST  and 
dehydration through a series of alcohol. Cells were mounted in SlowFade Gold anti-
fade reagent (Invitrogen).  
For  embryonic  sections  (15  µm  thick)  the  first antibody  was  diluted  1:100  in 
immunostaining buffer (10% goat serum, 2% BSA, 0.1% Triton-X-100) and incubated 
overnight at 4ºC. Sections were rinsed with PBS containing 0.1% Triton-X-100 for 3 x 
5 minutes at room temperature and further incubated for 3 hours at room temperature 
with the secondary antibody diluted 1:500 in the immunostaining buffer. Mounting of 
sections was as above. 
Antibody staining on retinas was performed as follows: Eyes were harvested and 
put into 4% PFA for fixation for 2 hours at 4ºC. Retinas were dissected and blocked in 
Immunostaining buffer (PBS containing 0.5% Tween-20 and 1% BSA) for 2 hours at 
room  temperature.  Isolectin  Alexa  Fluor  568  and  Streptavidin  Alexa  Fluor  488 
(Invitrogen)  directly  coupled  antibodies  were  applied  1:200  in  the  immunostaining 
buffer and left for 3 hours at room temperature. Washes and mounting were done as 
above.  
For visualising of the nuclei, 4',6-diamidino-2-phenylindole (DAPI, Invitrogen) 
was added at a final concentration of 54.5 nM to the last wash and incubated for 5 
minutes. Confocal imaging was performed on a Zeiss LSM 510 using a 40X water 
immersion  lens.  Digital  images  were  processed  and  arranged  using  the  Adobe 
Photoshop and Illustrator CS2 software. 
Antibody  Company 
Streptavidin Alexa Fluor 488  Invitrogen 
Isolectin Alexa Fluor 568  Invitrogen 
Cleaved Notch1 (Valine 1744)   Cell Signaling 
Goat α-rabbit Alexa Fluor 568  Invitrogen 
Table 7.15 Antibodies used for Immunohistochemistry. CHAPTER 7: Materials and Methods
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7.5  Biochemistry 
7.5.1  Glutathione-S-Transferase (GST) protein purification  
Small  scale  GST-protein  purification  of  GST-Hes7
bHLH,  GST-Hes7
N-terminus  and 
GST-Hes7
ORF proteins from E. coli BL21-CodonPlus (DE3)-RIL cells showed that only 
the Hes7
bHLH protein could be isolated efficiently without being degraded. Large scale 
GST-protein purification from E. coli BL21-CodonPlus (DE3)-RIL [Hes7
bHLH] cells was 
prepared as follows: Cells were grown in 2 litres of LB medium containing 100 µg/ml 
Ampicillin  until  the  culture  reached  an  optical  density  at  600  nm  (OD600)  of  0.7. 
Induction  of  the  GST-fusion  was  done  by  adding  0.1  mM  Isopropyl  β-D-1-
thiogalactopyranoside (IPTG, Sigma-Aldrich) and further incubation at 18ºC overnight. 
Cells were harvested by centrifugation at 6,000 x g and 4ºC for 20 minutes. The pellets 
were washed once with 1xMTPBS (0.15 M NaCl, 0.16 M Na2HPO4, 4 mM NaH2PO4) 
including protease inhibitors (Complete EDTA free, Roche). Resuspended cells were 
aliquoted in 6 x 15 ml and sonicated twice for 1 minute with a Soniprep 150. Sonication 
was typically at 12-14 microns amplitude, as judged by a ‘frying egg’ noise. 0.2% of 
Igepal  CA-630  (Sigma-Aldrich)  was  added  and  insoluble  material  removed  by 
centrifugation at 12,000 x g for 10 minutes and 4ºC. Supernatants were pooled and 
mixed  with  1  ml  of  50%  glutathione-Sepharose  4B  beads  (Pharmacia;  2  ml  of  1:1 
MTPBS slurry). The beads were prepared by pre-swelling and washing in MTPBS. The 
beads and supernatant were rolled for 30 minutes at 4ºC. To remove unbound material, 
the mixture was centrifuged at 500 x g for 5 minutes at 4ºC. The beads were further 
washed 6 times with MTPBS containing 0.1% β-Mercaptoethanol (Sigma-Aldrich) and 
spun as previously.   
To cleave off the GST-tag 80 units of thrombin (Amersham Biosciences) were 
added  to  920  µl  of  MTPBS  and  incubated  with  the  beads  for  2  hours  at  room 
temperature. Removal of the thrombin protease was done by incubation with 40 µl of 
Benzaminobenzamidine beads (Sigma-Aldrich) for 30 minutes at 4ºC. Beads were spun 
out and the supernatant removed and stored at -80ºC in 10% glycerol.  CHAPTER 7: Materials and Methods
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7.5.2  Protein gel electrophoresis 
Proteins were separated and transferred using the NuPAGE system (Invitrogen) 
according  to  the  manufacturers’  instructions.  NuPAGE  Novex  4-12%  Bis-Tris  gels 
(Invitrogen) were used for most applications. For separation of small proteins Novex 
Tricine gels were run. Depending on the range of protein separation MOPS or MES 
running buffers (Invitrogen) were used for high molecular weight or low molecular 
weight  proteins,  respectively.  Tricine  gels  were  run  in  Tricine  SDS  running  buffer 
(Invitrogen). For protein visualisation, gels were stained with Novex
  Colloidal Blue 
Staining Kit (Invitrogen). 
Blotting  of  gels  was  performed  as  described  in  the  manufacturers’  manual. 
Proteins were blotted onto a Hybond-ECL membrane during the 90 minutes transfer in 
the supplied transfer buffer (Invitrogen). 
7.5.3  Western blotting 
Membranes were blocked for 1 hour at room temperature with 5% milk (Marvel) 
in PBS for standard western blot or with 5% BSA (Sigma-Aldrich) in TBS (10 mM 
Tris, 150 mM NaCl, pH 7.6) including 0.2% Tween-20 for detection of biotinylated 
proteins with streptavidin. Primary antibody incubation was performed for one hour at 
room temperature or overnight at 4ºC in blocking solution (Table 7.16). Following three 
washes  for  5  minutes  at  room  temperature  in  PBS  including  0.1%  Tween-20  for 
standard  procedures  or  in  TBS  containing  0.5  M  NaCl  and  0.3%  Triton-X-100  for 
biotinylated proteins the secondary antibody was applied. After incubation for 1 hour at 
room temperature, the membrane was washed as above and detection was carried out 
with  the  ECL  Plus  Western  Blotting  Detection  System  (GE  Healthcare,  formerly 
Amersham Biosciences) according to the manual. The membrane was exposed to the 
high performance chemiluminescence film Hyperfilm ECL (GE Healthcare) and the 
film further developed in the JPI Automatic X-ray Film Processor (Model JP-33). 
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Antibody  Source  Dilution  Company 
Cleaved Notch1 (Valine 1744) 
antibody  Rabbit  1:1,000  Cell Signalling 
Streptavidin-HRP    1:25,000  NEN 
α-HA  Mouse  1:5,000  Roche 
RBP-Jκ (H-50): sc-28713  Rabbit  1:1,000  Santa Cruz 
Biotechnology, INC 
α-Hes7
bHLH  Rat  1:10,000  CR-UK Monoclonal 
Antibody Service 
Goat α-Rat IgG Peroxidase Conjugate  Goat  1:10,000  Calbiochem 
α-mouse IgG, Horseradish Peroxidase 
linked whole antibody 
Sheep  1:10,000  Amersham Biosciences 
Peroxidase-conjugated AffiniPure Goat 
α-Rabbit IgG (H+L)  Goat  1:10,000  Jackson ImmunoResearch 
Laboratories 
Table 7.16 Antibodies used for western blotting. 
7.5.4  Preparation of whole cell lysates 
Whole cell lysates from cultured cells and mouse tissues were prepared using the 
Radio Immuno Precipitation Assay buffer (RIPA; 50 mM Tris/HCl pH 8, 150 mM 
NaCl,  1%  Igepal  CA-630,  0.5%  sodium  deoxycholate,  0.1%  SDS,  2  mM  EDTA). 
Briefly, cells were washed with ice-cold PBS and lysed in 1 ml RIPA per 10
7 cells/100 
mm dish and further incubated under constant agitation for 30 minutes at 4ºC. Upon 
centrifugation at 16,000 x g at 4ºC the supernatant was removed and aliquoted. For 
storage protein lysates were quick-freezed in liquid nitrogen and kept at -80ºC. 
Tissues  of  interest  were  dissected  in  ice-cold  PBS  and  snap  frozen  in  liquid 
nitrogen for further storage at -80ºC or immediate homogenisation. For a 5 mg piece of 
tissues  300  µl  of  RIPA  buffer  were  added  and  the  tissue  homogenised.  Constant 
agitation at 4ºC was maintained for 2 hours. After centrifugation at 16,000 x g at 4ºC 
the supernatant was transferred into a new tube and stored as above. 
7.5.5  Crude nuclear extract preparation 
Nuclear extracts from a small number of cells (up to 10
7) were prepared according 
to Andrews et al. (Andrews and Faller, 1991). Adherent cells were scraped in cold PBS 
on ice, pelleted by centrifugation for 30 seconds in an Eppendorf 4515D centrifuge and CHAPTER 7: Materials and Methods
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resuspended in 1.5 ml cold PBS. Cells were pelleted for 10 seconds and resuspended in 
400 µl cold Buffer A (10 mM HEPES-KOH pH 7.9 at 4ºC, 1.5 mM MgCl2, 10 mM 
KCL, 0.5 mM dithiothreitol (DTT), 0.2 mM phenylmethanesulphonylfluoride (PMSF)) 
by flicking the tubes. The cells were allowed to swell on ice for 10 minutes and were 
then vortexed for 10 seconds. Samples were centrifuged for 10 seconds, the supernatant 
discarded and the pellet taken up in 1½ volumes of cold Buffer B (20 mM HEPES-
KOH pH 7.9 at 4ºC, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 
mM  dithiothreitol  (DTT),  0.2  mM  phenylmethanesulphonylfluoride  (PMSF)).  After 
incubation for 20 minutes on ice cellular debris is removed by centrifugation at 4ºC for 
2 minutes. Protein lysates were stored as in section 7.5.4.  
7.5.6  Protein concentration determination 
The protein concentration was determined using either the Bio-Rad Protein Assay 
(Bio-Rad)  or  the  RC  DC  Protein  Assay  (Bio-Rad)  depending  on  the  lysis  buffer 
formulation and according to the manufacturers’ guidelines.  
7.5.7  Binding to streptavidin beads 
Paramagnetic  streptavidin  beads  (Dynabeads  M-280,  Dynal)  were  blocked  by 
washing three times in TBS containing 200 ng/µl ovalbumin (Sigma-Aldrich). Binding 
was done in 1 x TBS/0.3% Igepal CA-630 at 4ºC for 1 h to overnight on a rotating 
wheel, followed by six washes in binding solution at room temperature. Bound material 
was eluted by boiling for 5 min in 2 x sample buffer (100 mM Tris/HCl pH 6.8, 4% 
SDS,  0.2%  bromophenol  blue,  20%  glycerol,  200  mM  β-Mercaptoethanol)  and 
analyzed by western blotting (section 7.5.3). 
7.5.8  Streptavidin protein pull-down from mouse embryos 
Wildtype, Rosa26
BirA/BirA  and Notch1
BAP/BAP;Rosa26
BirA/BirA E12.5 embryos were 
dissected in homogenisation buffer (0.25 M Sucrose, 10 mM HEPES-KOH pH 7.9, 25 
mM  KCl,  1  mM  EDTA,  0.15  mM  Spermine,  0.5  mM  spermidine)  and  further 
homogenised using a B Dounce homogeniser (5 ml per g). The homogenate was filtered 
through  a  cell  strainer  and  diluted  1:1  with  homogenisation  buffer.  Following  a 
centrifugation step at 800 x g at 4ºC for 10 minutes the pellet was resuspended in 10 ml 
homogenisation buffer and spun as above. The pellet was further taken up in 9 volumes CHAPTER 7: Materials and Methods
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of sucrose cushion buffer (2.2 M sucrose, 10 mM HEPES-KOH pH 7.9, 25 mM KCl, 1 
mM EDTA, 0.15 mM spermine, 0.5 mM spermidine) and put on ice for 20 minutes. 
Ultracentrifugation in a swinging-bucket rotor (Sw55Ti) for 2 hours at 4ºC and 141,000 
x g resulted in a pellet of nuclei. The nuclei were lysed in an adequate volume of lysis 
buffer (10 mM HEPES-KOH pH 7.9, 100 mM KCl, 3 mM MgCl2, 0.1 mM EDTA, 20% 
glycerol) and extracted by drop-wise addition of 3 M KCl until a final concentration of 
400  mM  was  achieved.  The  samples  were  kept  on  ice  for  20  minutes. 
Ultracentrifugation for 1 hour at 4ºC and 300,000 x g eliminated cellular debris. The 
supernatant corresponding to the nuclear extract was snap frozen in liquid nitrogen and 
stored  at  -80ºC.  Protein  concentration  determination  was  performed  as  described  in 
section 7.5.6.  
For the streptavidin protein pull-down, 2 mg of nuclear extracts were mixed with 
40 µl of blocked streptavidin M280 beads (Dynal). Blocking of beads was done for 1 
hour at room temperature in 1ml of HENG buffer (10 mM HEPES-KOH, pH 9, 1.5 mM 
MgCl2, 0.25 mM EDTA, 20% glycerol, 1 mM PMSF) including 200 ng/µl ovalbumin 
(Sigma-Aldrich). The beads were immobilized using a magnetic rack (Dynal MPC-S) 
and  the  blocking  solution  was  removed.  Nuclear  extracts  were  diluted  with  HENG 
buffer to adjust to a final KCl concentration of 150 mM. Igepal CA-360 was added to a 
0.3% final concentration. The nuclear extract was further mixed with the beads and 
incubated  at  4ºC  for  2  hours  to  overnight.  Using  the  magnetic  rack,  the  unbound 
fraction was discarded and the beads washed with HENG wash buffer (10 mM HEPES-
KOH, pH 9, 250 mM KCl, 1.5 mM MgCl2, 0.25 mM EDTA, 0.3% Igepal CA-360, 20% 
glycerol, 1 mM PMSF) as follows: 2 quick rinses followed by three washes, 10 minutes 
each at room temperature rotating. After the last wash, the beads were resuspended in 
50  µl  2x  sample  buffer  (100  mM  Tris/HCl  pH  6.8,  4%    (w/v)  SDS,  0.2%  (w/v) 
bromophenol blue, 20% (w/v) glycerol, 200 mM β-Mercaptoethanol) and boiled at 95ºC 
for 5 minutes to elute proteins. Gel electrophoresis was done as described in 7.5.2. 
7.5.9  Mass spectrometry 
7.5.9.1  Sample preparation, digestion and extraction 
Excised bands were diced, placed in 0.5 ml tubes (Bioquote) and de-stained in 
200 µl 50% acetonitrile (CAN, Rathburn)/50% 10 mM triethylammonium bicarbonate 
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were swollen in 200 µl 10 mM TEAB for 10 minutes. This was removed and 200 µl 
ACN was used to dehydrate the gel pieces for 10 minutes. After removal of ACN the 
gel pieces were fully dehydrated in a SpeedVac (ThermoSavant) for 15 minutes. The 
gel pieces were reduced with 200 µl 10mM dithiothreitol (DTT, Sigma-Aldrich) in 10 
mM TEAB for 45 minutes at 50˚C on a heating block. The DTT was removed and the 
gel pieces were alkylated with 200 µl 50 mM iodoacetamide (IAA) for 60 minutes at 
room temperature in darkness. This solution was removed and gel pieces were washed 
with 200 µl 10 mM TEAB. After its removal 200 µl ACN was added and subsequently 
dehydrated for 15 minutes in a SpeedVac, followed by a repetition of the washing. 
Porcine Trypsin (Promega) was re-suspended in 10 mM TEAB and a 10 µl aliquot 
containing 50 ng of trypsin was administered to the dehydrated gel pieces and left to re-
swell on ice. After 20 minutes 30 µl of 10 mM TEAB was added and incubated for 16 
hours at 37ºC. Digests were placed on dry ice for 5 minutes, allowed to thaw and the 
extract transferred to 0.2 ml PCR tubes (Bioquote). 30 µl of 10% ACN/5% formic acid 
(BDH) was added to gel pieces and placed in a sonicator (Jencons) for 15 minutes. The 
resulting extract was transferred to the PCR tubes. This was repeated once and the 
whole extract concentrated to dryness in a SpeedVac. Two separate 30 µl aliquots of 
HPLC Grade water (Rathburn) were administered to the extracts after each dry-down 
with all samples being stored dry at -20ºC until analysis. 
7.5.9.2  NanoLC-MS/MS 
The dried digest was reconstituted in 8 µl 1% formic acid and 2-6 µl (crudely 
determined by band intensity inspection) was analysed via electrospray on  a QTOF 
6510  mass  spectrometer  with  Chip  Cube™  source  interface  and  1200  series  HPLC 
running MassHunter B.01.03 (Agilent Technologies). The samples were run with an 
automated acquisition method using an integrated 40 nl enrichment column, a 150 mm 
analytical column (both 300 Ǻ C18 packing) and electrospray needle. The peptides were 
loaded onto the enrichment column at 3 µl/min in A buffer (0.1% formic acid) with a 
sample flush out factor of 5 µl and an injection flush volume of 10 µl. The enrichment 
column was then switched in-line with the analytical column that was equilibrated at 
10% B buffer (80% acetonitirile/0.1% formic acid) and the following gradient was run 
at 300 nl/min:  
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Time  % B buffer 
0  10 
2  20 
10  70 
11  100 
16  100 
17  10 
Table 7.17 Gradient for NanoLC-MS/MS. 
MS data was acquired in the 290-2500 m/z (mass-to-charge) range at a scan rate 
of 6 spectra/second and MS/MS data was acquired in the 57-3000 m/z range at a scan 
rate of 4 spectra/second. The 3 highest peaks in an MS spectrum above 1000 counts 
were targeted for MS/MS with charge state preference being 3, 2, >3, unknown and the 
same m/z mass was actively excluded from fragmentation for 0.1 minutes. An internal 
reference mass of 299.294457 was introduced as per manufacturers’ recommendations 
for calibration.  
Data  was  exported  as  mzdata.xml  within  the  MassHunter  qualitative  analysis 
software with no filters applied and searched against the NCBInr 20080210 database, on 
a Mascot in-house server version 2.2.04 (Matrix Science) using Mascot Daemon version 
2.2.2 (Matrix Science). The search parameters were: peptide tolerances of 10 ppm and 
fragment tolerances of 0.05 Da with 1 missed cleavage and carboamidomethylation of 
cysteines as a fixed modification and oxidation of methionine, protein N-terminally 
acetylated, Gln>pyro-Glu as variable modifications. The Mascot generated search result 
files  (*.dat)  were  loaded  into  Scaffold  software  2.1  (Proteome  Science).  Peptide 
identifications  were  accepted  if  they  could  be  established  at  greater  than  20% 
probability as specified by the Peptide Prophet algorithm (Keller et al., 2002). Protein 
identifications  were  accepted  if  they  could  be  established  at  greater  than  99% 
probability  and  contained  at  least  2  identified  peptides.  Protein  probabilities  were 
assigned by the Protein Prophet algorithm (Nesvizhskii et al., 2003).  CHAPTER 7: Materials and Methods
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7.6  Protein-DNA interaction studies 
7.6.1  bioChIP experiments 
7.6.1.1  bioChIP from cultured cells 
Chromatin immunoprecipitation (ChIP) from cultured cells was performed using 
the buffer formulations from the Upstate (now Milipore) ChIP Assay Kit. 10
7 cells were 
fixed by adding formaldehyde (Sigma-Aldrich) at a final concentration of 1% directly to 
the growth medium. Cells were incubated at 37ºC for 10 minutes. Crosslinking was 
stopped  by  adding  1/20  volume  of  2.5  M  glycine  and  further  incubation  at  room 
temperature for 5 minutes. Next, cells were washed twice with cold PBS and scraped in 
1 ml PBS. Cells were pelleted for 4 minutes at 4ºC and 400 x g and subsequently taken 
up in 5 volumes of lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris pH 8.1). Lysis 
was  allowed  to  perform  for  10  minutes  on  ice.  Sonication  of  the  chromatin  was 
performed using the Bioruptor (diagenode) at setting ‘H’ for 10 times 30 seconds ON, 1 
minute OFF. Samples are spun at 16,000 x g for 10 minutes at 4ºC and the chromatin 
aliquoted and stored at -80ºC. An aliquot was taken to confirm shearing of chromatin by 
agarose gel electrophoreses.  
For  the  bioChIP,  20  µl  of  streptavidin  M280  beads  were  blocked  with  40  µl 
sonicated herring sperm DNA (Sigma-Aldrich) in 1 ml of ChIP dilution buffer (0.01% 
SDS, 1.1% Trition X-100, 1.2 mM EDTA, 16.7 mM Tris/HCl pH8.1, 167 mM NaCl) 
and rotated for 1 hour at room temperature. Before adding to the chromatin, beads were 
washed twice in ChIP dilution buffer. Chromatin was thawed at 4ºC on a rotating wheel 
and  diluted  with  chromatin  dilution  buffer  including  protease  inhibitors  (Complete 
EDTA-free, Roche) to give a final volume of 1 ml. 20 µl of chromatin solution were 
taken and kept as Input fraction. Binding of chromatin to streptavidin beads was done 
overnight  at  4ºC  on  a  rotating  wheel.  The  next  day,  beads  were  washed  using  the 
magnetic rack with 1 ml of each once: low salt immune complex wash buffer (0.1% 
SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris HCl, pH 8.1, 150 mM NaCl), high 
salt immune complex wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM 
Tris HCl, pH 8.1, 500 mM NaCl), LiCl immune complex wash buffer (0.25 M LiCl, 1% 
Igepal CA-630, 1% deoxycholic acid (sodium salt), 1 mM EDTA, 10 mM Tris pH 8.1) 
and twice with 1 ml of TE. Elution was done by reversing the crosslinks in 500 µl of 
ChIP elution buffer (0.1% NaHCO3, 1% SDS and 200 mM NaCl) and incubation at CHAPTER 7: Materials and Methods
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65ºC for 6 hours. To 20 µl of input 480 µl of elution buffer was added and incubated as 
above. This was followed by proteinase K (Roche) treatment at 45ºC for 15 minutes and 
phenol/chloroform extraction. DNA was precipitated by adding 20 µg of glycogen, 50 
µl of 3 M NaOAc pH 5.2 and 0.9 ml isopropanol and further incubation at -20ºC for 20 
minutes. Samples were centrifuged at 16,000 x g and 4ºC for 15 minutes and washed 
with 70% ethanol. Finally, the DNA was resuspended in 200 µl of water.  
For analysis of promoter sequences quantitative PCR was performed using the 
Platinum  SYBR  Green  qPCR  SuperMix-UDG  with  ROX  (Invitrogen)  chemistry 
including 4 µl of eluted DNA and 10 µM of each primer (Table 7.18 and Table 7.19). 
Reactions were run on the ABI 7900HT (Applied Biosystems) real time PCR machine 
and  analysed  using  the  SDS  1.9.1  software  (Applied  Biosystems).  Enrichment  of 
specific promoter sequences was calculated using the comparative CT method (Litt et 
al., 2001). The formula 2
Ct(IP)-Ct(Ref) was used to calculate the enrichment of bound DNA 
over input. 
 
Primer position  Forward primer  Reverse primer 
EKLF enhancer   5’- CTG GCC CCC CTA CCT 
GAT -3’ 
5’- GGC TCC CTT TCA GGC 
ATT ATC -3’ 
EKLF basic promoter  5’- TAT CGC ACA CAC CCC 
TCC TT -3’ 
5’- CCC ACA TCT GAT TGG 
CTG TCT -3’ 
EKLF negative  5’- TGC TCC CCA CTA TGA 
TAA TGG A -3’ 
5’- GCC ACA ACC AAA GAA 
GAC ATT TT -3’ 
necdin  5’- GGT CCT GCT CTG ATC 
CGA AG -3’ 
5’- GGG TCG CTC AGG TCC 
TTA CTT -3’ 
Table 7.18 Primer sequences for amplification of EKLF (see Figure 3.1 for diagram of the EKLF 
promoter) and necdin promoter fragments. 
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Primer position  Forward primer  Reverse primer 
mHes1_1  5’- TCC TCC CAT TGG CTG 
AAA GT -3’ 
5’- GCG AAC GGC TCG TGT 
GA -3’ 
mHes1_2  5’- GCC AGA CCT TGT GCC 
TAG C -3’ 
5’- TTC TTT CCC ACA GTA 
ACT TTC AGC -3’ 
mHes1 negative  5’- GGA CGG TAA GGG CAT 
GTT TA -3’ 
5’- TTC CCG CTC GAA CTC 
TGT AT -3’ 
mGAPDH  5’- GTG GGC ACT GTA CGG 
GTC TA -3’ 
5’- CAT CAC GTC CTC CAT 
CAT CC -3’ 
hHes1  5’- CCT CCC ATT GGC TGA 
AAG T -3’ 
5’- GGC CTC TAT ATA TAT 
CTG GGA CTG C -3’ 
hHes1 upstream  5’- GGC AGC TAC CAC GTC 
TCT G -3’ 
5’- GCC TGA GGA CTT GAA 
GCT TTT -3’ 
hHes1 negative  5’- CCA GAC CAT GTT CCC 
TGA AT -3’ 
5’- CTT AGT CGT GGG CTG 
GAG AG -3’ 
hGAPDH  5’- CTC TGC TCC TCC TGT 
TCG AC -3’ 
5’- TAG CCT CCC GGG TTT 
CTC -3’ 
hc-Myc  5’- CCC TGT GGA GAG CAC 
TCA TTT -3’ 
5’- CCC GCA GGA GCC TTG 
TAG -3’ 
hc-Myc negative  5’- CAG GGA GCA AAC AAA 
TCA TGT -3’ 
5’- ACT GTA TGT AAC CCG 
CAA ACG -3’ 
Table 7.19 Mouse (m) and human (h) qPCR primer sequences for validation of NICD bioChIP 
experiments from mouse C3H10T½ [NICD
BAP; BirA] and human MCF10A [NICD
BAP; BirA] cell 
lines. 
7.6.1.2  bioChIP from retina tissue 
5 day old (P5) mouse pups from Rosa26
BirA/BirA and Notch1
BAP/BAP;Rosa26
BirA/BirA 
strains were injected sub-cutaneously with 100 µg/g of γ-secretase inhibitor, N-[(3,5-
Difluorophenyl)acetyl]-L-alanyl-2-phenyl]glycin  e-1,1-dimethylethyl  ester  (DAPT; 
Calbiochem). After 3 hours pups were killed by decapitation, eyes harvested and retinas 
dissected in ice-cold PBS. Crosslinking of retinas was performed by adding 27 µl of 
36.5%  formaldehyde  (Sigma-Aldrich)  to  1  ml  of  PBS  including  protease  inhibitors 
(Complete EDTA-free, Roche). Following the homogenisation of the retinas using a 
Dounce homogeniser, the samples were incubated for 10 minutes at room temperature 
with gentle agitation. 1/20 volume of 2.5 M glycine was added to stop the crosslinking 
and further incubation for 5 minutes at room temperature. Samples were centrifuged at CHAPTER 7: Materials and Methods
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4ºC and 16,000 x g for 5 minutes, washed in ice-cold PBS plus protease inhibitors and 
spun again. Fixed retinas were snap frozen in liquid nitrogen and stored at -80ºC.  
Chromatin preparation and bioChIP was carried out using a modified protocol for 
tissue  ChIP  from  the  Farnham  Lab 
(http://www.genomecenter.ucdavis.edu/farnham/protocols/tissues.html).  Pellet  volume 
of pooled retinas (20-30) was measured and retinas subsequently lysed in 6 volumes of 
cell lysis buffer (5 mM PIPES pH 8.0, 85 mM KCl, 0.5% Igepal CA-630 and protease 
inhibitors  added  fresh)  for  10  minutes  on  ice. The  suspension  was  dounced  with  5 
strokes to aid nuclei release before centrifugation at 1,000 x g and 4ºC for 5 minutes. 
Nuclei were lysed in 5 volumes of nuclei lysis buffer (50 mM Tris/HCl pH 8.1, 10 mM 
EDTA, 1% SDS, protease inhibitors added fresh). Lysis was allowed to proceed for 20 
minutes  on  ice.  Samples  were  flash  frozen  in  liquid  nitrogen  and  thawed  once. 
Sonication of chromatin was done using the Bioruptor (diagenode) at setting ‘high (H)’ 
for 10 cycles of 30 seconds ON and 1 minute OFF. After centrifugation at 16,000 x g 
and 4ºC for 15 minutes the supernatant corresponding to the chromatin solution was 
aliquoted  and  stored  at  -80ºC.  An  aliquot  was  used  to  check  the  quality  of  the 
chromatin. 
For  the  bioChIP,  streptavidin  M-280  beads  were  blocked  with  1  mg/ml  BSA 
(Sigma-Aldrich) and 0.4 mg/ml single stranded herring sperm DNA (Sigma-Aldrich) in 
dialysis buffer (2 mM EDTA, 50 mM Tris/HCl pH 8.0) for 2 hours at 4ºC rotating. The 
beads were taken up in an equivalent volume of dialysis buffer and 1mM PMSF added. 
For each 200 µl aliquot of chromatin 800 µl of ChIP dilution buffer (0.01% SDS, 1.1% 
Triton X-100, 1.2 mM EDTA, 16.7 mM Tris/HCl pH 8.1, 167 mM NaCl) was added. 
10% of input was taken from the chromatin solution and stored at -20ºC. 20 µl of 
blocked streptavidin beads were added to the chromatin and incubated overnight at 4ºC 
on a rotating wheel. Beads were further washed twice with dialysis buffer including 
0.2% Sarkosyl and three times with IP wash buffer (100 mM Tris/HCL pH 8, 500 mM 
LiCl, 1% Igepal CA-630, 1% deoxycholic acid) at room temperature for 3 minutes each. 
Bound chromatin was eluted by adding 200 µl of elution buffer (50 mM NaHCO3, 1% 
SDS) and NaCl to a final concentration of 0.5 M. Samples were incubated at 95ºC for 
15 minutes. Input samples were processed as bioChIP samples apart from the fact that 
they were also treated with RNase and proteinase K. Purification of DNA was done 
using the QIAquick PCR Purification Kit (Qiagen) and elution in 50 µl of H2O. CHAPTER 7: Materials and Methods
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For high throughput sequencing, samples were sent to the Cancer Research UK 
Leeds Institute of Molecular Medicine and run on an Illumina GAII sequencer machine. 
Sample preparation and processing was done as described by the manufacturer. The 
data  was  analysed  by  the  Cancer  Research  UK  Bioinformatics  and  Biostatistics 
department. 
 
Sample  Mouse strain  DAPT treatment [w or w/o] 
Input_BirA neg  Rosa26
BirA/BirA  w/o 
ChIP_BirA neg  Rosa26
BirA/BirA  w/o 
Input_BirA pos  Rosa26
BirA/BirA  w 
ChIP_BirA pos  Rosa26
BirA/BirA  w 
Input_Bio-Notch neg  Notch1
BAP/BAP;Rosa26
BirA/BirA  w/o 
ChIP_ Bio-Notch neg  Notch1
BAP/BAP;Rosa26
BirA/BirA  w/o 
Input_ Bio-Notch pos  Notch1
BAP/BAP;Rosa26
BirA/BirA  w 
ChIP_ Bio-Notch pos  Notch1
BAP/BAP;Rosa26
BirA/BirA  w 
Table 7.20 Samples from Notch bioChIP experiment for sequencing. w, with; w/o, without. 
7.6.1.3  Analysis of high-throughput sequencing 
In order to call peaks of alignments Model-based Analysis of ChIP-Seq (MACS) 
was used (Zhang et al., 2008). However, this produced no peaks at a convincing false 
detection threshold. Examination of the data revealed that this was most likely due to an 
imbalance  of  forward  and  reverse  strand  alignments  of  reads,  more  specifically, 
although  “reverse”  alignments  were  being  made,  those  regions  displaying  apparent 
peaks of forward alignments did not display corresponding peaks of reverse alignments, 
thus confounding the MACS algorithm. 
In order to investigate the possible effects of nucleotide calling bias (Dohm et al., 
2008), the R package Rolexa (Rougemont et al., 2008) was used to recall the sequences 
from the raw intensity files. Rolexa is specifically designed to combat the “A” bias, 
which  has  been  observed  on  the  Illumina  platform.  Once re-called,  sequences  were CHAPTER 7: Materials and Methods
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aligned by Bowtie (Langmead et al., 2009) and peaks called by MACS. Unfortunately 
the forward alignment bias was still present resulting, once again, in a failure to detect 
peaks. 
Standard  approaches  have  failed  to  call  peaks  and  therefore  rather  than  using 
paired forward and reverse alignments to identify excess binding sites excess binding, 
whether  forward  or  reverse,  irrespective  of  pairing  was  considered.  Using  the 
Bioconductor  (Gentleman  et  al.,  2004)  package  “Short  Reads” 
(http://bioconductor.org/packages/2.4/bioc/html/ShortRead.html)  so  called  “pileups” 
were created of ELAND aligned reads; a pileup is simply a count of how many reads 
align across a particular nucleotide. Each aligned read (36bp) was adjusted to the full 
fragment length (300bp) taking into account directionality (forward alignments were 
extended 264 bp 3’, reverses extended 264 bp 5’ to correspond with the alignments 
reporting standards). Alignments were then filtered so that each 300 bp stretch of the 
genome was covered exactly by at most one forward and at most one reverse alignment. 
Finally, for each nucleotide, a count was made of how many alignments covered that 
nucleotide.  This  process  was  carried  out  for  each  experiment  and,  to  control  for 
“background”, the results from the control (BirA) were subtracted from the Bio-Notch 
samples, and the results examined for peaks (resulting in four experimental conditions: 
Input neg and ChIP neg, w/o DAPT; Input pos and ChIP pos w DAPT). 
Since many chromosomes displayed evidence of apparent PCR artefact  spikes 
(Nix et al., 2008) (Chromosome 11 being a particularly good example), approximately 
half of the chromosomes needed to have the peak threshold adjusted to compensate for 
this skew. However, after these corrections in all four of the experimental conditions, 
most chromosomes had a threshold between 8 and 10 (that is, any nucleotide covered by 
more than 10 reads was deemed to be a peak. 
Wiggle  files  (http://genome.ucsc.edu/goldenPath/help/wiggle.html)  were 
produced  to  aid  visualization  on  the  UCSC  genome  browser 
(http://genome.ucsc.edu/cgi-bin/hgGateway) and those peaks, which covered a gene in 
the  UCSC  database  were  further  annotated  from  the  Ensembl 
(http://www.ensembl.org/index.html)  database  using  biomaRt 
(http://bioconductor.org/packages/2.4/bioc/html/biomaRt.html). 
All pileup analyses subsequent to the Solexa pipeline (i.e. post ELAND) were 
carried out with scripts written in R 2.8.1, using packages from Bioconductor 2.3 CHAPTER 7: Materials and Methods
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7.6.2  Electrophoretic Mobility Shift Assay (EMSA) 
For Hes7 promoter EMSA 18 fragments of 300 bp length covering 5 kb of the 
Hes7  promoter  were  amplified  by  PCR  from  the  pENTR-Hes7_5kp  template  using 
PfuTurbo  DNA  polymerase  (section  7.1.1  and  Table  7.21).  Purification  of  DNA 
fragments was performed through elution from a 1.2% agarose gel using QIAquick Gel 
Purification Kit (Qiagen). DNA was eluted in H2O and the concentration determined by 
NanoDrop (Thermo Scientific) measurement. A 300 bp fragment containing the 6 N-
box repeat from pN6-luc served as positive control whereas a 300 bp random vector 
sequence was chosen as negative control. 
Fragments  were  labelled  with  T4  Polynucleotide  Kinase  (PNK;  New  England 
Bioloabs) and γ
32P-dATP (GE Healthcare) in kinase buffer (0.5 M Tris/HCL pH 7.9, 0.1 
M MgCl2, 50 mM DTT, 10 mM spermidine, 1 mM EDTA) for 37 minutes at 37ºC. The 
enzyme was inactivated by incubation at 68ºC for 15 minutes. For the binding reaction 
3 fmol of the DNA fragment was mixed with 30 pmol of Hes7
bHLH protein (section 
7.5.1) and incubated in binding buffer (25 mM HEPES pH 7.5, 100 mM KCl, 20% 
glycerol, 0.1% Igepal CA-630, 10 µM ZnSO4, 50 mM DTT) with 0.5 µg Poly [d(I-C)] 
(Roche), 0.18 M BSA for 30 minutes on ice. Reactions were run on a NuPAGE precast 
6% DNA retardation gel at 100 V constant and 4ºC. The gel was dried on Whatman 
paper, sealed with Saran Wrap and exposed to KODAK BioMax MS Film for 1 hour at 
-80ºC.  
Mutation  of  N-boxes  was  achieved  through  the  QuikChange  XL  site  directed 
mutagenesis Kit (Stratagene) according to the manufacturers’ guidelines (Table 7.22). 
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Fragment  Forward primer  Reverse primer 
1  5’- GCC TTA TTA TAC AGC TTT 
ATG G -3’ 
5’- TGC TCC TCC GGA CCC 
TTC -3’ 
2  5’- TGT GGG AAT TGA GTA GAA 
GAG ACA -3’ 
5’- GTA TAA TAA GGC GGG 
ACC CAA C -3’ 
3  5’- TGT AAA CGG AAA GGT ATC 
GCT TC -3’ 
5’- GCG CCG TTG TAT CTG 
TCT CTT C -3’ 
4  5’- GCC TTC TTG TCG TGT TAA 
ATT TCG -3’ 
5’- GCC GAG AAG CGA TAC 
CTT TCC -3’ 
5  5’- CAT TTG GCT GAA GTA GGG 
GAA GG -3’ 
5’- GGG CGA AGT GCC TGA 
GAA G -3’ 
6  5’- TTC TCA GAG GCA GAT CCA 
ATC C -3’ 
5’- CCC TCA GTA CAT CCC 
ACC TTC C -3’ 
7  5’- TGC GGA GTC AGA GAA 
TAA TTT TGG -3’ 
5’- GGA TTG GAT CTG CCT 
CTG AGA A -3’ 
8  5’- AAC TGG AAT GCC CAG GAC 
TGA A -3’ 
5’- CGG CTT GGA CGT TCC 
AAA ATT A -3’ 
9  5’- AGG GAG CTG CAG GGA 
ACT GG -3’ 
5’- GCA CCT TTT CCC CAT ATT 
CAG TCC -3’ 
10  5’- ATT CCG AGA CCA GGC TGA 
AAC -3’ 
5’- GCT CGC ACC CCC AGT TC 
-3’ 
11  5’- TTC TGC CTT CTT GGA TGT 
TTC C -3’ 
5’- TTC TCC TCT CTG GGC TGT 
CTC C -3’ 
12  5’- CTT ACA CCT GCC ATC CCC 
AAA T -3’ 
5’- CCA TTT TGA CGG GGA 
TGG T -3’ 
13  5’- GGA GAT GGA GGG TAT GAT 
GTT GG -3’ 
5’- GAA CCC GGA ACA GAG 
AAT TTG G -3’ 
14  5’- GGT GAA TCA GCC TTG CAC 
TTG A -3’ 
5’- ATA CCC TCC ATC TCC 
CGA CCA C -3’ 
15  5’- CCT GTC TCA GAA ATG GGT 
ACA ACG -3’ 
5’- GCA GAA GAA CTT CAA 
GTG CAA GG -3’ 
16  5’- ATT GGC TCT GGG CCA CTT 
C -3’ 
5’- ATC ATC ACA GTC ATC 
GTT GTA CCC -3’ 
17  5’- CCA GTT CAT TCA GCT GGT 
CTC C -3’ 
5’- ACG GAA GTG GCC CAG 
AGC -3’ 
18  5’- CAC CTC CCT AGA GGC CTA 
CAT G -3’ 
5’- CTT CTC AGG CCC TCC 
AGC -3’ 
Table 7.21 PCR primer sequences for amplification of Hes7 promoter fragments for EMSA. 
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Fragment  Forward primer  Reverse primer 
N-box1 Mut1  5’- CCG GGA GCC TCT TGC CGG 
GGT CCT TGA G -3’ 
5’- CTC AAG GAC CCC GGC 
AAG AGG CTC CCG G -3’ 
N-box1 Mut2  5’- CTT TCC GGG AGC CAC GTG 
CCG GGG TCC -3’ 
5’- GGA CCC CGG CAC GTG 
GCT CCC GGA AAG -3’ 
N-box1 Mut1+2  5’- CTT TCC GGG AGC CAC TTG 
CCG GGG TCC TTG AG -3’ 
5’- CTC AAG GAC CCC GGC 
AAG TGG CTC CCG GAA AG -3’ 
N-box10 Mut1  5’- GGG TCG CTCA TAA GTG 
GCC CCA GCA GG -3’ 
5’- CAC CTG CTG GGG CCA 
CAT GTG AGC GAC CC -3’ 
N-box10 Mut2  5’- GGG TCG CTC ACA TGT GGC 
CCC AGC AGG TG -3’ 
5’- CAC CTG CTG GGG CCA 
CAT GTG AGC GAC CC -3’ 
Table 7.22 Primer sequences to generate mutations in N-boxes of Hes7 promoter fragments F1 and 
F10. 
 
For  EMSA  of  30  bp  oligonucleotides  from  fragment  1  (F1),  HPLC  purified 
oligonucleotides (Sigma-Aldrich; Table 7.23) were annealed in annealing buffer (10 
mM Tris/HCl pH 7.5, 1 mM EDTA, 50 mM KCl) for 15 minutes at 99ºC and cooling to 
4ºC at 0.1ºC/second. Labelling of oligonucleotide probes and binding to the Hes7
bHLH 
protein was done as above. 
 
Oligo  Forward primer  Reverse primer 
1  5’- GTT GGG TCC CGC CTT ATT 
ATA CAG CTT TAT -3’ 
5’- ATA AAG CTG TAT AAT 
AAG GCG GGA CCC AAC -3’ 
2  5’- TTA TGG TCC TTA AAC CAG 
CCT GTG GCC CCT -3’ 
5’- AGG GGC CAC AGG CTG 
GTT TAA GGA CCA TAA -3’ 
3  5’- CCC TTC CTC CCC TCA CTT 
CCC ACA TTT GGG -3’ 
5’- CCC AAA TGT GGG AAG 
TGA GGG GAG GAA GGG -3’ 
4  5’- TGG GGC TAG TTC CTC CCC 
TTC CCC TCC CCC -3’ 
5’- GGG GGA GGG GAA GGG 
GAG GAA CTA GCC CCA -3’ 
5  5’- TCC CCC TTC ACT CCC TGC 
CTT TCC GGG AGC -3’ 
5’- GCT CCC GGA AAG GCA 
GGG AGT GAA GGG GGA -3’ 
6  5’- GGG AGC CTC GTG CCG GGG 
TCC TTG AGC TGG -3’ 
5’- CCA GCT CAA GGA CCC 
CGG CAC GAG GCT CCC -3’ 
7  5’- CTG GGC ATC TAG GGG CTG 
AAG GGG GCG GGG -3’ 
5’- CCC CGC CCC CTT CAG 
CCC CTA GAT GCC CAG -3’ 
8 
5’-GGG CCG GGC CCT AGC CCT 
CCT ACC CTG CAG-3’ 
5’- CTG CAG GGT AGG AGG 
GCT AGG GCC CGG CCC -3’ 
9  5’- CAG CGG CGG GAT ATA 
AGG ATC TAG GCA GCA -3’ 
5’- TGC TGC CTA GAT CCT 
TAT ATC CCG CCG CTG -3’ 
10 
5’- GCA CGC GCT GAG TCC ACC 
GAA GGG TCC GGA GGA GCA -
3’ 
5’- TGC TCC TCC GGA CCC 
TTC GGT GGA CTC AGC GCG 
TGC -3’ 
Table 7.23 Oligonucleotide sequences of Hes7 promoter fragment F1 for EMSA. CHAPTER 7: Materials and Methods
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7.6.3  DNaseI footprinting assay 
7.6.3.1  Labelling of DNA fragments 
Hes7 promoter fragments F1 (-269 bp - +1 bp) and F10 (-2611 bp - -2318 bp) 
were subcloned into pCR-BluntII-TOPO (Invitrogen) and 10 µg of each plasmid cut 
with HindIII (New England Biolabs) overnight. Digests were run on a 1% agarose gel 
and DNA purified by QIAquick gel extraction Kit (Qiagen). Probes were labelled by 
Klenow (New England Biolabs) fill-in with 50 µCi α-
32P dATP (GE Healthcare) and 50 
µCi α-
32P dCTP for 30 minutes at room temperature. 1 µl of 10 mM dNTPs was added 
and the reaction incubated for another 15 minutes at room temperature. Unincorporated 
nucleotides were removed using Micro Bio-Spin P-30 Tris chromatography columns 
(Bio-Rad)  according  to  the  manufacturers’  guidelines.  The  DNA  was  further 
precipitated  with  ethanol  and  digested  with  EcoRV  (New  England  Biolabs).  Probes 
were purified from a 6% non-denaturating polyacrylamide gel and Cerenkov counted in 
a scintillation counter. 10,000 cpm of each probe were used per DNaseI footprinting 
reaction. 
7.6.3.2  DNaseI footprinting binding reaction 
DNaseI  footprinting  reactions  contained  30-300  ng  of  Hes7
bHLH  (1-83 
aminoacids), 10,000 cpm of 5’ radiolabelled probe in DNaseI buffer (200 mM Tris/HCl 
pH7.5, 500 mM NaCl, 30 mM MgCl2, 10 mM CaCl2, 20 mM DTT, 10 µM ZnCl2, 20% 
glycerol,  1  mg/ml  BSA,  protease  inhibitors  added  fresh)  with  2.5  ng  Poly  [d(I-C)] 
(Roche), 3 mM spermidine. After incubating at room temperature for 30 minutes, 0.25 
units  of  DNaseI  (Worthingtons)  were  added  for  5  minutes  on  ice.  Reactions  were 
stopped with stop buffer (20 mM Tris HCl pH7.5, 50 mM EDTA, 2% SDS, 0.25 mg 
linear acrylamide, 0.2 mg proteinase K) at 50ºC for 1 hour. The DNA was precipitated 
with 10 µl of 1 M LiCl and 3 volumes 96% ethanol on dry ice for 30 minutes. After 
washing with 70% ethanol the DNA was pelleted and resuspended in 6 µl of formamide 
loading buffer (95% formamide, 20 mM EDTA, 0.01% (w/v) xylene cyanol, 0.01% 
(w/v)  bromophenol  blue)  denaturated  and  run  on  a  6%  denaturating  gel  (SequaGel 
system, National Diagnostics: 4.8 ml SequaGel  concentrate, 1 ml 10xTBE, 14.2 ml 
SequaGel  diluent,  30  µl  20%  ammonium  persulfate  (Sigma-Aldrich)  and  30  µl 
N,N,N',N'-Tetramethylethylenediamine (TEMED, Sigma-Aldrich). Samples were run at 
16 mAmps in 0.5x TBE for 5 hours. Gels were transferred onto 3MM Whatman paper CHAPTER 7: Materials and Methods
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and  dried  on  a  gel  drier  at  80ºC  for  45  minutes.  The  footprint  was  visualised  by 
overnight exposure to a KODAK BioMax MS film at -80ºC. 
7.6.4  Hes7 promoter comparison 
Alignment of Hes7 promoter sequences was done using the PipMaker programme 
according to the guidelines (pipmaker.bx.psu.edu/pipmaker/pip-instr.html; (Schwartz et 
al., 2000). 
Accession  numbers  of  sequences  used  are  Mus  musculus  (mouse; 
ENSMUSG00000023781),  Rattus  norvegicus  (rat;  ENSRNOG00000007391),  Homo 
sapiens  (human;  ENSG00000179111),  Macaca  mulatta  (macaque; 
ENSMMUG00000019851), Canis lupus familiaris (dog; ENSCAFG00000016957), Bos 
taurus  (cow;  ENSBTAG00000012436),  Monodelphis  domestica  (opossum; 
ENSMODG00000007704),  Ornithorhynchus  anatinus  (platypus; 
ENSOANG00000022456), Xenopus tropicalis (frog; XB-GENE-876464). CHAPTER 8: References 
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